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Abstract 
 
Cyclic enaminones are versatile precursors for the synthesis of alkaloids and 
nitrogen-containing bioactive compounds. The development of efficient functionalization 
methods is vital to their synthetic utility. C–H functionalization is a tool to efficiently 
construct C–C bonds with high atom-economy, and to reduced waste. The work in this 
dissertation is directed towards the development of efficient and selective C–H 
functionalization methods for cyclic enaminones. 
Chapter 1 serves as an introduction to cyclic enaminone chemistry. The synthesis and 
reactivity of cyclic enaminones, including applications in total synthesis, are summarized. 
In particular, our recent developments regarding enaminone chemistry are highlighted.  
Chapter 2 surveys recent advances in Pd-catalyzed C–H functionalization at sp2 
carbons. The highlights and problems for C–H functionalization are discussed in detail. 
Chapter 3 describes a regioselective C–H arylation of cyclic enaminones with aryl 
iodides. The wide availability of aryl iodides allowed rapid access to 3-arylpiperidines.  
Chapter 4 expands the reaction scope of cyclic enaminones and presents a unique 
dehydrogenative alkenylation. This pioneering work is among the early examples of a C–
H cross-coupling reaction between alkenes. A variety of cyclic enaminones and alkenes 
were employed. A mechanistic study of the C–H palladation is also included. 
Chapter 5 focuses on the synthesis of 5-alkenyluracil scaffolds of medicinal 
importance. A practical, high-yielding dehydrogenative alkenylation method is presented. 
The generality of this new method shows a significant improvement over past syntheses. 
Chapter 6 explores the synthetic utility of alkenylated cyclic enaminones. A superior 
dehydrogenative alkenylation reaction was discovered using a biomimetic approach. A 
tandem reaction was found serendipitously that led to a novel synthesis of chalcones. 
Chapter 7 documents progress concerning the C–H trifluoromethylation of cyclic 
enaminones. Existing protocols were examined and a palladium-catalyzed protocol was 
pursued. Remarkably, it was discovered that a metal-free protocol was similarly effective. 
Our efforts have afforded practical means to functionalize cyclic enaminones. These 
protocols will undoubtedly increase the synthetic value of cyclic enaminones. 
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Chapter 1  Cyclic Enaminones 
 
Heterocyclic compounds are featured in the majority of natural products and 
pharmaceutical agents (e.g. alkaloids and antibiotics).1-4 The efficient synthesis of 
biologically active molecules under exclusive stereo- and regioselective control still 
remains a challenging goal in synthetic organic chemistry.5-8 Nitrogen-containing 
heterocycles, in particular, claim a distinctive position as historical pharmacophores and 
represent a major synthetic challenge in this field.9-13 
 
1.1 Introduction to cyclic enaminones 
Cyclic enaminones, also known as 2,3-dihydropyridin-4(1H)-ones, can be considered 
as β-acyl enamines or amides with an interpolated alkene (vinylogous amides). The 
chemical properties of cyclic enaminones are very unique. The addition of an alkene into 
an amide perfectly balances the reactivity and stability of enaminones between those of 
enamines and amides (Scheme1-1). For example, enamines are very reactive, thus 
unstable under hydrolytic and oxidative conditions,14 whereas enaminones are more 
robust and compatible under these conditions. On the other hand, amides are the most 
stable among the three, while enaminones maintain a certain degree of stability but also 
exhibit a more diverse reactivity profile (more details in Section 1.4). In addition, 
enaminones also have also been seen in pharmaceutical development, serving as 
anticonvulsants and Pgp modulators.15-19 
 
N
O
R
N
R
N
R
O
enamine enaminone amide
stability
reactivity  
Scheme 1-1. Enamine, enaminone, and amide. 
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The synthetic versatility of cyclic enaminones renders them valuable building blocks 
for a variety of highly functionalized heterocyclic natural products, e.g. piperidines, 
quinolines, quinolizidines, and indolizidines (Scheme 1-2).20-23 These heterocycles 
encompass a broad spectrum of biological and pharmacological activities.17, 18 Due to the 
ubiquity of these biologically active piperidine-containing heterocycles, practical 
methods for constructing cyclic enaminones, particularly those with stereocenters, are of 
great interest. 
 
N
O
H
N
N
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N
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3 4 5
6
OHPh
(-)-sedamine
H
H
H
(-)-pumiliotoxin C
O Me
(-)-porantheridine
O
OH
(+)-elaeokanine C  
Scheme 1-2. Scaffold transformation from cyclic enaminones. 
 
1.2 Current approaches for synthesizing cyclic enaminones 
Given the importance of cyclic enaminones in total synthesis, a number of preparative 
protocols have been developed in the past two decades.24-30 Only a few are capable of 
constructing enaminones with good stereoselectivity (Scheme 1-3). One well-established 
method is Comins’ modification of N-acylpyridinium salts 1.2 with chiral auxiliaries.31, 32 
This method has been very successful in synthesizing advanced intermediates in 
numerous natural product syntheses. Other methodologies often use open chain 
precursors. For instance, the aza-Diels-Alder reaction of Danishefsky’s diene 1.4 with 
imines is another straightforward protocol.33 Further advances in related [4+2] 
cycloaddition reactions employ Lewis or Brønsted acid catalysis, such as Yb(OTf)334 and 
HBF4,35 in organic,36 aqueous,37 and ionic liquids.38 The chiral auxiliaries attached to 
  3 
imines also enhance asymmetric control.36 Combinatorial synthesis in solid39 and liquid40 
phases supported by polymers, such as PEG, also provides efficient access to the library 
production of cyclic enaminone analogs via this cycloaddition pathway.41 In a similar 
vein, the Rovis group developed a novel [2+2+2] cycloaddition method catalyzed by Rh 
complexes.42-46 This protocol offers an efficient approach to bicyclic enaminones (i.e. 
indolizidinones 1.9) with very good enantioselectivity. In another approach, Dallemagne 
and co-workers converted chiral β-aryl-β-amino acids 1.10 to δ-aryl-δ-amino-β-
ketoketones 1.11 followed by intramolecular cyclization which furnishes enantiopure 
cyclic enaminones 1.12 in high yields.47  
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Scheme 1-3. Well-established protocols to construct nonracemic cyclic enaminones. 
 
Recently, more flexible and novel procedures have emerged (Scheme 1-4). Svetlik’s 
[4+1+1] strategy via cyclocondensation of methyl 3,5-dioxohexanoate (1.13) with aryl 
aldehydes 1.14 in the presence of ammonium acetate is a simple, efficient and 
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diastereoselective method.48 In addition, Dong and co-workers discovered a novel 
[5C+1N] annulation process that combined readily available α-alkynoyl ketene-(S,S)-
acetals (1.16) and aliphatic primary amines in one step to provide functionalized 
mono/bicyclic enaminones.49 Last, but not least, our group successfully devised two 
remarkably concise methods to directly access asymmetric mono/bicyclic enaminones 
from the widely available chiral amino acid pool. Our first protocol uses β-amino acids 
1.19 to afford ynones 1.20, which undergo a seemingly 6-endo-dig cyclization to furnish 
enaminones in high yields.50, 51 Our second approach applies even more readily accessible 
α-amino acids 1.22.52 A one-pot transformation yields diazoketones 1.23 and a following 
Wolff rearrangement quickly constructs the cyclic enaminone scaffold in excellent yields.  
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Scheme 1-4. Novel approaches to construct cyclic enaminones. 
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1.3 Cyclic enaminones in total synthesis 
With all these preparative methods available, cyclic enaminones have been 
increasingly employed in total synthesis of heterocyclic natural products.17, 53 For 
example, the tetracyclic tetrahydro-β-carboline framework 1.27 of the ajmaline/sarpagine 
alkaloids can be easily assembled using simple indole derivative 1.25 through two major 
steps (i.e. aza-Diels-Alder and intramolecular Heck cyclization) (Scheme 1-5, top).54 
More recently, Comins reported the first asymmetric synthesis of (+)-cannabisativine 
(1.29) in 19 steps with a high degree of stereocontrol (Scheme 1-5, middle).32  
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Scheme 1-5. Total synthesis examples involving cyclic enaminones. 
 
Our group has been particularly interested in indolizidine alkaloids, which are 
prevalent in nature and exhibit a variety of biological properties.55-58 Hence, their 
medicinal importance led us to prepare a series of phenanthropiperidine derivatives. For 
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example, in eight short steps, both (+)-antofine (1.32) and (+)-ipalbidine (1.33) were 
derived from simple Boc-L-proline (1.30) with up to 96% ee (Scheme 1-5, bottom).59 
Cyclic enaminone 1.31 was a key intermediate, which set the stage for subsequent C–H 
arylation and phenanthrene scaffold construction. Notably, (+)-antofine has shown potent 
antiproliferative activity on the nanomolar scale against COLO-205, MCF-7, and drug-
resistant NCI/ADR-RES cell lines.60 More alkaloids derived from cyclic enaminones in 
the past 5 years are summarized in Scheme 1-6, which clearly demonstrates the synthetic 
value of cyclic enaminones.59, 61-66 
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Scheme 1-6. Selected alkaloids derived from cyclic enaminones since 2008. 
 
1.4 Versatility of cyclic enaminones 
The wide applicability of cyclic enaminones in alkaloid synthesis is derived from 
their versatile reactivity in addition to the broad scope of their preparative methods. 
Indeed, the scaffold of cyclic enaminones is a functionality-dense six-membered ring, 
where amine, enamine, enone, and alkene moieties are all embedded. The combination of 
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enamine’s nucleophilicity and enone’s electrophilicity as a result permits a plethora of 
transformations of considerable value (Figure 1-1).67, 68  
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Figure 1-1. The chemical versatility of cyclic enaminones. 
 
As an electrophile, due to the enone character, conventional 1,2-additions at the C4 
position41 and 1,4-additions at the C6 position32 are both tolerated, which potentially 
serves as a means for annulation.69, 70 As an nucleophile, enolate chemistry can be 
accomplished at the C3 position.71 N- and O-functionalization are feasible as well.72 A 
new functionalizing method developed in Comins’ group involves the tandem C6,C5-
directed lithiation, which allows the attachment of various substituents to both the C5 and 
C6 positions sequentially.73 In addition, cycloaddition was also achieved on cyclic 
enaminones. An intramolecular [2+2] process generates a tricyclic scaffold,74 which was 
used toward the synthesis of spirolucidine.75 Moreover, the C2 position can be utilized as 
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a handle to exert steric influence. Thus, the aforementioned manipulations can be greatly 
enhanced with stereoselectivity. 
Most interestingly, cyclic enaminones possess a strong nucleophilicity at the C5 
position. This unique nucleophilicity stems from both the electron-withdrawing feature of 
the enone moiety and the electron-donating feature of the enamine moiety. Hence, the 
polarized double bond in this non-aromatic ring structure displays a similar high 
reactivity towards electrophilic substitution as an aromatic compound. Halogenation at 
the C5 position is therefore a facile process. Comins76 and Kunz77 both have shown that 
the iodinated enaminones can undergo Pd-catalyzed cross-coupling reactions. Our group 
later reported that under microwave conditions a Suzuki-Miyaura coupling could easily 
take place to afford the arylated enaminones in excellent yields (Scheme 1-7).78 
 
NR1
R2
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Pd(PPh3)4
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R3
Ar
1.34 1.35 1.36  
Scheme 1-7. Two-step arylation of cyclic enaminones. 
 
1.5 C–H functionalization of cyclic enaminones in the Georg group 
Given the intrinsic nucleophilicity of cyclic enaminones and the electrophilicity of 
cationic transition metal catalysts, these complementary properties inspired us to design a 
one-step process to arylate non-preactivated cyclic enaminones. This proposed arylation 
was first found by Ge and Niphakis using aryl trifluoroborates as the coupling partners 
(Scheme 1-8, top).79 A series of electron-rich, mono- and bi-cyclic enaminones were 
arylated in this one-step process with excellent yields. It is worth noting that this new 
protocol prompted our efforts on extensive development of C–H functionalization of 
cyclic enaminones.  
In order to expand the substrate scope, we continued to evaluate other aryl sources of 
more availability and less cost. A Hiyama-like protocol was therefore developed by Bi 
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using aryl triethoxysilanes (Scheme 1-8, middle).80 Interestingly, CuF2 served as a 
fluoride source to activate the silane and also as the reoxidant to convert Pd0 to PdII. In 
2012, Kim successfully applied aryl boronic acids as aryl coupling partners (Scheme 1-8, 
bottom).81 A mixture of two CuII additives was found to be crucial for respectively 
assisting Pd0 reoxidation and transmetalation through a putative [Ar–Cu] intermediate. 
Remarkably, both electron-rich and electron-poor aryl boronic acids were compatible 
with high yields. This is a significant improvement over the two previous methods that 
exhibited a strong preference for electron-rich aryl precursors.  
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Scheme 1-8. Development of C–H arylation of cyclic enaminones. 
 
The efficiency of these transformations via Pd catalysis have proven that cyclic 
enaminones are promising substrates for the ever-emerging C–H functionalization 
reactions. This new reactivity is an exciting addition to the already ample versatility of 
enaminones’. Further development in this regard will undoubtedly offer quick access to 
more highly functionalized enaminone derivatives for total synthesis and medicinal 
chemistry. 
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Chapter 2  Palladium-Catalyzed C–H Functionalization 
 
C–C bond construction is the center of organic synthesis. Traditional transition metal-
catalyzed C–C bond formation by cross-coupling reactions is a powerful method in 
synthetic applications.82 These methods usually require stoichiometric amounts of pre-
made nucleophilic organometallic reagents, represented as a C–M bond, as well as the 
pre-activation of precursors by halogenation or triflation, where the C–halide/triflate 
bond is represented as a C–X bond (Figure 2-1, left). However, there are many 
drawbacks of this “C–M/C–X” coupling strategy. (1) The preparation of both precursors 
is often a multi-step process, which is time-consuming and economically inefficient. (2) 
A stoichiometric amount of undesired metallic salts (MX) are generated as waste, which 
is environmentally hazardous. The need to improve efficiency and reduce hazardous 
waste has driven chemists to explore new catalytic reactions. One attractive solution to 
these problems is to treat C–H bonds as functional groups for direct transformations.83-86 
This strategy obviates the need for stoichiometric amounts of organometallic 
components, and the byproducts will be relatively more environmentally benign acids 
(HX) (Figure 2-1, right). On the other hand, C–H bonds are overall inert, rendering the 
direct utilization of C–H bonds very challenging. In addition, the ubiquity of C–H bonds 
in organic molecules introduces another fundamental obstacle—selectivity. Nevertheless, 
C–H functionalization chemistry has made tremendous progress in the past decade and it 
remains an area full of challenges and opportunities in the practice of organic synthesis.87-
93   
 
C C
C C
C CC H
Traditional Functionalization C–H Functionalization
X
CX
M
CX
MX
HX
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Figure 2-1. Traditional functionalization and C–H functionalization.87 
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2.1 “Innate” C–H functionalization and “guided” C–H functionalization 
A multitude of research have addressed the inertness problem of C–H bonds for direct 
functionalization. Transition metals have been proven to react with C–H bonds to 
generate C–M bonds via “C–H activation”.84-87, 94-98 The resulting C–M bonds are much 
more reactive, and can be transformed to a variety of functional groups under mild 
conditions. 
Selective activation of one specific C–H bond in a complex molecule is another key 
challenge associated with C–H functionalization. To date, two distinctive strategies have 
been developed to meet this challenge.99 The most common strategy is to employ external 
reagents or directing groups to achieve specifically targeted C–H functionalization.89, 91, 
100, 101 This “guided” approach usually relies on coordination of heteroatoms to transition 
metals and selectively delivers the catalyst to the desired, proximal C–H bond. Nitrogen-
containing groups, such as pyridinyl, have played an important role in the control of 
regioselectivity.102, 103 Oxygen-containing groups, such as carboxylate, were also 
employed frequently in synthesis recently.104, 105 Another powerful strategy is to solely 
capitalize on the intrinsic electronic nature of substrates without the presence of other 
directing forces.79, 106 This “innate” approach is mostly applicable to the realm of 
heterocycles as heteroatoms easily induce electronic bias.107  
It is worth noting that these two strategies are not superior but complementary to each 
other. The targeted molecule often dictates which strategy to be employed and in many 
cases a rational usage of both strategies can be very effective.  
 
2.2 C–H functionalization via Pd catalysis 
In the new millennium, the direct transformation of C–H bonds to C–C bonds has 
received much attention and significant progress has been made. Pd-catalyzed C–H 
functionalization has proven to be particularly effective.91, 101, 108-112 It is the most widely 
studied reaction for many reasons: (1) Pd catalysts can install many types of bonds, 
including C–C, C–O, C–N, C–X, C–S bonds. Few other transition metal catalysts have 
shown such versatility. (2) Pd catalysts are compatible with many oxidants. (3) 
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Cyclopalladated intermediates can be selectively functionalized. (4) A variety of 
directing groups can bind with Pd catalysts. (5) A majority of Pd-catalyzed C–H 
functionalization reactions can be conducted in the presence of air and moisture. All these 
features set Pd apart from other transition metals in catalyzing C–H functionalization. In 
this regard, the current chapter will mainly focus on Pd-catalyzed C–C bond construction 
via C–H activation. 
 
2.3 Plausible mechanisms for C–H activation 
Pd-catalyzed C–H activation has been proposed to proceed through five distinct 
mechanisms (Figure 2-2): (1) Electrophilic palladation (SEAr),113-117 (2) a concerted SE3 
process,118 (3) σ-bond metathesis,114, 119, 120 (4) Heck carbopalladation,114-117, 121, 122 (5) C–
H oxidative addition.119, 123  
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Figure 2-2. Plausible modes of C–H activation. 
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It should be noted that the exact mechanism for any given process depends largely on 
the nature of the substrates, Pd catalysts, additives, solvents, and ligands involved. 
Historically, SEAr reactions, Heck processes, and C–H oxidative addition are favored in 
most cases. The SEAr mechanism, however, has fundamental limitations, because not all 
the aromatics are sufficiently nucleophilic. Very recently, a number of experimental and 
computational studies supported the “concerted-metalation-deprotonation” (CMD) 
processes, involving a SE3 process or σ-bond metathesis.124-130 The key in these processes 
is the reactivity/acidity of the proton activated by the electron-withdrawing substituents. 
Hence, the C–H acidity could be used as a new parameter for tuning reactivity and 
regioselectivity, which offers an entirely different approach for designing C–H 
functionalization experiments.  
 
2.4 Generic approaches for C–H functionalization  
Over the course of the development of C–H functionalization chemistry, chemists 
have been striving to replace either C–M or C–X (or both) with C–H to improve the 
efficiency of cross coupling. Overall, there are three strategic routes to functionalize C–H 
bonds (Figure 2-3).   
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Figure 2-3. Three synthetic paths for C–H functionalization.  
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The most studied scenario involves direct C–H functionalization with organic 
halides/pseudohalides (Figure 2-3, Path A).100, 109, 131, 132 As depicted in Figure 2-4, 
oxidative addition of organic halides/pseudohalides onto Pd0 species initiates the 
catalysis. Next, one of the aforementioned mechanisms (Figure 2-2) can account for the 
subsequent C–H activation process, followed by reductive elimination to afford the 
coupling product and regenerate the Pd0 catalyst. Variables such as ligands, bases, polar 
solvents, and high temperatures are critical in enabling these coupling reactions. Because 
hydrocarbons (C–H) are nucleophiles and organic halides/pseudohalides (C–X) are 
electrophiles, their coupling mechanism is a Pd0/II cycle, where no reoxidation is needed. 
 
Pd0Ln
R–X
PdIILn
X
R
PdIILn
R'
R
R–R'
R'–HHX  
Figure 2-4. Generic mechanism of C–H functionalization with organic (pseudo)halides. 
 
Recently, the cross-coupling reactions between hydrocarbons (C–H) and 
organometallic reagents (C–M) have started to gain more attention (Figure 2-3, Path 
B).132-134 As the two coupling partners are both nucleophiles, these transformations 
apparently undergo a different process. Shown as a generic mechanism (Figure 2-5), C–H 
activation takes place first to generate the R–PdII species. Transmetallation delivers the 
R’ group onto the Pd center, followed by reductive elimination to furnish the coupling 
product, as well as the reduced Pd0 species. To complete the catalytic cycle, oxidants are 
needed to reoxidize Pd0 to PdII. Such a process is a PdII/0 cycle, defined as an oxidative 
cross-coupling. The challenges associated with this method are: (1) the homo-coupling of 
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organometallic reagents; (2) the incompatibility of the initial C–H activation and the 
following transmetallation; and (3) the instability of organometallic reagents under C–H 
activation conditions. Among the available organometallic reagents, Grignard reagents 
(organomagnesium), organolithium, organoaluminum, and organozinc reagents are 
highly reactive and therefore very unstable, which makes them hardly useful under C–H 
activation conditions. On the other hand, organoboron, organosilicon, and organotin 
reagents are superior candidates for C–H functionalization purposes.133, 134 
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Figure 2-5. Generic mechanism of C–H functionalization with organometallic reagents. 
 
Under the current trend of green chemistry, the best scenario to form a C–C bond is 
the coupling between two C–H bonds (Figure 2-3, Path C). This transformation is the 
most environmentally benign one in terms of ideal atom economy and minimal waste. 
Similar to Path B (in Figure 2-3), this coupling strategy also employs two nucleophiles 
and thus reoxidation is needed. However, this process is often extremely challenging and 
problematic with respect to regioselectivity. Mechanistically (Figure 2-6), the most 
difficult step is the second C–H activation (i.e. R’–H), because conditions must be found 
whereby the second C–H activation proceeds with complete reversal of chemoselectivity 
against the first C–H activation (i.e. R–H). This obstacle seems formidable at first glance 
because the competing homocoupling would be the most reasonable yet undesired 
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outcome. Fortunately, innovative solutions to this issue have been discovered. In recent 
years, there have been ever-increasing reports about these types of coupling reactions.92, 
133, 135-139 Overall, double C–H functionalization still remains much underdeveloped.  
 
PdIIX2
R'–H
PdII
X
R
PdII
R'
R
HX
Pd0
R–H
HX
R–R'
[Ox]
 
Figure 2-6. Generic mechanism of C–H functionalization with hydrocarbons. 
 
In the following a brief review is provided that covers the most important advances of 
modern C–H functionalization chemistry, by highlighting the various coupling strategies. 
Given our goal to functionalize the C(sp2)–H bond at the C5 position of 2,3-
dihydropyridin-4(1H)-ones, the following review will be focusing on C(sp2)–H 
functionalization. 
 
2.5 Couplings between C(sp2)–H and C–X 
To date, numerous research efforts have been devoted to the coupling between 
nucleophiles (C–H) and electrophiles (C–X). Therefore, it is judicious to divide this 
section into four parts: C–H alkynylation, alkenylation, arylation, and alkylation.  
 
2.5.1 C–H alkynylation with alkynyl (pseudo)halides – “Inverse Sonogashira”  
Sonogashira cross-coupling reactions have been extremely valuable for preparing 
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functionalized (hetero)aryl alkynes, which are widely used in modern organic synthesis 
and material science.140-142 The traditional version is a reaction between an aryl (or 
alkenyl) halide and a terminal alkyne. Recently, a complementary strategy was devised, 
namely an “inverse Sonogashira” coupling, which entails the direct C–H alkynylation of 
unactivated (hetero)arenes with readily available alkynyl halides.143 
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Scheme 2-1. “Inverse Sonogashira” reactions of heteroarenes. 
 
The first example of this new alkynylation was developed on sydnones 2.1 in 1992 
(Scheme 2-1, top).144 This Pd0-catalyzed protocol reported by Kalinin required a 
stoichiometric amount of CuI to form an organocopper intermediate for transmetallation. 
After that, the development of this coupling reaction almost halted until 2007, when 
Gevorgyan and co-workers reported a versatile protocol for the alkynylation of N-
heteroarenes (Scheme 2-1, middle).145 A series of electron-rich heterocycles 2.4 coupled 
with alkynyl bromides in high yields and regioselectivity. The authors showed that an 
alkynyl–Pd species, generated from the oxidative addition of Pd0 into the alkynyl–Br 
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bond, was the key intermediate that enabled the installation of the alkynyl groups onto N-
heterocycles by electrophilic substitution. Later, Gu reported a similar method to 
regioselectively alkynylate indoles at the C3-position with a wide range of substituted 
alkynyl bromides (Scheme 2-1, bottom).146 The same electrophilic mechanism was 
proposed for this reaction as well.  
In 2009, Chatani and co-workers reported the first Pd-catalyzed C–H alkynylation of 
anilides 2.10 (Scheme 2-2, top).147 Directed by an acetamido group, ortho-alkynylation 
furnished a variety of aryl alkynes in good yields and excellent regioselectivity. Very 
recently, Chen applied the same strategy to directly alkynylate benzylamine 
picolinamides 2.13 (Scheme 2-2, bottom).148 The picolinamide group-directed process 
attained excellent ortho-selectivity, and both electron-rich and electron-poor arenes 
afforded similar high yields.  
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Scheme 2-2. “Inverse Sonogashira” reactions of benzenes. 
 
2.5.2 C–H alkenylation with alkenyl (pseudo)halides – “Inverse Heck”  
The Heck reaction was first introduced in 1971.149 The reactants of Heck reactions 
typically involve an unsaturated (pseudo)halide and an alkene. As the traditional Heck 
reactions do not involve organometallic coupling partners, they hence possess better atom 
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economy compared to other related reactions, such as Suzuki, Negishi, and Still 
reactions. Due to the wide availability of substrates, the Heck reaction soon became one 
of the most useful coupling reactions in organic synthesis.150-153 
Complementary to this approach is the “inverse Heck” reaction, which couples 
unfunctionalized arenes with alkenyl halides. This strategy expanded the substrate scope 
and provided alternative routes to alkenyl arenes.  However, this approach has received 
much less attention.154-160 
In 2005, Daugulis first reported a C–H alkenylation of anilides with haloolefines 2.16 
(Scheme 2-3, top).154 The authors proposed a C–H palladation/migratory alkenylation 
mechanism, which implied the feasibility of β-halide elimination, instead of β-H 
elimination, as the terminating step to regenerate the Pd catalyst. This acetamido group-
directed coupling reaction afforded excellent ortho-selectivity and tolerated more 
functional groups compared to the traditional Heck reaction. Recently, Chen and co-
workers employed a similar strategy to directly alkenylate benzylamine 2.13 (Scheme 2-
3, bottom).148 A broad scope of benzylamine picolinamides 2.13 and vinyl iodides was 
shown to be compatible with the Pd-catalyzed conditions and provided the reaction 
products in excellent regioselectivity and good to excellent yields.  
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Scheme 2-3. “Inverse Heck” reactions of benzenes. 
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Scheme 2-4. “Inverse Heck” reactions of heteroarenes. 
 
The “inverse Heck” reaction is also applicable to heteroarenes in the absence of 
directing groups. Berteina-Raboin and co-workers devised a Pd-catalyzed regioselective 
C–H alkenylation of imidazol[1,2-a]pyridines 2.20 under microwave conditions (Scheme 
2-4, top).160 The innate nucleophilicity of 2.20 enhanced the C3-regioselectivity. 
Different from the proposed mechanism for arenes with directing groups, Berteina-
Raboin proposed a discrete route following an oxidative addition/electrophilic 
palladation/reductive elimination sequence. Later, Doucet extended the scope of 
heteroarenes to electron-rich benzoxazole and benzothiazole derivatives 2.23 (Scheme 2-
4, bottom).155 A set of alkenylated heteroarenes 2.25, which was difficult to prepare 
before, was obtained in moderate yields, demonstrating the advantage of this coupling 
reaction. Similarly, Hoarau later reported that oxazoles were also suitable substrates for 
direct alkenylation.157 
 
2.5.3 C–H arylation with aryl (pseudo)halides  
Direct arylation with aryl (pseudo)halides is arguably the most studied C–H 
functionalization reaction. One reason is the importance of biaryl structural motifs in 
various natural products and pharmaceutical molecules.82, 132, 161-163 Traditional arylation 
reactions have significant value for cross-coupling reactions, such as high regioselectivity 
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and reactivity, albeit with some drawbacks such as low atom-economy and poor substrate 
availability. Direct arylation with accessible and inexpensive aryl (pseudo)halides could 
overcome these disadvantages while retaining the desirable feature of high 
regioselectivity. 
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Scheme 2-5. Early examples of C–H arylation with aryl halides.  
 
The early discovery of the direct arylation with aryl halides was made 
serendipitously. In 1982, Ames observed an intramolecular direct arylation product 2.27 
when studying a Heck reaction with ethyl acrylate (Scheme 2-5, top).164 Soon after, an 
intermolecular direct arylation with iodobenzene was observed on isoxazole 2.28 by 
Tajima and co-workers (Scheme 2-5, middle).165 In 1997, Miura devised the first protocol 
of directing group-assisted regioselective intermolecular C–H arylation of 2-
phenylphenol (2.31) with aryl iodides (Scheme 2-5, bottom).166 These early 
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developments paved the road for the subsequent explorations of this valuable coupling 
strategy. Given the enormous amount of reports on this particular topic versus the limited 
space for this dissertation, the current section will only highlight the recent advance in 
direct arylation involving challenging substrates and novel mechanistic strategies. 
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Figure 2-7. Proposed CMD mechanism with pivalic acid as a proton shuttle. 
 
One major breakthrough in this field was the discovery of the concerted metalation–
deprotonation (CMD) mechanism. Echavarren and co-workers first conducted a series of 
well-designed intramolecular competition experiments, which showed that the less 
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nucleophilic, thus more C–H acidic, fluorinated arenes were better substrates for direct 
arylation.167-170 Meanwhile, Fagnou observed that electron-poor heteroarenes (e.g. 
pyridine N-oxide) underwent C2-regioselective direct arylation with aryl bromides.171 
Intermolecular competition experiments showed again that the less nucleophilic, thus 
more C–H acidic, heteroarenes were more reactive. In addition, the intermolecular kinetic 
isotope effect (KIE) was observed at 4.7 (i.e. primary KIE), which does not support an 
SEAr mechanism.171 Further experimental and computational studies indicated that the 
pivalate anion was a crucial component in the C–H cleavage, acting as a proton shuttle 
and lowering the transition state energy of C–H cleavage (Figure 2-7).124, 126 In many 
cases, a direct correlation was found between the acidity of aromatic C–H bonds and the 
regioselectivity of the direct arylation.126, 129 Electron-withdrawing substituents would 
increase the C–H acidity, thus activating those C–H bonds in the CMD process. Hence, 
the regioselectivity for direct arylation of (hetero)arenes, especially electron-deficient 
ones, could be predicted by the C–H acidities.126, 129  
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Scheme 2-6. Directed and non-directed C–H arylation of arenes. 
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The application of chelation control (i.e. directing groups) has also enabled 
intermolecular direct arylation of arenes with excellent ortho-selectivity. Following their 
original work,166 Miura and co-workers continued to develop protocols for a variety of 
carbonyl directing groups, such as ketones, amides, and aldehydes (Scheme 2-6, top).172, 
173 Aryl bromides and triflates were used as good arylating reagents. Later, Daugulis 
expanded the scope of aryl halides to aryl iodides (Scheme 2-6, middle).174 More 
substrates with other directing groups (e.g. acetamido, carboxylate, pyridine, etc.) were 
regioselectively functionalized with aryl iodides.175-177 On the other hand, direct arylation 
of arenes without directing groups have been very rare. Fagnou and co-workers 
successfully arylated unactivated simple benzene through a CMD process with aryl 
bromides (Scheme 2-6, bottom).124 Remarkably, this protocol furnished only mono-
arylated benzenes 2.41.  
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Scheme 2-7. Innate C–H arylation of heteroarenes with aryl halides. 
 
Direct arylations of heteroarenes with aryl (pseudo)halides have also experienced fast 
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development. Indoles are arguably the most abundant heteroarene moieties in natural 
products.178, 179 A significant amount of research has been carried out to functionalize this 
electron-rich heterocycle.180 The direct arylation of indoles can take place at either the C2 
or C3 positions. Sames and co-workers reported a ligand-free protocol for the direct C2-
arylation of indoles (Scheme 2-7, top),181 while later Zhang182 and Bellina,183 
respectively, devised an efficient protocol for the regioselective C3-arylation of indoles 
(Scheme 2-7, middle). Many other heteroarenes (e.g. thiophenes,184 azoles,185 
indolizines,116 etc.) were all found to be good substrates for regioselective direct arylation 
without the assistance of directing groups. For example, Hocek and co-workers 
developed the first direct arylation of unprotected purine nucleosides 2.48, thereby 
offering quick access to a variety of arylated adenine nucleosides 2.50 (Scheme 2-7, 
bottom).186 
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Scheme 2-8. Norbornene-mediated direct arylation. 
 
Another elegant strategy for direct arylation is the use of strained norbornene 2.52 as 
a removable external directing group for sequential C–H functionalization.187 Norbornene 
(2.52) forms palladacycle 2.54, which directs the subsequent arylation and termination 
coupling selectively (Scheme 2-8). The installation of the R1 group has two purposes: (1) 
Regioselectivity can be controlled at the other ortho-position; (2) The steric encumbrance 
in 2.55 exerted by the R1 and Ar groups can facilitate the expulsion of norbornene. As 
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shown in Scheme 2-8, a Heck reaction can intercept the Pd species 2.56 in the end. The 
intermediate 2.56 can also be employed in other traditional coupling reactions to 
construct C–H, C–C, C–N, and C–O bonds.187 
This novel concept has been used to quickly assemble complex molecules.188 For 
example, Lautens applied this strategy to prepare a series of polycyclic 2H-indazoles 
such as 2.60 (Scheme 2-9, top).189 Key features include one-pot procedures, high 
tolerance of functional groups, and readily available starting materials. Similarly, via a 
direct arylation/amination sequence, two C–C/C–N bonds were constructed 
regioselectively to form 2.63 in moderate yield (Scheme 2-9, bottom).190 
 
N
N
Br
F3C
I
H
+
NN
F3C
Pd(OAc)2 (10 mol%)
(2-furyl)3P (22 mol%)
norbornene (2 equiv)
Cs2CO3 (2 equiv)
MeCN, 90 ºC, 24 h
2.60
96%
Lautens group
O
NH2
I
H
Br
+
Pd(OAc)2 (10 mol%)
(m-ClPh)3P (22 mol%)
norbornene (2 equiv)
K2CO3 (6 equiv)
MeCN, 135 ºC, 18 h
NH
O
2.63
50%
NO2
NO2
2.58 2.59
2.61 2.62
 
Scheme 2-9. Synthesis of polycycles via norbornene-mediated direct arylation. 
 
Of all aryl (pseudo)halides, the chlorides are potentially the most accessible 
electrophiles due to their low cost and broad commercial availability. However, aryl 
chlorides have been very difficult to use for direct arylation. Until recently, examples of 
intermolecular direct arylation with aryl chlorides have been scarce.191, 192 In 2006, 
Fagnou reported two examples of intermolecular direct arylation of 1,3-benzodioxole 
(2.64) using aryl chlorides (Scheme 2-10, top).193 Later Daugulis disclosed a protocol for 
direct arylation of benzoic acids with aryl chlorides (Scheme 2-10, bottom).194 Benzoic 
acids of any electronic nature can be employed in this reaction.  
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Scheme 2-10. Early examples of direct arylation with aryl chlorides. 
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Scheme 2-11. Direct arylation of electron-deficient (hetero)arenes with aryl chlorides. 
 
More recently, more electron-rich (hetero)arenes were also used for the direct 
arylation with aryl chlorides, such as benzoxazols,195 thiazoles,195 furans,196 triazoles,197 
etc. Examples of electron-poor (hetero)arenes, albeit scarce, have also gained more 
attention. For example, diazine N-oxides 2.70 were regioselectively coupled with aryl 
chlorides in good yields via a CMD mechanism (Scheme 2-11, top).198 These inexpensive 
and readily available substrates are good replacements for problematic diazine 
organometallic precursors for coupling reactions. In addition, mild and general protocols 
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were also established with aryl chlorides to functionalize perfluoroarenes (2.73, Scheme 
2-11, bottom), a class of important structures particularly in material chemistry.199, 200 
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Scheme 2-12. Direct arylation using aryl pseudohalides. 
 
Lately, other arylating electrophiles (pseudohalides) are emerging as good alternative 
aryl sources. Particularly, compared to aryl triflates,201-203 aryl tosylates and mesylates are 
highly desirable, because they are stable towards hydrolysis and highly crystalline, thus 
easy to handle. These electrophiles can be prepared easily from inexpensive and readily 
available phenol derivatives. However, their good stability results in reduced reactivity 
towards coupling reactions. The development of these reagents for C–H functionalization 
has just begun to burgeon.204-210 Ackermann and co-workers reported the first protocol 
using aryl tosylates in the C–H arylation of heteroarenes 2.76 in 2009 (Scheme 2-12, 
top).209 Later, the protocol was modified for electron-poor heteroarenes 2.79 to provide 
excellent regioselectivity and high yields (Scheme 2-12, bottom).208 The reaction 
conditions were also found to be applicable to reactions with aryl mesylates, which are 
more atom-economical than the tosylates. Very recently, aryl tosylates have also been 
effectively applied to the direct arylation of perfluoroarenes,205, 207 as well as the 
intramolecular C–H arylation of simple arenes to construct a variety of heterocycles.211 
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2.5.4 C–H alkylation with alkyl (pseudo)halides 
Conventional Pd-catalyzed alkylation requires the use of stoichiometrically 
metallated substrates and alkyl halides.212-215 Its inherently low atom-economy and poor 
efficiency has motivated organic chemists to explore other coupling options, including 
direct C–H alkylation. However, a tremendous challenge associated with using alkyl 
(pseudo)halides is to eliminate the competing β-H elimination when β-hydrogens are 
present in the alkyl group. Contrary to the well developed use of aryl (pseudo)halides, the 
application of alkyl (pseudo)halides for intermolecular C–H alkylation is still in its 
infancy.216-219  
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Scheme 2-13. Direct alkylation of heteroarenes using alkyl (pseudo)halides. 
 
In recent years, remarkable progress has been made. Hoarau and co-workers reported 
the first intermolecular direct alkylation of heteroarenes in 2009.157 The conditions they 
developed for the direct alkenylation of oxazoles 2.81 were also applicable for the direct 
alkylation and benzylation (Scheme 2-13, top), provided that the alkyl halides were in 
excess. Shortly thereafter, Fagnou significantly expanded the scope of heteroarenes for 
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direct benzylation (Scheme 2-13, middle).220 A wide range of previously incompatible 
heterocycles, including thiazole, thiophene, 1,2,3-triazole, oxazole, furan, indolizidine, 
and imidazopyrimidine, were shown to regioselectively couple with benzyl chloride in 
excellent yields. Recently, Ackermann applied user-friendly benzyl phosphate 2.87 to 
replace the conventional benzyl halides as benzylating reagents (Scheme 2-13, 
bottom).221 Similarly, Miura also demonstrated that benzyl carbonates can be used as 
electrophiles for the direct benzylation of azoles.222  
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Scheme 2-14. Direct alkylation of arenes using alkyl halides. 
 
Meanwhile, Tremont and co-workers first showed that C–H alkylation of acetanilide 
(2.89) could be achieved with methyl iodide, albeit in a low turnover number (1.5–1.8) 
(Scheme 2-14, top).223 The mechanism was proposed to proceed through a PdII/PdIV 
cycle. However, the addition of excess AgOAc to regenerate more electrophilic Pd(OAc) 
catalyst significantly increased the TON to 10. In 2010, Yu devised a similar alkylation 
protocol for benzoic acids with 1,2-dichloroethane or dibromomethane to form 
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benzolactones 2.93 (Scheme 2-14, middle).219 A mechanistic study showed that the initial 
reaction was an intermolecular ortho-C–H alkylation directed by the carboxylate group, 
which was followed by an intramolecular SN2 cyclization. In contrast, Yu’s protocol did 
not require Ag salts to regenerate the Pd catalyst. Unfortunately, monochloropentane 
(without the subsequent SN2 cyclization) only furnished 26% of the desired ortho-
alkylated product. In this regard, Daugulis developed a more applicable alkylation 
protocol between arenes and primary alkyl halides (Scheme 2-14, bottom).224 Their 
auxiliary-assisted new protocol was also applicable for direct arylations with aryl halides.  
 
Wang group
N
N
O
O
R
O
R
O
H
+
Pd(OAc)2 (10 mol%)
PPh3 (20 mol%)
Cs2CO3, o-xylene
130 ºC, 6 h
X Alk
N
N
O
O
R
O
R
O
AlkX = Br, I
2.98
22–55%
Fu group
N
O
+
Pd(OAc)2dppf (5 mol%)
Cs2CO3 (2 equiv)
toluene, 100 ºC, 12 h
N
O
H
2.101
26–88%
R1 R1
Br
2.97
2.99 2.100
 
Scheme 2-15. New development in direct alkylations. 
 
Most studies with arenes that have used primary alkyl electrophiles have achieved 
excellent ortho-selectivity thanks to the directing group effect. More recently, Wang and 
co-workers have shown that meta-selective C–H alkylation is also achievable (Scheme 2-
15, top).225 The electron-poor perylene bisimides 2.97 underwent C–H alkylation with 
open-chain alkyl halides in moderate yields but excellent regioselectivity. The authors 
proposed a CMD mechanism to account for the meta-selectivity. In regard to the 
difficulty of using secondary alkyl halides, one reason is that the Pd-catalyzed SN2 
process is sensitive to the steric bulk of the substrate. In 2013, Fu and co-workers 
demonstrated a remarkable protocol for direct alkylation using secondary and even 
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tertiary alkyl bromides 2.100 (Scheme 2-15, bottom).226 Pyridine N-oxides were alkylated 
with high yields and excellent regioselectivity. Surprisingly, primary alkyl bromides were 
less reactive. A mechanistic study suggested a radical-type process for the C–Br bond 
cleavage, which may offer more opportunities for employing secondary and tertiary 
aliphatic electrophiles in Pd catalysis. 
  
2.6 Couplings between C(sp2)–H and C–M 
Compared to the abundance of C–H functionalization protocols using 
(pseudo)halides, the application of organometallic reagents has just begun to be 
explored.134 In addition to controlling regioselectivity, suppressing homo-coupling of 
organometallic reagents is another key matter. Due to the difference between 
organometallic reagents, the progress in this area will be highlighted accordingly. 
(Because the couplings between alkenes and organometallic reagents are known as 
oxidative Heck reactions,151 these couplings are not technically C–H functionalization 
reactions. In that regard, the corresponding research will not be outlined in this thesis.)  
 
2.6.1 Organoboron reagents 
Suzuki-Miyaura reactions with organoboron reagents have been a powerful and 
convenient tool to build C–C bonds.227-232 The wide applications of organoboron reagents 
in organic synthesis can be attributed to their nontoxicity, availability, stability, and ease 
of handling. Besides boronic acids, organoboron reagents also exist in other forms 
(Scheme 2-16), such as boronic esters, boroxines, and trifluoroborate salts, all of which 
have shown great reactivity in many cross-coupling reactions.233-238  
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Scheme 2-16. Common forms of organoboron reagents. 
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Scheme 2-17. “Guided” C–H functionalization using organoboron reagents in Yu’s lab. 
 
Reports about the “Suzuki-type” C–H functionalization are still rare, but recent 
advances have seen more application of organoboron reagents in this field. To date, using 
directing groups has been the best way to tune the reactivity and control the site 
selectivity. Prof. Jin-Quan Yu’s work has been the most prominent.239, 240 In 2006, his 
group first reported a Pd-catalyzed ortho-C–H alkylation of simple arenes directed by a 
pyridinyl group (Scheme 2-17, top).239 Methylboroxine (2.103) was found to be the best 
methyl source. A variety of functional groups attached to the arene were compatible, 
although electron-withdrawing groups slightly lowered the yields. They were also able to 
use other alkylboronic acids to alkylate simple arenes under the same conditions, only 
replacing the Cu oxidant with Ag2O and DCM solvent with t-AmOH. They later reported 
a similar transformation directed by a carboxylate group (Scheme 2-17, middle).240 A 
sodium salt (2.105) of benzoic acids was crucial for reactivity. In order to use benzoic 
acids directly, the base K2HPO4 was essential to activate their reactivity in 
transmetallation by forming potassium salts in situ. However, the scope of this protocol 
was limited to only a few benzoic acids, and electron-poor arenes afforded very low 
yields. Hence, Yu and co-workers devised an improved method using aryltrifluoroborate 
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salts such as 2.108 (Scheme 2-17, bottom).241 The scope and yield of the C–H arylation 
was greatly enhanced.  
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Scheme 2-18. “Guided” C–H functionalization with organoboron reagents. 
 
In 2006, Shi and co-workers reported an acetamido-directed ortho-C–H arylation of 
acetanilide 2.110 (Scheme 2-18, top).242 The coupling outcome was influenced by the 
electronics of the arylboronic acids. Electron-rich arylboronic acids afforded higher 
yields than the electron-poor ones. Later, they developed a similar ortho-arylation 
procedure, which was instead directed by O-methyl oximes (Scheme 2-18, middle).243 
They found that 2,6-dimethyloxypyridine (DMOP) was the most efficient base to 
improve the yield. In this protocol, the electronic properties of the aromatic substituents 
did not affect the yield very much. Moreover, other directing groups (e.g. oxazole, 
pyridylsulfinyl) were also reported to guide ortho-C–H arylation processes with 
arylboronic acids.244, 245 Recently, Sanford and co-workers devised a mild method for 
ligand-directed C–H alkylation using MnF3 in conjunction with organotrifluoroborates 
2.117 (Scheme 2-18, bottom).246 Their new method can install methyl and primary alkyl 
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groups onto substrates bearing either pyridine or amide directing groups. The mechanism 
was proposed to involve a more reactive R–PdIII or R–PdIV intermediate, thereby 
addressing several of the key limitations of prior protocols (e.g. slow reductive 
elimination and high temperatures).  
With regard to innate C–H functionalization with organoboron reagents, more reports 
have been emerging in recent years. In 2008, Shi reported an innate C–H arylation of 
mesitylenes 2.119 with phenylboronic acid (Scheme 2-19, top).247 Electron-rich arenes 
showed good yields, although the substrate scope is quite limited. In fact, innate C–H 
functionalization is most suitable for heteroaromatic systems.247, 248 A variety of electron-
rich heteroarenes 2.122 underwent C–H arylation regioselectively with good yields 
(Scheme 2-19, bottom). However, the acetyl-protected indole afforded a poor yield, 
because the decrease of electron density disfavored the electrophilic palladation process.  
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X X
H Ph
X = S, 68%     
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X = NH, 83%
X = NMe, 77%
X = NBn, 73%
X = NAc, 16%
2.119 2.120 2.121
2.122 2.120 2.123  
Scheme 2-19. “Innate” C–H functionalization with organoboronic acid. 
 
2.6.2 Organotin reagents 
Stille reactions with organotin reagents have been widely studied.249-251 Because of 
their high tolerance of functional groups, moderate reactivity, and mild reaction 
conditions, organotin reagents have found many applications in total synthesis.252-254 
However, in regard to atom economy, only one of the four groups on Sn is actually 
delivered to the final product, rendering this process more costly. Lastly, the toxicity of 
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organotin reagents is another significant drawback that limits their applications.  
Stille-type C–H functionalization by palladium catalysis was first reported by Yu and 
co-workers in 2005 (Scheme 2-20, top).255 They found that PdII-catalyzed C–H alkylation 
of 2.124 could be achieved with alkyltin reagents by using stoichiometric amounts of 
Cu(OAc)2 and benzoquinone (BQ) in MeCN under air. The oxazolinyl (Oxa) group 
served as the directing group and the dimethylated product was dominating. Interestingly, 
when the authors extended the directing group by one carbon, monoalkylation was 
achieved exclusively (Scheme 2-20, middle). A series of primary alkyl groups were 
installed in good yields. They noted that adding the organotin reagents in batches was 
crucial to eliminate homo-coupling products, which however led to extended reaction 
times. 
 
N
O Me
Me
H
H
SnMe4+
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (1.0 equiv)
BQ (0.5 equiv)
MeCN, 100 ºC, 40 h
N
O Me
Me
Me
R
R = H, 20%
R = Me, 64%
H
SnR4+
Pd(OAc)2 (5 mol%)
Cu(OAc)2 (1.0 equiv)
BQ (1.0 equiv)
MeCN, 100 ºC, 60 h
R
R = Me, 71%
R = Et, 79%
R = Pr, 82%
R = Bu, 75%
R = Oct, 83%
Oxa Oxa
0.75 equiv
in 10 batches
2.125
0.75 equiv
in 20 batches
2.128
H
+ ArSnCl3
PdCl2, CuCl2
DCE, 80 ºC, 16 h
Ar
Ar = Ph, 80%
Ar = 4-Tol, 80%
Ar = 2-Tol, 76%
Ar = 4-F-C6H4, 82%
Ar = 4-CF3-C6H4, 82%
Yu group
Inoue group
2.124 2.126
2.127 2.129
2.130 2.131 2.132  
Scheme 2-20. C–H functionalization with organotin reagents. 
 
Recently, the Inoue group reported a C–H arylation reaction on simple arene 2.130 
with aryltin reagents (Scheme 2-20, bottom).256 Notably, aryltin trichloride is much less 
toxic than triorganotins, the byproducts from using tetraorganotin reagents. CuCl2 served 
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as both an activator and an oxidant for the Pd catalyst. Under the optimized condition, a 
variety of arylated phenanthrenes 2.132 were obtained. This transformation proceeded 
without a directing group, which greatly expanded the substrate scope. In 2012, Xue and 
Xiao group developed a room-temperature coupling protocol between aryl ureas and 
tetraarylstannanes, thus furnishing a mild approach for direct arylation.257 
 
2.6.3 Organosilicon reagents 
Hiyama reactions with organosilicon reagents are another important class of coupling 
reactions.258-261 The C–Si bonds are only slightly polarized because there is little 
difference of electronegativity between carbon and silicon. Compared with other 
organometallic reagents, organosilicon reagents are the least reactive and as a result are 
better at tolerating a variety of functionalities. A common strategy to activate 
organosilicon reagents is using fluorides as additives to facilitate transmetallation. 
Hiyama couplings have been widely used in organic synthesis.262-265  
 
Shi group
HN O
Ar–Si(OR)3H +
Pd(OAc)2 (5 mol%)
Cu(OTf)2 (2 equiv)
AgF (2 equiv)
dioxane, 110 ºC, 48h
HN O
Ar
Ar = Ph, 74%
Ar = 4-MeO-C6H4, 71%
Ar = 4-Cl-C6H4, 61%
Ar = 4-F-C6H4, 63%
Loh group
O
HN O
Ph–Si(OR)3H +
Pd(OAc)2 (10 mol%)
AgF (3 equiv)
dioxane, 80 ºC
O
HN O
Ph
R = Me, 73%
R = Et, 66%
Zhang group
N
+ Ph Si(OR)3
Pd(OAc)2 (10 mol%)
Ag2O, TBAF
AcOH/EtOH, rt
N2, 18 h
N
Ph
R = Me, 76%
R = OMe, 68%
R = NO2, 16%
R R
H
2.133 2.135
2.136 2.138
2.139 2.141
2.134
2.137
2.140  
Scheme 2-21. C–H functionalization with organosilicon reagents. 
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In contrast, “Hiyama-type” oxidative C–H functionalization is very rare. In 2007, Shi 
and co-workers reported a PdII-catalyzed ortho-C–H arylation of acetanilide (Scheme 2-
21, top).266 The acetamido group was used as a directing group. AgF was proposed to 
serve as both a fluoride source and a co-oxidant. A series of arylsilicon reagents were 
used to install aryl groups in good yields. Later, the Loh group disclosed a similar ortho-
C–H arylation reaction on cyclic enamines (Scheme 2-21, middle).267 In this case, Cu 
oxidants were not necessary. Pd(OAc)2 and AgF were proven to be the best combination.  
As to heteroarenes, Zhang and co-workers reported an innate C–H arylation on 
indoles with arylsiloxanes (Scheme 2-21, bottom).268 Ag2O and TBAF were used as the 
oxidant and the fluoride source respectively. This protocol showed high regioselectivity 
at the C2 position of indole. As electron-rich indoles afforded higher yields than electron-
poor ones, an electrophilic substitution mechanism was proposed.  
 
2.7 Couplings between C(sp2)–H and C–H 
The ideal situation for C–H functionalization is the direct transformation of two C–H 
donors to a C–C bond, namely a dehydrogenative process. Despite the tremendous 
challenges, its green and sustainable features have attracted much attention.90, 92, 136, 137, 139 
 
2.7.1 C(sp2)–H and C(sp)–H cross-coupling 
The cross-coupling between an sp2 carbon and an sp carbon generates aryl acetylenes 
or enynes, which are important intermediates for total synthesis. The Sonogashira 
reaction has been the most efficient method for constructing C(sp2)–C(sp) bonds by 
traditional Pd-catalysis.140-142 In contrast, the dehydrogenative version of C(sp2)–C(sp) 
coupling has been mostly catalyzed by Au and Cu.137, 269-271 Pd-catalyzed cross-coupling 
reactions between C(sp2)–H and C(sp)–H donors are very rare.272 One main complication 
with this transformation is fast homocoupling of alkynes.  
The first example using a Pd catalyst was reported by Li and co-workers in 2010 
(Scheme 2-22, top).273 Innate C–H alkynylation of 3-substituted indoles with terminal 
alkynes under an atmosphere of O2 furnished a series of C2-alkynylated products in 
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moderate yields. To suppress the homocoupling of alkynes, slow addition of alkynes was 
required. Later, Chang demonstrated another Pd-catalyzed dehydrogenative alkynylation 
of azole heterocycles such as 2.145 with moderate to good yields (Scheme 2-22, 
middle).274 Besides the critical choice of Pd catalysts and bases for optimal reaction 
efficiency, ambient air was successfully utilized as an environmentally benign oxidant. 
Shi and Larock also reported a similar innate dehydrogenative alkynylation on 
monosubstituted sydnones as 2.148  (Scheme 2-22, bottom).275 A specific procedure for 
slow addition of alkynes and Pd(OAc)2 was necessary to eliminate homo-coupling 
products as well as prolonging the lifetime of the active Pd species. Although this 
protocol has a limited scope of alkynes, it offers a convenient method to synthesize 4-
alkynylsydnones.  
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Ar = m-F-C6H4, 51%
Chang group
O
N
H + H Ar
Pd(PPh3)4 (5 mol%)
LiOtBu (4 equiv)
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N
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CuCl2 (10 mol%)
Ag2O (2 equiv)
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Ar = Ph, 69%
Ar = p-Tol, 78%
Ar = m-MeO-C6H4, 73%
Ar = p-Ac-C6H4, 76%
Ar = m-Cl-C6H4, 66%N
N
O
Cl
O
Ar
2.142 2.143 2.144
2.145 2.146 2.147
2.148 2.149 2.150  
Scheme 2-22. Dehydrogenative alkynylation of heteroarenes. 
 
Most recently, Murai and Shibahara developed a widely applicable C–H alkynylation 
protocol for 5-membered heteroarenes (Scheme 2-23).276 With a combination of Pd 
catalysts and silver salts, imidazole, benzimidazole, imidazo[1,5-a]pyridine, oxazole, 
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benzoxazole, thiazole, and benzothiazole could all be effectively alkynylated. 
Interestingly, the C–H alkynylation conditions left the bromine atom on the substrates 
intact, not susceptible to the traditional Sonogashira reaction. Based on these results, they 
further devised a straightforward route to dialkynylate imidazo[1,5-a]pyridines and 
thiazole via C–H functionalization. In early 2013, Su and co-workers tackled the 
homocoupling problem by reducing the catalyst loading down to 0.2 mol %.277 They 
found alkynylation conditions for heterocycles such as thiophenes and furans, which were 
not suitable substrates for direct alkynylation before.  
 
Murai and Shibahara
N
N
H
N
X
Ph
2.151
X = O, S, NBn
R
2.154
R = H, C≡C–Ar', Br
+ H Ph
N
X
H
Pd cat (0.5 mol%)
Ag2CO3 (1.5 equiv)
AcOH (1.0 equiv)
DMF/DMSO
120 ºC
2.153
34%–62%
+ H Ar
Pd(OAc)2 (2.5 mol%)
Ag2CO3 (1.5 equiv)
AcOH (1.0 equiv)
DMF/DMSO
120 ºC
2.156
7%–78%
N
N
Ar
R
2.152
2.155
 
Scheme 2-23. Recent examples of dehydrogenative alkynylation of heteroarenes. 
 
Similarly, the synthesis of enynes in a dehydrogenative fashion was not reported until 
recently. Jung reported the first example of constructing conjugated enynones 2.159 via 
Pd catalysis (Scheme 2-24, top).278 Remarkably, molecular oxygen was used as the only 
oxidant to reoxidize Pd0. A series of terminal alkyl- or aryl-alkynes were employed under 
the optimized conditions providing E-selectivity and yields of up to 92%. However, the 
scope of alkenes 2.157 was limited to acrylates and vinyl ketones. In 2012, Zhang and 
Zhong reported an efficient method using unactivated allylic ethers 2.160 as substrates 
for direct alkynylation (Scheme 2-25, bottom).279 Various arylalkynes could participate in 
the coupling and interestingly afforded Z-enynes 2.162 in moderate to good yields. 
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K2CO2 (2 equiv)
DMF, rt, O2, 4 h
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2.1612.160
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X
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Scheme 2-24. Dehydrogenative alkynylation of alkenes. 
 
2.7.2 C(sp2)–H and C(sp2)–H cross-coupling 
Cross dehydrogenative couplings of two C(sp2)–H bonds are the most widely 
studied.133, 136, 138, 151 The first example of double C(sp2)–H functionalization dates back 
to 1967.280, 281 Fujiwara and Moritani used benzene and styrene without any preactivation 
to produce the coupling product 2.165 (Scheme 2-25). Although the reaction used 1.0 
equiv of Pd(OAc)2, their findings revolutionized C(sp2)–H functionalization and guided 
the research for the following decades.  
 
+
Pd(OAc)2 (1.0 equiv)
benzene, AcOH
reflux, 8h
2.165, 90%
Fujiwara and Moritani
2.163 2.164  
Scheme 2-25. Fujiwara-Moritani reaction. 
 
Due to the enormous amount of research conducted towards this type of cross-
coupling, this section will be divided into three parts: the dehydrogenative couplings 
between an arene and an arene, between an arene and an alkene, and between an alkene 
and an alkene. 
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2.7.2.1 Arene and arene coupling 
Biaryl linkages are embedded in a plethora of natural products, pharmaceuticals, and 
materials. The most attractive approach towards the formation of biaryls would be the 
direct oxidative coupling of two aryl C–H donors. The study on dehydrogenative 
coupling between arenes started with the oxidative homocoupling of benzene in the 
presence of stoichiometric amounts of PdCl2 by VanHelden and Verberg.282 Since then, 
organic chemists have made significant progress in terms of using catalytic amounts of 
Pd catalysts, applying green conditions, controlling the regioselectivity, and achieving 
cross-coupling between different arenes, etc.283-285  
 
S
H
PdCl2(CH3CN)2 (3 mol%)
AgF
DMSO, 60 ºC S S
2.167
41–85%
Mori group
N
H
Pd(TFA)2 (5 mol%)
Cu(OAc)2•H2O (1.5 equiv)
DMSO, N2, rt, 8 h
N
2.169
28–95%
Zhang group
H
R
R
N
R
R = H, 91%
R = 5-Me, 88%
R = 5-OMe, 94%
R = 5-Br, 68%
R = 5-CN, 28%
2.166
2.168
 
Scheme 2-26. Dehydrogenative homocouplings of heteroarenes. 
 
In 2000, Sasson and co-workers developed a protocol for the Pd-catalyzed 
homocoupling of substituted benzenes under mild aerobic oxidation.286 Different from 
earlier protocols that required extreme conditions, such as high O2 pressure and 
temperatures, they combined two sets of catalysts (i.e. PdCl2 for the coupling reaction, 
and CoII/MnII/ZrIV salts to activate molecular oxygen) in a one-pot procedure, which 
therefore enabled low O2 pressure.287 However, regioselectivity was an issue. As to 
heteroarenes, their dehydrogenative homocoupling was developed earlier,288 but their 
catalytic transformations were not reported until recently. In 2003, Mori first reported 
thiophenes underwent C–H homocoupling in the presence of 3 mol % of PdCl2(CH3CN)2 
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(Scheme 2-26, top).289 A series of bithiophenes 2.167 were obtained regioselectively in 
good yields. In addition to symmetric C–H homocouplings, unsymmetrical 
homocouplings of arenes are also possible in the presence of more than one active C–H 
bond. For example, Zhang developed mild conditions for unsymmetrical homocoupling 
of substituted indoles 2.168 with high yields and excellent regioselectivity (Scheme 2-26, 
bottom).290 Electron-rich and moderately electron-poor indoles were compatible.  
In order to control regioselectivity, a widely applicable strategy is employing 
directing groups. The pyridyl group has been very useful in directing Pd catalysts to the 
desired reaction site. For example, Sanford reported an oxidative homocoupling of 
substituted benzenes directed by a pyridyl group with high levels of regioselectivity 
(Scheme 2-27).291 The coupling proceeded at room temperature and tolerated halide 
groups.  
 
 
Sanford group
N
H
Pd(OAc)2 (5 mol%)
Oxone (2 equiv)
iPrOH, rt, 17 h
N
N
R
R
R
R = H, 41%
R = F, 82%
R = Br, 67%
2.170 2.171  
Scheme 2-27. Directing group-assisted regioselective C–H homocouplings. 
 
Cross dehydrogenative couplings of two different arenes are much more problematic 
than homocoupling because both homo- and cross-coupling products can be obtained. 
Current strategies often include (1) introducing directing groups and (2) tuning the 
substrate’s properties. The Sanford group first introduced a regioselective protocol for 
Pd-catalyzed oxidative cross-coupling of arenes aided by a directing ligand (Scheme 2-
28, top).292 Based on their findings in dehydrogenative homocoupling of 2.170 (Scheme 
2-27),291 the intermediate palladacycle after the first C–H activation was unreactive 
towards homocoupling, which enhanced the chemoselectivity for cross-coupling 
products. Their results showed that the reactivity of two C–H activation processes were 
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controlled by proximity to a ligand (for the first C–H activation) and the adjacent steric 
environment (for the second C–H activation) respectively.293 Later, Shi and co-workers 
introduced the acetamido group to direct the dehydrogenative cross-coupling of arenes 
(Scheme 2-28, bottom).294 Similar to Sanford’s strategy, the high regioselectivity of this 
work was also controlled by the directing group and the steric hindrance in the 
corresponding C–H activation steps. Other directing groups, such as oxazoline and O-
carbamate, were also shown to direct dehydrogenative coupling of different arenes in 
high regioselectivity.295-297 
 
Sanford group
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H
Pd(OAc)2 (10 mol%)
Ag2CO3 (2 equiv)
DMSO, 130 ºC, 12 h
NH+ R
R
2.174
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Shi group
N
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Scheme 2-28. Cross dehydrogenative couplings of arenes. 
 
In the absence of a directing group, Lu and co-workers made the first attempt in 2006 
to synthesize 1-arylnaphthalenes 2.180 directly from benzene and naphthalene (Scheme 
2-29, top).298 The concentrations of arenes and TFA were found critical. In spite of the 
low yields, the chemoselectivity of 2.180 was very good. In the following year, Fagnou 
reported a groundbreaking result of the dehydrogenative coupling between benzene and 
indoles in high selectivity and yields (Scheme 2-29, middle).125 The N-substituent of 
indole was vital to the reactivity. Free N-H indole did not react at all while N-
methylindole predominantly furnished a homocoupling product. In contrast, indoles 
bearing electron-withdrawing groups (as in 2.181) exhibited superb reactivity and yields. 
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Interestingly, replacing Cu(OAc)2 with AgOAc reversed the regioselectivity favoring the 
C2-position of indole. Concurrently, DeBoef reported a similar cross-coupling between 
benzofuran and benzene (Scheme 2-29, bottom).299 O2 was used as the green oxidant. The 
regioselectivity was controlled at the C2-position of benzofuran. In contrast to Fagnou’s 
results, DeBoef’s protocol was applicable to N-methylindole. 
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H
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Scheme 2-29. Cross dehydrogenative couplings of arenes without directing groups. 
 
Recently, more Pd-catalyzed cross dehydrogenative couplings between (hetero)arenes 
have been explored.300 In 2010, Hu and You reported the first example between two 
heteroaryl C–H donors (Scheme 2-30, top).301 A series of electron-rich and electron-poor 
N-heteroarenes (e.g. azoles, xanthines, indolizines, pyridine N-oxides, etc.) were 
compatible to furnish products with high regioselectivity and yields. Later, electron-
deficient 2.190 was also successfully coupled to other (hetero)arenes in Zhang’s and Su’s 
groups respectively (Scheme 2-30, bottom).302, 303 Further developments are directed 
towards finding additional substrates and milder conditions.304-306  
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Scheme 2-30. Recent examples of cross dehydrogenative couplings of arenes. 
 
2.7.2.2 Arene and alkene coupling 
Ever since Fujiwara and Moritani reported the seminal example of dehydrogenative 
coupling of arenes with alkenes in the 60s, a broad range of arenes have undergone direct 
coupling with alkenes.138, 151 For many years, early oxidative coupling reactions were 
usually assisted by stoichiometric amounts of Pd. In order to develop catalytic protocols, 
stoichiometric amounts of oxidants were used to regenerate Pd catalysts in later 
development.  
 
Fujiwara group
+
Pd(OAc)2/BQ
tBuOOH
AcOH–Ac2O
50–90 ºC, 12–15 h
HX
R1 H
X
R1
2.193
X = O, NH
2.195
15–75%
TON up to 280
R2
R2
R3
R3
2.194
 
Scheme 2-31. Early example of catalytic dehydrogenative alkenylation. 
 
Conventional oxidants include metal salts (e.g. AgI and CuII salts) and organic 
peroxides (e.g. tBuOOH and PhCO3tBu). The application of these oxidants significantly 
reduced the loading of Pd catalysts.138 For example, in 1999, Fujiwara and co-workers 
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reported an efficient dehydrogenative coupling between arenes and alkenes with only 1 
mol % of Pd(OAc)2 with t-butyl hydroperoxide as the oxidant.307 Their protocol was 
particularly effective for heteroarenes 2.193 (e.g. furans and indoles) with excellent 
regio- and stereoselectivity (Scheme 2-31). With benzoquinone as a co-catalyst, 
impressive turnover numbers (TON) up to 280 were achieved.  
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Scheme 2-32. Green conditions of dehydrogenative alkenylation using O2. 
 
In the interests of green chemistry, molecular oxygen is undoubtedly the optimal 
terminal oxidant.308, 309 Initially, Fujiwara discovered that in the presence of oxygen or 
air, Cu(OAc)2 or AgOAc could catalytically assist Pd(OAc)2 in catalyzing oxidative 
cross-couplings (Scheme 2-32, top).310 The first example of using oxygen as the sole 
oxidant was disclosed in 1971 by Shue and co-workers (Scheme 2-32, middle).311 The 
drawback was that the pressure of oxygen required much more than 1 atm, which 
unfortunately was a common issue for many earlier conditions. The main reason was that 
the concentration of molecular oxygen was low in solutions and Pd0 therefore could not 
be oxidized effectively. Recent improvement on oxidative couplings often involved 
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oxygen “activators/co-catalysts” under much lenient conditions.309 For example, 
molybdovanadophosphoric acid (HPMoV) was applied as a co-catalyst in Ishii’s report in 
2002 (Scheme 2-32, bottom).312 In this mild protocol, dehydrogenative coupling of 
benzene with acrylates was achieved under 1 atm of O2. Other activators, such as 
benzoquinone and catechol, also showed good efficiency in assisting the reoxidation of 
Pd0.312, 313 
From a mechanistic perspective, the two C–H activation processes involved in 
dehydrogenative alkenylation of arenes are discrete in nature. Compared to the 
perplexing chemoselectivity in dehydrogenative cross-couplings of arenes, the 
chemoselectivity of C–H alkenylation of arenes has not been a key issue. On the other 
hand, the regioselectivity remains problematic. 
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Scheme 2-33. Regioselectivity of dehydrogenative alkenylation of heteroarenes. 
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For heteroarenes, the regioselectivity of alkenylation can be tuned with either a 
directing group or their innate electronic and steric properties. Ricci first reported an N-
substituent-directed alkenylation of indoles with excellent C2-regioselectivity (Scheme 2-
33, top).123 Gaunt and co-workers demonstrated another N-substituent-controlled 
oxidative alkenylation of pyrroles under aerobic conditions (Scheme 2-33, middle).314 
Electron-withdrawing N-substituents, such as N-Boc and N-Ts, regioselectively afforded 
C2-arylated pyrroles 2.206 due to reduced nucleophilicity, while sterically bulky N-TIPS 
group shielded the C2-position and predominantly afforded C3-alkenylated products 
2.205. In addition, the choice of solvents also significantly affected the regioselectivity 
(Scheme 2-33, bottom).315 As Gaunt noted, oxidative coupling reactions carried out in 
polar solvent such as DMSO and DMF produced C3-alkenylated indoles 2.210, while the 
nonpolar solvent dioxane with AcOH as a cosolvent showed C2-regioselectivity (e.g. 
2.209) instead.   
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Scheme 2-34. Regioselectivity of dehydrogenative alkenylation of arenes. 
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For C–H alkenylation of arenes, using a directing group is very effective to achieve 
excellent regioselectivity. van Leeuwen and de Vries first reported using an acetamido 
group to direct the C–H alkenylation (Scheme 2-34, top).316 Only ortho-alkenylation was 
observed, where electron-rich arenes afforded higher yields than electron-poor ones. Yu 
also employed triflamido and carboxyl groups as directing groups and achieved excellent 
regioselectivity (Scheme 2-34, bottom).317, 318 A wide range of 2-phenylethylamines 
2.214 and phenylacetic acids 2.217 were employed for ortho-C–H alkenylation reactions 
with high yields. Intriguingly, they found a significant ligand-promoted 
reactivity/selectivity when mono-N-protected amino acids were used. The strange ligand 
effect was later attributed to the acceleration of the C–H cleavage step, where the original 
electrophilic palladation mechanism was changed to a CMD process.319 In addition, other 
functional groups (e.g. urea, sulfonamido, and hydroxyl) have been excellent in directing 
regioselective C–H alkenylation through weak ligation.320  
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Scheme 2-35. Dehydrogenative alkenylation of electron-deficient (hetero)arenes. 
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Because electrophilic palladation is the dominant pathway for C–H activation, most 
(hetero)arenes involved in dehydrogenative alkenylation are electron-rich. On the 
contrary, electron-deficient (hetero)arenes are more difficult substrates for C–H 
activation due to their poor coordination with Pd(OAc)2.219 Hence, fewer reports are 
available.219, 321-323 Yu developed the first protocol to meta-alkenylate electron-poor 
arenes in 2009 (Scheme 2-35, top).219 2,6-dialkylpyridine as the ligand was vital to the 
meta-selectivity. Although the origin of this ligand effect is unclear, the loss of reactivity 
at the ortho-position might be attributed to a steric effect. An electrophilic substitution 
appears to be a plausible rational for the meta-selectivity over para-selectivity. In another 
example, Chang and co-workers unveiled an efficient protocol for ortho-alkenylation of 
pyridine N-oxides in high yields (Scheme 2-35, middle).322 The coupling proceeded with 
excellent regio-, stereo- and chemoselectivity. As to perfluoroarenes 2.226, Zhang and 
co-workers reported an efficient protocol, which succeeded with a variety of activated 
and unactivated alkenes in moderate to high yields (Scheme 2-35, bottom).323  
 
2.7.2.3 Alkene and alkene coupling 
Polyenes and conjugated dienes are important structural motifs found in many 
pharmaceutically active compounds and natural products, such as carotenes, vitamin A, 
bombykol, etc. Synthesis of these compounds can be categorized into two classes: (1) 
carbonyl alkenylation reactions,324 represented by the Wittig reaction;325 (2) Cross 
alkenylation couplings, represented by the Heck reaction.326 Compared with the 
aforementioned two coupling modes between C(sp2)–H and C(sp2)–H, dehydrogenative 
alkenylation of alkenes is still a very underdeveloped area. Examples of this sort are very 
limited.136 The earliest example involved the dehydrogenative homocoupling of 
camphene reported by Gusevskaya.327 
Research on dehydrogenative cross-couplings of alkenes has started to gain more 
attention very recently. Ishii first demonstrated the oxidative cross-coupling of vinyl 
acetate 2.229 and acrylates 2.230 in 2004 (Scheme 2-36, top).328 This protocol used O2 as 
the terminal oxidant with HPMoV as the co-catalyst. A series of linear dienes were 
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efficiently constructed in good yields, albeit with moderate stereoselectivity. Five years 
later, Loh and co-workers reported a similar protocol involving acrylates and styrene 
derivatives under mild conditions (Scheme 2-36, middle).329 The stereoselectivity was 
improved, favoring the E-configuration. However, only 2-substituted styrenes 2.232 were 
compatible in the reaction. In 2010, Yu reported another cross-coupling between α-
oxoketene dithioacetals 2.235 with terminal alkenes (Scheme 2-36, middle).330 A series 
of functionalized 1,3-dienes were obtained in high yields with excellent E-selectivity. 
Most recently, Liu’s group expanded the substrate scope to electron-rich alkenes 2.239 
for dehydrogenative cross-coupling (Scheme 2-36, bottom).331 Common leaving groups 
were tolerated under their conditions. Different from Loh’s results, styrene without 2-
substituents worked well under Liu’s protocol with good yields. 
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Scheme 2-36. Dehydrogenative alkenylation of linear alkenes. 
 
In addition to linear alkenes, cyclic alkenes have also been shown to participate in 
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dehydrogenative coupling reactions. In 2011, Liu and co-workers first disclosed an 
effective method to directly alkenylate glycals as 2.241 with excellent regioselectivity 
and stereoselectivity (Scheme 2-37, top), which could be valuable for synthesizing pyran-
containing natural products.332 Similarly, when nonaromatic cyclic enamides as 2.244 
was subjected to oxidative alkenylation conditions, high yields and excellent regio- and 
stereoselectivity were achieved (Scheme 2-37, bottom).333  
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Scheme 2-37. Dehydrogenative alkenylation of cyclic alkenes. 
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Scheme 2-38. Directing group-assisted dehydrogenative cross-alkenylation. 
 
The excellent regioselectivity shown in the above examples relied on the innate 
electronic properties of the substrates. Although the stereoselectivity (of E/Z isomers) 
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was superior for cyclic alkenes, it still remains a significant challenge for linear alkenes. 
One solution is using directing groups. So far, only one example with directing group 
assistance was reported (Scheme 2-38).334 Good yields and excellent selectivity were 
achieved. A vinylpalladium cyclic species 2.250 was isolated (when Ar = 2-naphthyl) and 
proposed to be the possible intermediate after the first C–H activation. 
 
2.7.3 C(sp2)–H and C(sp3)–H cross-coupling 
Unlike C(sp2)–H bonds, C(sp3)–H bonds do not have empty low-energy orbitals or 
filled high-energy orbitals that could readily interact with orbitals of the metal. Therefore, 
C(sp3)–H activation is significantly more challenging. So far, many transition metal 
catalysts have been used to catalyze dehydrogenative alkylation of (hetero)arenes or 
alkenes.90, 92, 137, 335 Most of the C(sp3)–H donors involve active sp3 carbon centers, such 
as α-amino carbons and allylic/benzylic carbons,336, 337 much less attention has been 
devoted to non-acidic C–H bonds of alkyl groups.338 
For Pd-catalyzed intermolecular dehydrogenative alkylation only a few examples are 
known so far. Bao and co-workers reported the first case involving a Pd catalyst to 
achieve dehydrogenative allylic indolation (Scheme 2-39, top).337 DDQ was found to be 
the most effective oxidant and the reaction needed to be carried out at 0 ºC to obtain the 
best yields. Indoles bearing electron-withdrawing groups afforded better yields. The 
regioselectivity revealed that the C3 position of indole was the most active site. 
Widenhoefer and co-workers reported the first example of a Pd-catalyzed addition of 
stabilized carbon nucleophiles 2.254 to ethylene and propylene (Scheme 2-39, middle).339 
The pressure of ethylene and propylene gas was critical in controlling the desired 
coupling and suppressing the competing protonolysis. Very recently, Cui and Wu 
developed a dehydrogenative C2-alkylation of quinoline N-oxides 2.257 with ethers in 
good yields (Scheme 2-39, bottom).340 The mechanism was proposed to involve a PdIII 
species via a radical process. This method offers a new and simple way to synthesize 
useful quinoline N-oxide derivatives. 
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Scheme 2-39. Dehydrogenative alkylation reactions. 
 
2.8 Summary 
C–H functionalization reactions are attractive methods in organic chemists. The 
ubiquity of C–H bonds makes such chemistry very promising, yet at the same time very 
challenging. A useful C–H functionalization protocol must be able to activate a targeted 
C–H bond in a selective manner that only one of the many will react.  
Over the past decade, this field has seen remarkable progress. First, more transition 
metals have been introduced as catalysts to activate C–H bonds. Palladium as a 
traditional catalyst has found new applications in various C–H coupling systems beyond 
traditional coupling reactions. Second, “innate” and “guided” approaches have effectively 
delivered excellent regioselectivity. More directing groups have been designed. For 
instance, weak coordination is becoming a new, powerful means for selective C–H 
functionalization. Third, new mechanisms have been discovered, leading to the 
development of new protocols for substrates not suitable for C–H functionalization 
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before. Notably, the discovery of the CMD mechanism opened the door for 
functionalizing C–H bonds of electron-deficient (hetero)arenes, a class of important 
molecules which were not compatible substrates not so long ago. Fourth, C–H 
functionalization is moving towards even “greener” directions. For example, molecular 
oxygen is being used as the terminal oxidant, room temperature conditions are becoming 
more available, and more research efforts are devoted to dehydrogenative cross-couplings 
with ideal atom economy. Lastly but not least, C–H functionalization are changing our 
way in designing organic synthesis. Many common linkages in natural products and 
pharmaceuticals, such as biaryls, can now be conveniently assembled with different 
choices thanks to a myriad of methods available. Their permeation in modern total 
synthesis has proven again the tremendous potential of C–H functionalization chemistry. 
However, the accessible tools for manipulating C–H bonds are far from sophistication. 
Many difficult tasks still remain. For example, functionalization of sp3 C–H bonds 
continues to be challenging compared to their sp and sp2 counterparts. Directing groups 
are often needed for selective C–H activation. The development of removable or 
convertible directing groups is hence preferable. In addition, the field of dehydrogenative 
cross-couplings is still in its infancy. Topics like controlling chemoselectivity and 
regioselectivity await innovative solutions. Finally, reducing use of expensive catalysts or 
abandoning use of catalysts entirely is essential for future practicality.  
Regardless of the challenges faced at the present stage, future exciting advances of this 
rapid evolving area can be expected undoubtedly. The increasing importance of this new 
chemistry will propel methodology development and further application in organic 
synthesis, materials sciences, and in the pharmaceutical industry. 
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Chapter 3  Pd-Catalyzed C–H Arylation of Cyclic Enaminones with Aryl Iodides 
 
3.1 Introduction 
Cyclic enaminones, namely 2,3-dihydropyrid-4(1H)-ones, have displayed a 
distinctive reactivity profile, including notably a strong innate nucleophilicity.78, 341-344 As 
piperidine surrogates, these non-aromatic substrates have been exploited as versatile 
synthetic intermediates in the syntheses of various heterocycles and heterocyclic natural 
products.61, 345-348 As our laboratory continues to investigate the pharmaceutical 
applications of phenanthropiperidine alkaloids, the syntheses of these natural products 
and analogs entail a regioselective C5-arylation of cyclic enaminone 3.1 as a key step 
(Scheme 3-1).59, 60, 65, 349 Our strategy has been employing direct C–H arylation reactions 
because of their convenience and efficiency.  
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Scheme 3-1. C–H functionalization in alkaloid syntheses. 
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Scheme 3-2. Direct arylation of cyclic enaminones. 
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Direct C–H arylation chemistry has been extensively studied over the years due to the 
ubiquity of heterocycle-aryl linkages in pharmaceuticals.88, 89, 91, 99, 108, 350, 351 Our earlier 
syntheses have demonstrated that the regioselective C5-arylation of cyclic enaminones 
can be achieved through convenient and high yielding C–H arylation protocols via 
oxidative Pd catalysis (Scheme 3-2.1).79-81 In these protocols, aryl metal precursors were 
used (i.e. aryl boronic acids,81 silanes,80 and trifluoroborates79). Issues of limited 
commercial availability or high cost led us to explore the widely available aryl iodides as 
alternative reagents (Scheme 3-2.2).109, 352-356 
 
3.2 Coupling strategy 
Among the possible C–H activation mechanisms,100, 117, 126 our past study suggested 
that an electrophilic palladation pathway was more likely involved in reactions with the 
nucleophilic enaminones (Figure 3-1, top).341 However, a carbopalladation process is also 
feasible and would lead to C6-arylation as the double bond in the non-aromatic 
enaminone scaffold could be a Heck-donor (Figure 3-1, bottom). 117, 357 Therefore, the 
regioselectivity of the coupling reaction presented another challenge. The following 
studies describe the development of a C5 regioselective direct C–H arylation of cyclic 
enaminones using aryl iodides. 
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Figure 3-1. Postulated competing pathways for direct C–H arylation. 
 
  59 
3.3 Condition optimization 
3.3.1 Initial trials 
Table 3-1. Initial screen of direct C–H arylation conditions 
N
O
+
N
O
p-TolH
I p-Tol
Bn Bn
PMPPMP
N
O
Bn
PMP
+
p-Tol
3.6 3.7 3.8 3.9
conditions
24 h
 
Entrya Catalytic Conditions 3.8 (%) 3.9 (%) 
1 Pd(PPh3)4 (10 mol %), TEA (2.0 equiv), CH3CN, 80 
°C, 18 h 0 1 
2 Pd2(dba)3 (10 mol %), Bu4NCl (2.0 equiv), NMP, 100 
°C, 18 h 8 1 
3 Pd(dba)2 (10 mol %), Bu4NCl (1.0 equiv), NaHCO3 
(2 equiv), DMF, 80 °C, 18 h 11 2 
4 PdCl2(PPh3)2 (10 mol %), AgNO3 (1.0 equiv), KF 
(2.0 equiv), DMSO, 100 °C, 24 h 16 4 
5 [Pd(dppf)Cl2]CH2Cl2 (10 mol%), Ag2CO3 (2.0 
equiv), DMSO, 80 °C, 24 h 0 0 
6 Pd(OAc)2 (10 mol%), PPh3 (40 mol %), TEA (2.0 
equiv), AgNO3 (1.5 equiv), CH3CN, 80 °C, 18 h 0 1 
7 Pd(OAc)2 (10 mol%), NaHCO3 (3.0 equiv), Bu4NCl 
(1.0 equiv), DMF, 80 °C, 18 h 30 2 
8 CuCl (10 mol %), LiOtBu (2.0 equiv), DMF, 140 °C, 
22 h 0 0 
9 DMEDA (20 mol%), KOtBu (3.0 equiv), dioxane, 80 
°C, 23 h 0 0 
10 KOtBu (2.5 equiv), dioxane, 140 °C, 23 h 0 0 
a NMR yields with Ph3SiMe (1.0 equiv) as the internal standard (p-Tol = para-tolyl). 
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We initiated our study by examining a collection of C–H arylation conditions (Table 
3-1). Pd0 catalysts showed very limited catalytic activity (entries 1–3). 
Triphenylphosphine as a strong stabilizing ligand failed to furnish any desired product 
3.8, possibly because it stabilizes the electrophilic PdII oxidative adduct and thus inhibits 
the succeeding electrophilic palladation process (entry 1). Based on this analysis, a less 
electron-donating ligand should help activate the catalysis. Indeed, Pd0 with 
dibenzylideneacetone (dba) afforded product 3.8, although the yield was only around 
10% (entries 2–3). The ligand effect was also prominent with PdII catalysts (entries 4–7).  
PPh3 and dppf respectively showed inhibitory effect on yields (entries 4–6), whereas a 
ligand-free protocol (i.e. the Jeffery conditions358) provided 30% of desired compound 
3.8 (entry 7). It is worth noting that the Jeffery conditions were initially developed for 
classic Heck reactions. As anticipated, in addition to the desired C5-arylated 3.8, C6-
arylated 3.9 was observed as well. However, the Heck byproduct 3.9 was interestingly 
not favored compared to 3.8 under the current conditions (entry 7). Moreover, a CuI-
catalyzed method was also tested in addition to two other metal-free conditions (entries 
8–10), but no desired product was observed. Therefore, we proceeded with the Jeffery 
conditions for further optimization. 
 
3.3.2 Detailed optimization 
We then undertook a thorough optimization of the arylation conditions (Table 3-2). A 
survey of seven solvents (entries 1–7) revealed that DMSO favored the formation of 3.8 
via the presumed electrophilic palladation pathway (e.g. 50% in DMSO, entry 7 vs. 10% 
in dioxane, entry 2), whereas toluene (entry 1) significantly increased the formation of 
3.9. Indeed, DMSO provided the highest yield and the best regioselectivity (entry 7). The 
choice of the base was also important (entries 8–15). NaHCO3 (entry 7) and Na2CO3 
(entry 9) were more effective in facilitating the deprotonation process than NaOAc (entry 
8). Addition of pivalic acid (PivOH) with Na2CO3 did not improve the yield (entry 10). 
The evaluation of carbonate salts showed that the sodium cation had beneficial effects on 
direct arylation (entries 11–13). Unsurprisingly, strong bases such as NaOH (entry 14) or 
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NaOtBu (entry 15) decomposed the enaminones. Thus, the originally chosen NaHCO3 
provided the best outcome (50%, entry 7). Next, the reaction temperature was tuned from 
20 ºC to 140 ºC in 30-degree intervals (entries 16–19). We found that 80 °C was the 
optimal temperature to activate the transformation without decomposing the heat-
sensitive enaminones. Moreover, several tetraalkylammonium salts were assessed as 
phase-transfer agents in order to enhance yields and selectivities (entries 20–22).358 The 
absence of Bu4NBr indeed resulted in a lower yield of 3a and a reduced regioselectivity 
(entry 20). Interestingly, Bu4NCl (entry 21) provided a better regioselectivity than Bu4NI 
(entry 22) or Bu4NBr (entry 7). Lastly, the ligand effect was investigated. Phosphine 
ligands (i.e. PPh3, P(OPh)3 and P(C6F5)3), regardless of their electronic properties, were 
detrimental to catalysis (entries 23–25). Amino acids (i.e. Boc-L-alanine and Boc-L-
phenylalanine), supposedly coordinating to the Pd center through weak ligation,359 
showed no improvement in either yields or regioselectivity (entries 26–27).  
 
Table 3-2. Detailed optimization of direct C–H arylation of cyclic enaminones 
N
O
+
N
O
p-TolH
I p-Tol
Bn Bn
PMPPMP
N
O
Bn
PMP
+
p-Tol
3.6 3.7 3.8 3.9
conditions
24 h
 
Entrya Ligand Additive Base Temp (°C) Solvent 3.8 (%)b 3.9 (%)b 
1 — Bu4NBr NaHCO3 80 toluene 14 18 
2 — Bu4NBr NaHCO3 80 dioxane  10 12 
3 — Bu4NBr NaHCO3 80 tBuOH 8 12 
4 — Bu4NBr NaHCO3 80 NMP 15 7 
5 — Bu4NBr NaHCO3 80 DMF 29 7 
6 — Bu4NBr NaHCO3 80 DMA 22 8 
7 — Bu4NBr NaHCO3 80 DMSO 50 6 
8 — Bu4NBr NaOAc 80 DMSO 36 5 
9 — Bu4NBr Na2CO3 80 DMSO 49 8 
10c — Bu4NBr Na2CO3 80 DMSO 51 8 
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11 — Bu4NBr Li2CO3 80 DMSO 29 3 
12 — Bu4NBr K2CO3 80 DMSO 16 0 
13 — Bu4NBr Cs2CO3 80 DMSO 0 0 
14 — Bu4NBr NaOH 80 DMSO 0 0 
15 — Bu4NBr NaOtBu 80 DMSO 0 0 
16 — Bu4NBr NaHCO3 20 DMSO 8 2 
17 — Bu4NBr NaHCO3 50 DMSO 31 3 
18 — Bu4NBr NaHCO3 110 DMSO 46 9 
19 — Bu4NBr NaHCO3 140 DMSO 35 7 
20 — — NaHCO3 80 DMSO 40 12 
21 — Bu4NCl NaHCO3 80 DMSO 49 3 
22 — Bu4NI NaHCO3 80 DMSO 35 16 
23 PPh3 Bu4NCl NaHCO3 80 DMSO 0 0 
24 P(OPh)3 Bu4NCl NaHCO3 80 DMSO 0 0 
25 P(C6F5)3 Bu4NCl NaHCO3 80 DMSO 0 0 
26d Boc-Ala-OH Bu4NCl NaHCO3 80 DMSO 52 6 
27d Boc-Phe-OH Bu4NCl NaHCO3 80 DMSO 45 4 
a 3.6 (0.2 M), 3.7 (1.5 equiv), Pd(OAc)2 (20 mol %), ligand (40 mol %), additive (1.0 
equiv), base (3.0 equiv) in DMSO (1 mL). (p-Tol = para-tolyl) b NMR yields with 
Ph3SiMe (1.0 equiv) as the internal standard. c With PivOH (40 mol %). d 3.7 (3.0 equiv), 
Bu4NCl (0.5 equiv) and NaHCO3 (1.0 equiv).  
 
3.3.3 The effect of silver salts 
Next, we examined eight silver salts as additives (Table 3-3). Silver salts are often 
used to irreversibly abstract halide anions from Pd complexes thus rendering them more 
electrophilic and preventing the formation of mostly inactive PdI2.360-362 Indeed, the 
regioselectivity was enhanced in the presence of a silver salt (entries 1–8). We found that 
AgCl not only increased the yield of 3.8, but also promoted exclusive reaction at the C5-
position (entry 6).  
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Table 3-3. Silver effect on the regioselectivity of C–H arylation of cyclic enaminone 
N
O
+
N
O
p-TolH
I p-Tol
Bn Bn
PMPPMP
N
O
Bn
PMP
+
p-Tol
3.6 3.7 3.8 3.9
conditions
24 h
 
Entrya Ag Salt 3.8 (%)b 3.9 (%)b 
1 AgTFA 33 <1 
2 AgF2 14 0 
3 AgNO3 32 0 
4 AgOAc 30 <1 
5 Ag2CO3 30 <1 
6 AgCl 65 0 
7c Ag2O + benzoic acid 30 0 
8c,d Ag2O + pivalic acid 49 3 
9 – 49 3 
a 3.6 (0.2 M), 3.7 (3.0 equiv), Pd(OAc)2 (20 mol %), Bu4NCl (1.0 equiv), NaHCO3 (3.0 
equiv), silver salt (1.2 equiv) in DMSO (1 mL) at 80 ºC. (p-Tol = para-tolyl) b NMR 
yields with Ph3SiMe (1.0 equiv) as the internal standard. c Ag2O (0.75 equiv), acid (1.5 
equiv), no NaHCO3. d No Bu4NCl.  
 
3.3.4 Fine-tuning the stoichiometry 
Lastly, we proceeded to tune the reagent stoichiometry extensively (Table 3-4). First, 
the concentration of Bu4NCl was tested from 0.1 to 3.0 equiv (entries 1–5). Arylation 
conditions with 0.5 equiv of Bu4NCl generated a comparable yield of 3.8 (64%, entry 2) 
as those with originally chosen 1.0 equiv of Bu4NCl (65%, entry 3). Further lowering and 
increasing the amount of Bu4NCl both resulted in a yield decrease of 3.8. Second, the 
loading of AgCl was changed from 0.1 to 3.0 equiv (entries 6–9). The highest yield was 
observed in the presence of 1.2 equiv of AgCl. Third, we controlled the amount of aryl 
iodide 3.7 (entries 10–15). As expected, the yield climbs from 52% when the addition of 
3.7 increases from 1.1 equiv. However, the yield plateaued at 64% after 3.0 or more 
equiv of 3.7 were added. Adding 3.7 to the reaction in up to 15.0 equiv unfortunately 
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showed no beneficial effect. We also altered the concentration of NaHCO3 from 1.0 to 
10.0 equiv (entries 16–19). Even though no higher yield was obtained, we were able to 
reduce the loading of NaHCO3 from originally 3.0 to 1.0 equiv with the same yield (64%, 
entry 16). In addition, the loading of Pd(OAc)2 was examined from 0.1 to 30 mol % 
(entries 20–24). We found that the reaction ceased with only 0.1 mol % of catalyst, while 
being the most productive (64%) in the presence of 20 mol % of Pd(OAc)2. We also 
monitored the reaction progress over a 24-h period (entries 25–30). The yield curve 
revealed that the C–H arylation reaction proceeded slowly in the first 12 hours and then 
stopped without decomposition of 3.8. Lastly, we evaluated the effect of the reaction 
scale from 0.067 to 0.4 M (entries 31–34). We were pleased to find that the reaction on a 
0.2 M scale in 0.5 mL of DMSO furnished the best yield of desired product 3.8 (72%, 
entry 32). It is worth mentioning that the byproduct 3.9 was not observed in most of the 
tested conditions.  
 
Table 3-4. Extensive optimization of reaction stoichiometry and time 
N
O
+
N
O
p-TolH
I p-Tol
Bn Bn
PMPPMP
N
O
Bn
PMP
+
p-Tol
3.6 3.7 3.8 3.9
conditions
24 h
 
Entrya 3.6 
(mmol) 
3.7  
(equiv) 
Pd(OAc)2 
(mol %) 
AgCl 
(equiv) 
NaHCO3 
(equiv) 
Bu4NCl 
(equiv) 
DMSO 
(mL) 
t 
(h) 
3.8 
 (%) 
3.9 
(%) 
1 0.2 3.0 20 1.2 3.0 0.1 1.0 24 48 0 
2 0.2 3.0 20 1.2 3.0 0.5 1.0 24 64 0 
3 0.2 3.0 20 1.2 3.0 1.0 1.0 24 65 0 
4 0.2 3.0 20 1.2 3.0 2.0 1.0 24 36 0 
5 0.2 3.0 20 1.2 3.0 3.0 1.0 24 19 0 
6 0.2 3.0 20 0.1 3.0 0.5 1.0 24 57 3 
7 0.2 3.0 20 0.5 3.0 0.5 1.0 24 58 1 
8 0.2 3.0 20 2.0 3.0 0.5 1.0 24 54 0 
9 0.2 3.0 20 3.0 3.0 0.5 1.0 24 55 0 
10 0.2 1.1 20 1.2 3.0 0.5 1.0 24 52 0 
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11 0.2 1.5 20 1.2 3.0 0.5 1.0 24 60 0 
12 0.2 2.0 20 1.2 3.0 0.5 1.0 24 63 0 
13 0.2 4.0 20 1.2 3.0 0.5 1.0 24 64 0 
14 0.2 6.0 20 1.2 3.0 0.5 1.0 24 64 0 
15 0.2 15.0 20 1.2 3.0 0.5 1.0 24 63 0 
16 0.2 3.0 20 1.2 1.0 0.5 1.0 24 64 0 
17 0.2 3.0 20 1.2 2.0 0.5 1.0 24 61 0 
18 0.2 3.0 20 1.2 5.0 0.5 1.0 24 59 0 
19 0.2 3.0 20 1.2 10.0 0.5 1.0 24 59 0 
20 0.2 3.0 0.1 1.2 1.0 0.5 1.0 24 0 0 
21 0.2 3.0 5 1.2 1.0 0.5 1.0 24 46 0 
22 0.2 3.0 10 1.2 1.0 0.5 1.0 24 56 0 
23 0.2 3.0 15 1.2 1.0 0.5 1.0 24 61 0 
24 0.2 3.0 30 1.2 1.0 0.5 1.0 24 60 0 
25 0.2 3.0 20 1.2 1.0 0.5 1.0 0.5 34 0 
26 0.2 3.0 20 1.2 1.0 0.5 1.0 1 47 0 
27 0.2 3.0 20 1.2 1.0 0.5 1.0 2 57 <1 
28 0.2 3.0 20 1.2 1.0 0.5 1.0 4 58 <1 
29 0.2 3.0 20 1.2 1.0 0.5 1.0 8 62 <1 
30 0.2 3.0 20 1.2 1.0 0.5 1.0 12 64 <1 
31 0.2 3.0 20 1.2 1.0 0.5 0.5 24 64 0 
32 0.1 3.0 20 1.2 1.0 0.5 0.5 24 75 (72b) <1 
33 0.2 3.0 20 1.2 1.0 0.5 2.0 24 55 0 
34 0.2 3.0 20 1.2 1.0 0.5 3.0 24 52 0 
a NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. (p-Tol = para-tolyl) b 
Isolated yield. 
 
In short, we decided to use the following optimized conditions for the investigation of 
the reaction scope: cyclic enaminone (0.1 M), aryl iodide (3.0 equiv), Pd(OAc)2 (20 mol 
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%), Bu4NCl (0.5 equiv), NaHCO3 (1.0 equiv), AgCl (1.2 equiv) in DMSO (0.5 mL) at 80 
ºC.  
 
3.4 Investigation of the reaction scope  
3.4.1 Scope of aryl iodides 
Table 3-5. Scope of aryl iodides for the Direct C–H arylationa 
N
O
+
Pd(OAc)2 (20 mol%)
Bu4NCl (0.5 equiv)
AgCl (1.2 equiv)
NaHCO3 (1.0 equiv)
DMSO, 80 ºC, 24 h
N
O
ArH
I Ar
Bn Bn
PMPPMP
3.6  
N
OPMP
Bn
3.10, 43%b
N
OPMP
Bn
3.8, 72%
N
OPMP
Bn
3.11, 72%
N
OPMP
Bn
3.12, 68%
N
OPMP
Bn
3.14, 74%
N
OPMP
Bn
3.13, 66%
N
OPMP
Bn
3.17, 83%
N
OPMP
Bn
3.15, 79%
N
OPMP
Bn
3.18, 75%
N
OPMP
Bn
3.16, 80%
N
OPMP
Bn
3.19, 80%
N
OPMP
Bn
3.20, 73%
3.22, 51%
N
OPMP
Bn
3.21, 50%
N
OPMP
Bn N
OPMP
Bn
3.23, 32%
t-Bu
O
OMe
OMe
N
Cl NO2 CF33.24, 30%
OMe
N
OPMP
Bn
Me
CO2Et
O
OMe
OMe
Me
O
Ph
Me
 
a 3.6 (0.2 M), aryl iodide (3.0 equiv), Pd(OAc)2 (20 mol %), Bu4NCl (0.5 equiv), 
NaHCO3 (3.0 equiv), AgCl (1.2 equiv) in DMSO (0.5 mL), 24 h. Isolated yields with full 
consumption of 3.6, unless otherwise noted. b 14% recovered 3.6. 
 
Next we explored the scope of aryl iodides in this reaction using the optimized 
conditions (Table 3-5) and found that the electronic properties of the aryl iodides affected 
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reaction yields significantly. Good yields were generally obtained with electron rich aryl 
iodides (3.8–3.20). Electron poor aryl iodides afforded slightly lowered yields (3.21–
3.24). Reactions of aryl iodides with strongly electron-withdrawing substituents, e.g. NO2 
(3.23) and CF3 (3.24), resulted in low yields. Steric hindrance, as expected, impeded the 
effectiveness of the cross coupling. For instance, compared to the 4-tolyl derivative (3.8), 
2-tolyl iodide afforded a lower yield (3.10) with 14% recovered 3.6. In addition, arylation 
of bifunctional 4-chlorophenyliodide proceeded exclusively at the iodine terminus with 
the chlorine terminus intact (3.22), which may be subjected to sequential cross-coupling 
reactions.363-366 It is worth mentioning that phenyl bromide was tested under the 
optimized conditions and afforded an inferior yield (21% with 32% recovered 3.6) 
compared to phenyl iodide, which afforded 3.12 in 68%. Neither 4-chlorotoluene nor 
phenyl triflate functioned as arylating reagents to afford the desired product.  
 
3.4.2 Scope of cyclic enaminones 
Given the high coupling efficiency of electron-rich aryl iodides, a series of cyclic 
enaminones was subjected to the optimized conditions with 4-iodoanisole (3.25, Table 3-
6). Consistent with our previous results,79-81, 341 electron-rich and monocyclic and bicyclic 
enaminones were all compatible with the optimized conditions (3.26–3.31). Compared to 
N-benzylenaminone 3.26, N-phenylenaminone 3.27 was formed in a decreased yield 
probably due to its attenuated nucleophilicity. Notably, these mildly basic conditions did 
not compromise the stereochemical integrity of the epimerizable enaminone 3.31. In 
contrast, no reaction took place on either the N-unprotected enaminone or the E-
enaminone to form products 3.32 or 3.33.79-81, 341 Electron-deﬁcient enaminones also 
failed to furnish desired 5-arylated products 3.34 or 3.35. 
Notably, cyclic enaminones with N-electron-withdrawing groups underwent C6-
arylation exclusively in sharp contrast to their lack of reactivity observed previously 
(Scheme 3-3).79-81 We postulate that the diminished nucleophilicity of enaminones blocks 
electrophilic palladation, thus rendering the carbopalladation pathway favorable. 
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Table 3-6. Scope of cyclic enaminones for the direct C–H arylationa 
N
O
+
Pd(OAc)2 (20 mol%)
Bu4NCl (0.5 equiv)
AgCl (1.2 equiv)
NaHCO3 (1.0 equiv)
DMSO, 80 ºC, 24 h
R3
R2
R1 N
O
R3
R2
R1H
OMe
OMe
I
3.25  
N
O
Me
OMe
H
H
N
O
Me
OMe
H
H
N
O
OMe
N
O
OMe
PhN
O
OMe
Bn
TBSO Ph
O
OMe
HN
OPh
N
O
OMe
OMe N
3.27, 50%3.26, 78% 3.28, 45%
3.30, 48%3.29, 63% 3.31, 60%
3.33, 0%c3.32, 0%b
N
O
OMe
3.34, 0%d
N
O
OMe
3.35, 0%e
Cbz Boc
Incompatible:
 
a cyclic enaminone (0.2 M), 3.25 (3.0 equiv), Pd(OAc)2 (20 mol %), Bu4NCl (0.5 equiv), 
NaHCO3 (3.0 equiv), AgCl (1.2 equiv) in DMSO (0.5 mL), 24 h. Isolated yields. b 60% 
recovered starting enaminone. c 65% recovered starting enaminone. d 15% recovered 
starting enaminone. e 27% recovered starting enaminone. 
 
N
O
N
O
Cbz
Boc
+
+
3.25
3.25
Pd(OAc)2 (20 mol%)
Bu4NCl (0.5 equiv)
AgCl (1.2 equiv)
NaHCO3 (1.0 equiv)
DMSO, 80 ºC, 24 h
Pd(OAc)2 (20 mol%)
Bu4NCl (0.5 equiv)
AgCl (1.2 equiv)
NaHCO3 (1.0 equiv)
DMSO, 80 ºC, 24 h
H
H
N
O
N
O
Cbz
Boc
OMe
OMe
3.36 3.37, 60%
3.38 3.39, 31%  
Scheme 3-3. C6-arylation of electron-deficient cyclic enaminones. 
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3.5 Mechanistic discussion 
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Figure 3-2. Proposed mechanism of direct arylation of cyclic enaminones. 
 
Mechanistically, the aforementioned electrophilic palladation pathway (Figure 3-1) 
for direct arylation can account for the observed C5-regioselectivity, the silver salt effect, 
the solvent dependency, and the substituent effects. Presumably, AgCl abstracts the 
iodide from the Pd oxidative adduct (i.e. Ar–Pd–I) to generate a cationic [Ar–Pd]+ 
complex, whose electrophilicity matches the innate C5-nucleophilicity of enaminones to 
yield C5-arylated enaminones. This unique C5-regioselectivity is enhanced by DMSO 
because the cationic [Ar–Pd]+ species should be stabilized by this highly polar and 
coordinating solvent. In addition, the [Ar–Pd]+ species should also be stabilized by 
electron-donating substituents, which would lead to less catalyst degradation and 
subsequently higher yields (e.g. 80% of 3.16 vs. 32% of 3.23). It is worth noting that a 
concerted-metalation-deprotonation (CMD) mechanism cannot be excluded at this time. 
However, the lack of reactivity of the electron-deficient enaminones (3.36 and 3.38) 
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indicates a low possibility for this process, which often works well on electron-deficient 
substrates.367 In addition, a PdII/PdIV catalytic cycle, albeit not ruled out, is also less likely 
because (1) more than one catalytic turnover was observed in the absence of silver salts 
(e.g. Table 3-2, entry 7, TON = 2.5), suggesting that silver salts did not serve to 
regenerate the Pd catalyst;194 (2) our initial optimization also demonstrated that other Pd0 
catalysts (e.g. Table 3-1, entries 2-3, Pd(dba)2 or Pd2(dba)3) would catalyze C5-arylation 
as well, albeit in low yields (8–11%).  
Therefore, we propose the following mechanism (Figure 3-2): First, the pre-catalyst 
Pd(OAc)2 is reduced in situ to Pd0, which undergoes oxidative addition with iodide I to 
form the adduct II. Silver chloride then abstracts the iodide anion from the Pd center and 
presumably generates a cationic PdII species III, which subsequently palladates the 
strongly nucleophilic enaminone IV to form the key intermediate VI after deprotonation 
by a base. Finally, reductive elimination furnishes the desired C5-arylated product VII 
with the regeneration of Pd0. 
 
3.6 Summary 
We have developed a straightforward method for the regioselective C–H arylation of 
cyclic enaminones with aryl iodides. In spite of showing reduced but nevertheless good 
yields compared to our earlier arylation protocols, the new method reported herein 
utilizes aryl iodides with broader commercial availability. This transformation tolerates a 
wide range of substrates and presents an alternative approach to synthesize 3-
arylpiperidine derivatives.  
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Chapter 4  PdII-Catalyzed Dehydrogenative Alkenylation of Cyclic Enaminones 
 
4.1 Introduction 
In order to further elaborate the cyclic enaminone scaffold and enhance its synthetic 
utility, we began to investigate a C–H alkenylation reaction on the C5-position. 
Following the strategy of C–H arylation of cyclic enaminones with aryl trifluoroborates 
(Figure 4-1, route a),79 we planned to use alkenyl trifluoroborates to synthesize the 
alkenylated enaminone VI (Figure 4-1, route b). Unfortunately, no desired product was 
observed. We speculated that the rate of transmetallation with the alkenyl reagents 
surpassed that of C5-palladation and as a result homocoupling depleted the alkenyl 
precursors and reoxidants. 
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O
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H PdII
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O
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N
O
R
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N
O
R
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O
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N
O
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H
KF3B Ar
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Scheme 4-1. PdII-catalyzed cross-coupling reactions of cyclic enaminones. 
 
4.2 Coupling strategy 
To address this problem, we examined the feasibility of a dehydrogenative 
alkenylation reaction (Figure 4-1, route c) to access 5-alkenyl enaminone derivatives. 
Notably, dehydrogenative processes of this sort that use two C–H bonds to form a new 
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C–C bond are highly sought after, because they require no prefunctionalization of either 
substrate and as a result have high atom economy.90, 92, 137, 138, 335 Key to this strategy 
would be the use of alkenes with complementary reactivity. We envisioned that the 
palladated enaminone II could be orthogonally intercepted by an electron-deficient 
alkene to furnish product VI. 
 
X
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Scheme 4-2. Development of the Fujiwara-Moritani reaction. 
 
The Fujiwara-Moritani reaction is a process by which aromatic substrates undergo 
intermolecular dehydrogenative alkenylation. As mentioned in Chapter 2.7.2, this 
reaction was initially developed using stoichiometric amounts of PdII (Figure 4-2a),280 but 
soon thereafter was shown to also take place with catalytic amounts of PdII (Figure 4-
2b).310, 368 In recent years, the scope of the Fujiwara-Moritani reaction has been expanded 
to a plethora of aromatic substrates.369-372 However, only a small number of 
dehydrogenative reactions involving two alkenyl C–H donors (Figure 4-2c) have been 
reported.136, 328, 330-333, 373 They are largely limited to select substrates, require high Pd 
loading, and need long reaction time. The realization of dehydrogenative alkenylation of 
cyclic enaminones will not only furnish convenient access to 3-alkenyl piperidine 
scaffolds, but also provide new examples to the field of cross-dehydrogenative coupling.  
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4.3 Condition optimization 
We selected enaminone 4.1 as the substrate and examined its reaction with tert-
butyl acrylate (4.2) (Table 4-1). Pd(OAc)2 (10 mol %) was initially selected because of its 
well-established reactivity.79, 374 
 
4.3.1 Solvent study 
Table 4-1. Solvent effect on the dehydrogenative alkenylation  
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (2.0 equiv)
solvent
80 °C, 24 h
4.1 4.2 4.3  
Entrya Solvent % Consumptionb % Yieldc 
1 toluene 52 33 
2 tAmOH 100 67 
3 tBuOH 100 55 
4 dioxane 100 64 
5 DMSO 100 53 
6 DMF 97 78 
7 NMP 100 78 
8 AcOH 92 8 
9 DMA 100 70 
10 CH3CN 97 67 
11 DMF/DMSO (20:1) 100 75 
12 NMP/DMSO (20:1) 100 75 
13 DMF/AcOH (4:1) 58 47 
14 DMF/AcOH/DMSO (20:5:1) 60 51 
a Other reaction conditions: enaminone 4.1 (0.4 mmol), 4.2 (2.0 equiv), Pd(OAc)2 (10 
mol%), Cu(OAc)2 (2.0 equiv) without additives under N2 at 80 °C through 24 h. b NMR 
% conversion of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal 
standard. c  NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
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An array of common solvents was examined (Table 4-1), and the choice of solvents 
showed significant effect on the yields.375, 376 Except for toluene (entry 1), all other single 
solvent systems proceeded with greater than 90% consumption, providing 8–78% of the 
desired product (entries 2–10). The acidic medium, acetic acid (entry 8), gave the poorest 
yield (8%), presumably due to the instability of the enaminones in an acidic environment. 
The highest yield (78%) was obtained in the presence of DMF (entry 6) or NMP (entry 
7). Together with DMA (entry 9), these three examples indicate that a nitrogen-
containing solvent may facilitate the catalytic process. Presumably this is because their 
coordinating ability may contribute to the stability of the PdII catalyst.  
Multi-solvent media were also examined. Mixing DMSO with either DMF or NMP 
gave the same yield after 100% consumption of enaminone 4.1 (entries 11–12). Although 
aprotic polar DMSO can function as a good ligand for the Pd catalyst, the 20:1 formula 
failed to improve the outcome. Neither did the combination of DMP, AcOH and DMSO 
(entries 13–14), where the consumption and yield both dropped to 50–60%. We again 
attribute this to the instability of enaminones in AcOH. As solvent mixtures were inferior 
to single solvents, less costly DMF was chosen for the subsequent optimization studies.  
 
4.3.2 Reoxidant study 
Eight more reoxidants were assessed in addition to Cu(OAc)2 (Table 4-2). CuCl2 and 
Cu(OTf)2 yielded no product at all (entries 2–3). Reducing the loading of Cu(OAc)2 to 
1.0 equiv under air or O2 resulted in similar consumption of 4.1, but lowered the yields to 
60–70% (entries 4–5). It is interesting to note that the yield obtained under an O2 
atmosphere was lower than that attained under air. Possibly, excess O2 could oxidize the 
enaminones in situ, therefore decreasing the yield. AgI salts, tert-butyl benzoperoxoate, 
and duroquinone were also tested and were not successful in increasing the yield of 4.3 
(entries 6–9). Hence, we continued to use Cu(OAc)2 as the most effective reoxidant. 
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Table 4-2. Reoxidant effect on the dehydrogenative alkenylation 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
reoxidant
DMF
80 °C, 24 h
4.1 4.2 4.3  
Entrya Reoxidant (equiv) % Consumptionb % Yieldc 
1 Cu(OAc)2 (2.0) 97 78 
2 CuCl2 (2.0) 77 0 
3 Cu(OTf)2 (2.0) 72 0 
4 Cu(OAc)2 (1.0) + air 94 70 
5 Cu(OAc)2 (1.0) + O2 98 60 
6 AgOAc (2.0) 81 43 
7 Ag2O (1.0) 41 6 
8 PhCO3tBu (1.0) 98 59 
9 duroquinone (1.0) 23 5 
a Other reaction conditions: enaminone 4.1 (0.4 mmol), 4.2 (2.0 equiv), Pd(OAc)2 (10 
mol%) without additives in DMF under N2 at 80 °C through 24 h. b NMR % conversion 
of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal standard. c  NMR % 
yield with Ph3SiMe (1.0 equiv) as the internal standard. 
 
4.3.3 Additive study 
Table 4-3 summarizes the effect of various additives on the alkenylation. The yield of 
4.3 was improved in most cases. The addition of lithium salts guaranteed a 100% 
consumption of 4.1 with the yields around 78% (entries 2–3). Three chloride additives 
showed varied results, indicating group I metals could be a good cation source (entries 3–
5), which is echoed by the comparable yields from the acetate salts of three group I 
metals (entries 6–8). We also tested carbonate and phosphate salts but no yield 
improvement was observed (entries 9–11). When KTFA was employed (entry 12), we 
obtained the highest yield (85%), which was verified by the isolated yield (81%). 
Surprisingly, the acid-sensitive enaminone tolerated the presence of 1.0 equiv of the 
strong acid TFA and afforded a similar yield (80%, entry 13). We speculate that the anion 
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exchange between TFA and OAc of Pd(OAc)2 may render the PdII center more 
electrophilic, thus more prone to electrophilic palladation. In addition, we also 
investigated the effect of varied additive concentrations. 1.0 equiv of KTFA was found 
the most effective in regard to the consumption and the yield (entries 12 and 14–15). 
 
Table 4-3. Additive effect on the dehydrogenative alkenylation 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (2.0 equiv)
additive
DMF, 80 °C, 24 h
4.1 4.2 4.3  
Entrya Additive (equiv) % Consumptionb % Yieldc 
1 — 97 78 
2 LiBF4 (1.0) 100 80 
3 LiCl (1.0) 100 76 
4 BiCl3 (1.0) 96 39 
5 MgCl2 (1.0) 86 51 
6 NaOAc (1.0) 94 78 
7 CsOAc (1.0) 92 77 
8 KOAc (1.0) 95 82 
9 Cs2CO3 (1.0) 94 79 
10 K2CO3 (1.0) 82 68 
11 K3PO4 (1.0) 90 75 
12 KTFA (1.0) 100          85 (81d) 
13 TFA (1.0) 100 80 
14 KTFA (0.5) 94 80 
15 KTFA (2.0) 98 80 
a Other reaction conditions: enaminone 4.1 (0.4 mmol), 4.2 (2.0 equiv), Pd(OAc)2 (10 
mol%), Cu(OAc)2 (2.0 equiv) with additives in DMF under N2 at 80 °C through 24 h. b 
NMR % conversion of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal 
standard. c  NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. d Isolated 
yield. 
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4.3.4 Temperature effect 
With the best solvent, reoxidant, and additive in hand, we continued to investigate the 
temperature impact on catalysis (Figure 4-1). Raising temperature from room temperature 
to 110 °C at 30 °C intervals increased the consumption of the starting material from 72% 
up to 100% (red bars). The yield followed a similar pattern (green bars), while the peak 
(85%) occurred at 80 °C. Further increasing the temperature up to 110 °C lowered the 
yield by 16%, presumably due to the thermal decomposition of enaminones. 
 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (2.0 equiv)
KTFA (1.0 equiv)
DMF, 24 h
temp
4.1 4.2 4.3  
 
a Other reaction conditions: enaminone 4.1 (0.4 mmol), 4.2 (2.0 equiv), Pd(OAc)2 (10 
mol%), Cu(OAc)2 (2.0 equiv) with KTFA (1.0 equiv) in DMF under N2 through 24 h. 
NMR % conversion of the starting enaminone and NMR % yield with Ph3SiMe (1.0 
equiv) as the internal standard. 
 
Figure 4-1. Temperature effect on the dehydrogenative alkenylation.a 
 
  °C 
% 
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4.3.5 Reaction time control 
Figure 4-2 illustrates the coupling process in a 24 h period. The consumption of the 
starting material was monitored with 1H NMR by testing every 0.1 ml aliquot from the 
mixture when the reaction reached 0.5, 1, 3, 5, 9, 12, and 24 h respectively. As indicated 
in the graph, the reaction went to completion within 3 h. During the succeeding 21 h, the 
yield remained constant, suggesting that the product was stable under the reaction 
conditions. The marginal deviations in yields may be attributed to the stochastic errors of 
1H NMR integration measurement. 
 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (2.0 equiv)
KTFA (1.0 equiv.)
DMF, 80 °C
time
4.1 4.2 4.3  
 
a Other reaction conditions: enaminone 4.1 (0.4 mmol), 4.2 (2.0 equiv), Pd(OAc)2 (10 
mol%), Cu(OAc)2 (2.0 equiv) with KTFA (1.0 equiv) in DMF under N2 at 80 °C. NMR 
% conversion of the starting enaminone and NMR % yield with Ph3SiMe (1 equiv) as the 
internal standard.  
 
Figure 4-2. Reaction time effect on the dehydrogenative alkenylation.a 
 
h 
% 
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4.3.6 Stoichiometry investigation 
Finally, the effect of stoichiometry was probed (Table 4-4). It is worth mentioning 
that the reaction time was kept at 24 h for the purpose of consistency. Entries 1–4 
demonstrate that by lowering the catalyst concentration not only did the consumption rate 
drop significantly, but the yield also decreased to 30%. In addition, the decrease of the 
alkene concentration furnished less product (entries 5–6). Lastly, we found that the 
variation of the reaction scale had no positive influence on yields (entries 7–9).  
Therefore, the optimized conditions for C–H alkenylation of enaminones are 
Pd(OAc) (10 mol %) with alkene (2.0 equiv), Cu(OAc)2 (2.0 equiv), and KTFA (1.0 
equiv) in DMF at 80 ºC on a 0.4 M scale.  
 
Table 4-4. Stoichiometry study on the dehydrogenative alkenylation 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2
Cu(OAc)2 (2.0 equiv)
KTFA (1.0 equiv)
DMF, 80 °C, 24 h
4.1 4.2 4.3  
Entrya 4.1  (M) 
4.2 
(equiv) 
Pd(OAc)2 
(mol %) 
% 
Consumptionb 
% 
Yieldc 
 1d 0.4 2.0 10 100 85 (81e) 
2 0.4 2.0 5 100 83 
3 0.4 2.0 2.5 88 72 
4 0.4 2.0 1 48 30 
5 0.4 1.5 5 98 76 
6 0.4 1.1 5 93 68 
7 0.1 2.0 5 98 76 
8 0.2 2.0 5 99 81 
9 0.8 2.0 5 98 71 
a Other reaction conditions: Cu(OAc)2 (2.0 equiv) with KTFA (1.0 equiv) in DMF under 
N2 at 80 °C through 24 h. b  NMR % conversion of the starting enaminone with Ph3SiMe 
(1 equiv) as the internal standard. c  NMR % yield with Ph3SiMe (1 equiv) as the internal 
standard. d The best conditions after the previous screens. e Isolated yield. 
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4.4 Investigation of the reaction scope 
With the optimized reaction conditions in hand, we embarked on exploring the 
substrate scope. A series of substituted alkenes and cyclic enaminones were evaluated. 
 
4.4.1 Alkene scope 
Table 4-5. Scope of alkenes for dehydrogenative alkenylation of cyclic enaminonesa 
N
O
Bn
+ R2
PMP Pd(OAc)2 (10 mol %)Cu(OAc)2 (2.0 equiv)
N
O
Bn
PMP
R2
4.1
KTFA (1.0 equiv)
DMF, 80 °C, 3 hR1
R3
R1
R3
 
N
O
Bn
PMP
CO2Me
N
O
Bn
PMP
CO2nBu
N
O
Bn
PMP
CO2Bn
N
O
Bn
PMP
COMe N
O
Bn
PMP
CONMe2
N
O
Bn
PMP
PO(OEt)2
N
O
Bn
PMP
Ph N
O
Bn
PMP
S(O)2Me
N
O
Bn
PMP
CO2H
N
O
Bn
PMP
OnBu
N
O
Bn
PMP
N
O
Bn
PMP
CO2tBu
N
O
Bn
PMP
O
O
N
O
Bn
PMP
CO2Me
4.3, 81% 4.4, 82%
4.9, 68%
4.5, 87%
4.10, 66%
4.6, 91%
4.11, 56%
4.7, 85%
4.12, ≤3%
4.8, 95%
4.13, ≤3% 4.14, 42%
4.16
(49%, a:b = 1:1.1c)
4.15
(83%, a:b = 1:2.5b)
a
b
a b
 
a Conditions: 4.1 (0.4 M), alkene (2.0 equiv), Pd(OAc)2 (10 mol %), Cu(OAc)2 (2.0 
equiv), KTFA (1.0 equiv) in DMF under N2 at 80 °C for 3 h. Isolated yield. b Isolated 
ratio. c 1H NMR ratio. 
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We were pleased to find that this direct alkenylation protocol was amenable to 
reaction with a variety of electron-deficient alkenes (Table 4-5). Acrylate esters and vinyl 
ketones readily reacted with 1, providing the desired dienes (4.3–4.7) in excellent yields 
up to 91%. Notably, the highest yield (95%) was observed with N,N-dimethylacrylamide 
(4.8). Phosphonates, styrene and sulfones were also viable coupling partners, yet 
furnishing the products (4.9–4.11) in slightly lower yields. Acrylic acid and vinyl ethers, 
however, failed to afford the desired products 4.12 or 4.13. 
Double bond isomerization in coupling products was observed in the cases of multi-
substituted alkenes bearing more than one β-hydrogen. Although methyl crotonate only 
formed a single E-isomer (4.14), α-methylene-γ-lactones afforded both the conjugated 
and unconjugated (to enaminone) diene products with a greater preference for the latter 
(4.15a:4.15b=1:2.5). This preference for the formation of unconjugated dienes has been 
previously noted.377-379  Interestingly, alkenylation of cyclohexene yielded two 
inseparable, unconjugated dienes (4.16a/4.16b). Mechanistically, we speculated that 
4.16b was generated from 4.16a through in situ Pd–H insertion and immediate β-H 
elimination.380 
 
4.4.2 Cyclic enaminone scope 
We next assessed a series of cyclic enaminones (Table 4-6). We found that this 
reaction could be extended to monocyclic and bicyclic, electron-rich enaminones (4.17–
4.22, 4.25) with yields up to 92%. Notably, compared to N-alkylenaminones, N-
phenylenaminone could afford a slightly decreased yield of 4.17 despite its attenuated 
nucleophilicity. Bicyclic enaminones generally gave lower yields than their monocyclic 
counterparts, where the indolizidine enaminone (4.20, 73%) appeared to be less effective 
in this reaction than the quinolizidine scaffold (4.21, 86%). Possibly, the conjugation 
between the lone pair of  the nitrogen and the p-orbitals of the double bond is impaired 
due to the more constrained 5,6-bicyclic scaffold of 4.20, which results in a less 
nucleophilic enaminone towards electrophilic palladation. We were glad to find that 
alkenylation of the diastereomeric substrates (4.22/4.25) took place without epimerization 
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of the stereocenters and with virtually the same yields. However, the installation of a C6-
methyl substituent on the cyclic enaminone significantly decreased the yield of 4.23 
presumably due to the steric repulsion to either palladation or migratory insertion.  
 
Table 4-6. Scope of enaminones for dehydrogenative alkenylation of cyclic enaminonesa 
N
O
R3
+ CO2tBu
R2 Pd(OAc)2 (10 mol %)Cu(OAc)2 (2.0 equiv)
N
O
R3
R2
CO2tBu
4.2
KTFA (1.0 equiv)
DMF, 80 °C, 3 h
R1 R1
R4 R4  
N
O
CO2tBu
N
O
Bn CO2tBu N
O
Me CO2tBu
N
O
Me CO2tBu
N
O
Me CO2tBu
N
O
BnN
O
Ph CO2tBu
4.25, 75%
4.22, 77%4.21, 86%
4.18, 84%
4.23, 22%
4.19, 92%4.17, 76%
N
O
CO2tBu
4.20, 73%
CO2tBu
HN
OPh
CO2tBu
N
O
Bn
N
N
OO
N
O
Cbz
PMP
CO2tBu
4.26, 7%
4.24, 33%
4.28, 0%
CO2tBu
CO2tBu
H
H
H
H
4.27, 6%
O
4.29, 0%
CO2tBu
NMe2
 
a Conditions: enaminone (0.4 M), 4.2 (2.0 equiv), Pd(OAc)2 (10 mol %), Cu(OAc)2 (2.0 
equiv), KTFA (1.0 equiv) in DMF under N2 at 80 °C for 3 h. Isolated yield. 
 
A small collection of cyclic enaminones was found incompatible under the optimized 
conditions. Interestingly, 4-pyridone was found to furnish a mono-coupling product 4.26 
albeit in only 7% yield. The N-unsubstituted enaminone only furnish 6% of the desired 
product 4.27 possibly due to the Pd catalyst poisoning by the free N-H group. N-Cbz 
enaminone (4.28) also showed no reactivity. We speculate that the electron-withdrawing 
nature of the Cbz group may significantly hamper the enaminone’s nucleophilicity, which 
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is vital for electrophilic palladation. An E-enaminone was also tested, but product 4.29 
was not observed. These results, however, are consistent with our previous findings.79-81 
As structurally akin to the enaminone scaffold, 1,3-dimethyluracil was also subjected 
to the optimized conditions. To our disappointment, only 33% of the desired alkenylated 
uracil 4.24 was formed with a large amount of 1,3-dimethyluracil remaining. We 
presume that the nucleophilicity of uracils is tempered by aromatic delocalization and the 
electron-withdrawing C2-carbonyl. Our 1H NMR study revealed that the chemical shifts 
for the two alkenyl protons from N-methylenaminone were 4.92 (C5) and 6.98 (C6) ppm, 
whereas those from 1,3-dimethyluracil were 5.74 (C5) and 7.17 (C6) ppm (Scheme 4-3). 
The chemical shift differences of the enaminone (2.06 ppm) vs. those of the uracil (1.43 
ppm) indicate a more polarized double bond (i.e. a more nucleophilic C5 and a more 
electrophilic C6). This preliminary observation may help to understand the reduced 
reactivity of 1,3-dimethyluracil. Nevertheless, due to the medicinal importance of 5-
alkenyluracils,381-385 the development of a high-yielding dehydrogenative alkenylation 
method for uracils was pursued and will be discussed in Chapter 5. 
 
N
N
N
O
O
Me
MeMe
O
H H
HH 4.92 ppm
6.98 ppm
5.74 ppm
7.17 ppm
Δ = 2.06 ppm Δ = 1.43 ppm
more polarized
double bond
less polarized
double bond  
Scheme 4-3. Chemical shifts of C5- and C6-protons from enaminone and uracil. 
 
4.5 Mechanistic study 
To probe the alkenylation mechanism, a mechanistic analysis of the initial interaction 
of PdII with enaminone 4.1 was carried out by 1H NMR (in DMSO-d6 at room 
temperature, Figure 4-3). 50 mol % of Pd(OAc)2 with 4.1 (Figure 4-3.2) furnished 
intermediate 4.30 at room temperature along with the same amount of acetic acid and 
unreacted 4.1. With 100 mol % of Pd(OAc)2 (Figure 4-3.3), a complete conversion of 4.1 
was observed after only 20 min, furnishing only 4.30 and acetic acid. The full spectrum is 
shown in Figure 4-4.  
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Figure 4-3. Palladation monitored by 1H NMR (in DMSO-d6). 
 
Intermediate 4.30 was further converted to product 4.3 under the treatment of 2.0 
equiv of acrylate 4.2 (Table 4-7).  Surprisingly, DMSO showed a strong stabilizing effect 
on 4.30 and only afforded 7% of 4.3 at the optimized temperature (80 ºC, entry 1). 
Raising the temperature did increase the yield presumably by breaking down the ligation 
of DMSO to activate the intermediate (entries 2–4). However, due to the thermal 
instability of 4.3 seen in Figure 4-1, the conversion (20%) at 140 ºC is not optimal. 
Nevertheless, the proposed intermediate 4.30 is proven to furnish the desired product. 
This suggests that the C–C bond formation may be the rate-limiting step. It is worth 
noting that intermediate 4.30 was not detected when DMF-d7 was used as the solvent, 
presumably because DMF does not stabilize 4.30 as well as DMSO.386 The discrepancy 
of their stabilizing effect as solvents was also shown in the yield of 4.3, where 78% was 
produced in DMF compared to 53% in DMSO (Table 4-1, entries 5 and 6). 
N
O
Bn
PMP Pd(OAc)2
rt, DMSO-d6
20 min
N
O
Bn
PMP
PdIIOAc
+ HOAc
H
H
H
4.1 4.30
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Figure 4-4. 1H NMR spectrum of palladation with Pd(OAc)2 (100 mol %, in DMSO-d6). 
 
Table 4-7. Conversion of product 4.3 from intermediate 4.30 
4.1
Pd(OAc)2 (100 mol %)
DMSO-d6
rt, 20 min
N
O
Bn
PMP
PdIIOAc
4.30
4.2 (2 equiv)
4.3
DMSO-d630 min, varied temp
 
Entrya Temp (ºC) % Yieldb 
1 80 7% 
2 100 10% 
3 120 18% 
4 140 20% 
a Procedure: 4.1 (29.3 mg, 0.10 mmol) was mixed with 100 mol % of Pd(OAc)2 in 
DMSO-d6 (1.0 mL) at rt under N2 for 20 min, followed by the addition of 4.2 (2.0 equiv). 
Reaction was further stirred at different temperatures for 30 min. The reaction was then 
quenched with 0.5 g of K2CO3 and filtered. The filtrate was concentrated and subjected to 
1H NMR analysis. b 1H NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
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Figure 4-5. Proposed mechanism of dehydrogenative alkenylation of cyclic enaminones. 
 
We therefore suggest a detailed catalytic cycle of the dehydrogenative alkenylation 
reaction (Figure 4-5). The key steps are: (1) The dissociation of Pd(OAc)2 forms an 
electrophilic cationic species VIII. (2) The electrophilic attack of [Pd(OAc)]+ onto the 
C=C bond of cyclic enaminone I followed by deprotonation generates the palladated 
intermediate X. (3) The alkene XI inserts into the newly formed Pd–C bond in a syn 
fashion. (4) β-Hydride syn-elimination occurs in the suitable conformer XIV as a result 
of the C–C bond rotation to furnish the final product VI along with palladium hydride 
XV. (5) The reductive elimination releases HOAc to form Pd0, which is then reoxidized 
by Cu(OAc)2 to regenerate the PdII catalyst.  
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4.6 Summary 
We developed a convenient and highly atom-economic approach for the 
dehydrogenative coupling of cyclic enaminones and unfunctionalized alkenes. This 
method addressed the problem of using alkenyl trifluoroborates as the alkene source, and 
expanded the reaction mode of cyclic enaminones from direct arylation to alkenylation. 
The generality of this transformation presents a useful strategy for directly cross-coupling 
alkenes and offers an attractive new approach to prepare 3-alkenyl piperidine scaffolds. 
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Chapter 5  PdII-Catalyzed Dehydrogenative Alkenylation of Uracils 
 
5.1 Introduction 
Functionalization of uracils at the C5-position is of interest for the purpose of 
labeling387-389 and the preparation of bioactive uracil derivatives.390-393 The C5-position of 
pyrimidines is the location of choice for structural modification because this site is not 
involved in Watson-Crick base pairing.394 5-Alkenyluracils have been shown to exhibit 
antitumor381, 395 and potent antiviral activities (Scheme 5-1).382-385 Structure-activity 
relationship (SAR) studies demonstrated that the antiviral activity was enhanced when 
the C5-position was equipped with an unsaturated, E-configured substituent bearing a 
hydrophobic electronegative functionality (such as an amide) in conjugation with the 
pyrimidine ring.396, 397 
 
     
N
H
HN
O
O
N
H
O
OH
S
O
S C8H17
5.1       
HN
N
O
OH
HO
O
O
Br
5.2  
Antitumor Leukemia L1210  Antiviral HSV-1 (KOS) VZV (YS) 
ID50 (µg/mL) 0.05  MIC (µg/mL) 0.02 0.001 
Scheme 5-1. Antitumor and antiviral activities of 5-alkenyluracils.  
 
C5-alkenylation of uracils has in the past typically involved transition metal-catalyzed 
cross-coupling reactions between pre-activated uracils (e.g. 5-iodo398, 399, 5-triflated400 
uracils) and metallated alkenes (e.g. stannane387, boron401). These methods rely on 
multistep reaction sequences, lack atom economy, and are therefore of low efficiency. In 
addition, toxic stannane impurities could be problematic for biological studies. Direct 
alkenylation of uracils in a dehydrogenative way would address all the above problems 
and provide an efficient method to synthesize 5-alkenylated uracils.90, 92, 137, 138, 335   
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5.2 Research progress on C–H functionalization of uracils 
Direct C–H functionalization chemistry has emerged as a powerful new tool to 
functionalize uracils. Hocek and co-workers first reported a protocol to regioselectively 
arylate uracils at the C5 position using aryl iodides (Scheme 5-2, top).402, 403 Interestingly, 
they also found that the coupling reaction in the presence of CuI furnished predominant 
C6-aryl derivatives. However, the yields and selectivity of C5-aryluracils were not 
satisfactory, and aryl iodides bearing electron-withdrawing groups were not compatible 
under their conditions. Later, Kim and co-workers devised another arylation protocol 
based on aryl bromides (Scheme 5-2, bottom).404 Although electron-deficient aryl 
bromides were tolerated in the new protocol, the yields and regioselectivity were 
moderate in most cases.  
 
N
N
O
R1
R2
O
+ I Ar
H
Pd(OAc)2 (5 mol%)
P(perFPh)3 (10 mol%)
Cs2CO3 (2.5 equiv)
DMF, 160 ºC
N
N
O
R1
R2
O
Ar
N
N
O
R1
R2
O
+ Br Ar
H
Pd(OAc)2 (10 mol%)
PPh3 (20 mol%)
PivOH (30 mol%)
K2CO3 (3 equiv)
DMF, 130 ºC
N
N
O
R1
R2
O
Ar
24–80%
Hocek group
Kim group
35–79%  
Scheme 5-2. Direct C–H arylation of uracils. 
 
During their study of the uracil substrate, Kim and co-workers also reported a Pd-
catalyzed C–H acetoxylation reaction (Scheme 5-3, top).405 This protocol can be applied 
to a collection of uracils and uridines with moderate to good yields. The mechanism was 
thought to proceed through an electrophilic palladation pathway. The PdII intermediate 
was further oxidized by PIDA (phenyliodonium diacetate) to form a PdIV species with 
high reactivity towards reductive elimination to generate the desired product. In addition, 
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the same group later examined the synthesis of uracil dimers (Scheme 5-3, bottom).406 
They found three types of homo-coupling dimers (i.e., C5–C5’, C5–C6’, and C6–C6’ 
linked dimers), the yield distribution of which largely depended on the reaction 
temperatures and time. Good yields were obtained for a series of uracil derivatives, 
including uracil nucleosides.  
 
N
N
O
R1
R2
O
H
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mesitylene (60 equiv)
120ºC, 4 h
N
N
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O
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N
N
O
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O
N
N
O
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O
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N
O
R1
R2
O
OAc
C–H acetoxylation
23–72%
+   PhI(OAc)2
 
Scheme 5-3. C–H acetoxylation and homo-coupling of uracils. 
 
Moreover, innate C–H trifluoromethylation was also achieved on uracils. MacMillan 
and co-workers developed a remarkable method via photoredox catalysis using 
Ru(phen)3Cl2 (Scheme 5-4, top).407 This trifluoromethylation reaction undergoes a 
radical-mediated mechanism under very mild conditions and has broad utility for 
trifluoromethylating a variety of non-preactivated aromatic and heteroaromatic systems, 
including 1,3-dimethyluracil with excellent yields. Meanwhile, Baran and co-workers 
employed peroxides to initiate a similar radical process for direct trifluoromethylation of 
a broad scope of electron-rich and electron-deficient heterocycles (Scheme 5-4, 
bottom).106 Their robust protocol is operationally simple, scalable, and proceeds at room 
temperature. Notably, uracil and 2’-deoxyuridine can also be trifluoromethylated without 
N- or O-protection. 
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Scheme 5-4. C–H trifluoromethylation of uracils. 
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Scheme 5-5. Research advances for the C–H alkenylation of uracils. 
 
In contrast, C–H alkenylation of uracils has been typically achieved using 
stoichiometric amounts of Pd (Scheme 5-5, top).  So far only one report has appeared that 
describes two examples employing catalytic Pd loading, using tert-butyl perbenzoate as 
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the reoxidant (Scheme 5-5, bottom).408 We therefore decided to investigate the substrate 
scope of the Pd-catalyzed direct C5-alkenylation in more detail. Herein, we disclose the 
development of an efficient dehydrogenative alkenylation of unactivated uracils with 
various alkenes via Pd-catalysis. 
 
5.3 Condition optimization  
We initiated our investigation with an extensive optimization of the alkenylation 
conditions (Table 5-1). Adapted from our alkenylation protocol for cyclic enaminones, 
1,3-dimethyluracil (5.3) and t-butyl acrylate (5.4) were chosen as test substrates with 
Pd(TFA)2 as the catalyst and DMF as the solvent. 
 
5.3.1 Reoxidant screening 
We first investigated the effect of reoxidants (Table 5-1). Alkenylation with 
Cu(OAc)2, as used in the enaminone protocol,341 only afforded a moderate yield (52%, 
entry 1). Additional CuII oxidants led to significantly reduced consumption of the starting 
uracil and yields (entries 2–4). Meanwhile, a few common organic oxidants were tested 
(entries 5–6). Duroquinone was chosen instead of o-quinone because o-quinone could 
react as an alkene coupling partner to compete with 5.4. (This was confirmed later in the 
study of the scope of the reaction, see 5.15.) Unfortunately, only 4% of the desired 
product was formed with duroquinone (entry 5). t-Butyl perbenzoate, used in the reported 
examples (Scheme 5-5),408 also failed to improve the coupling efficiency (entry 6). We 
then turned to Ag oxidants. Initial trials with a series of Ag salts showed very poor yields 
(entries 7–12). The use of Ag2CO3 increased the TON to 2, but the yield was still low 
(entry 13). In comparison, AgOBz (entry 14) showed better oxidation capability and 
provided a similar yield (55%) to that of Cu(OAc)2 (52%, entry 1). To our delight, 
AgOAc significantly improved the consumption of the starting uracil and increased the 
yield to 68% (entry 15).  
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Table 5-1. Reoxidant effect on the dehydrogenative alkenylation 
N
N
O
O
N
N
O
CO2tBu
CO2tBu
Pd(TFA)2 (10 mol %)
reoxidant
DMF, 80 ºC, 24 h O
+
5.3 5.4 5.5  
Entrya Reoxidant (equiv) % Consumptionb    % Yieldc 
1 Cu(OAc)2 (2.0) 74 52 
2 CuCl2 (2.0) 9 0 
3 Cu(OTf)2 (2.0) 8 6 
4 Cu(TFA)2 (2.0) 10 0 
5 duroquinone (2.0) 15 4 
6 PhCO3tBu (2.0) 60 45 
7 AgF2 (2.0) 0 0 
8 AgCl (2.0) 7 0 
9 AgNO3 (2.0) 10 3 
10 AgSbF6 (2.0) 32 0 
11 AgOTf (2.0) 27 0 
12 Ag2O (1.0) 26 11 
13 Ag2CO3 (1.0) 37 20 
14 AgOBz (2.0) 64 55 
15 AgOAc (2.0) 86 68 
a Reaction conditions: uracil 5.3 (0.2 M), acrylate 5.4 (2.0 equiv), Pd(TFA)2 (10 mol%), 
oxidant, DMF (0.5 mL) under air at 80 °C, 24 h. b 1H NMR % Consumption of the 
starting uracil with Ph3SiMe (1.0 equiv) as the internal standard. c  1H NMR % yield with 
Ph3SiMe (1.0 equiv) as the internal standard. 
 
5.3.2 Additive study 
We next examined the effect of additives (Table 5-2). Addition of K2CO3 was 
detrimental to the reaction, where significant reduction of yield was observed (entry 2). 
With regard to acids, the strong acid TFA showed similar reaction inhibition as K2CO3 
did (entry 3). The use of the weak acid AcOH virtually has no effect on the alkenylation 
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yield (70%, entry 4 vs. 68%, entry 1). When a weaker acid, pivalic acid (PivOH), was 
used, the consumption of the starting uracil was almost complete, which furnished the 
desired 5-alkenyluracil in a 77% yield (entry 5). Given the above results, we speculated 
that the OAc anion had little effect on the coupling process and AgOPiv formed in situ by 
anion exchange might be the real effective oxidant/additive. Therefore, the combination 
of Ag2O and PivOH was assessed to generate AgOPiv in situ for direct alkenylation of 
uracils. Indeed, a comparable yield was recorded, albeit slightly lower (entry 6).   
 
Table 5-2. Additive effect on the dehydrogenative alkenylation 
N
N
O
O
N
N
O
CO2tBu
CO2tBu
Pd(TFA)2 (10 mol %)
AgOAc (2 equiv)
additive
DMF, 80 ºC, 24 h O
+
5.3 5.4 5.5  
Entrya Reoxidant (equiv) Additive (equiv) % Consumptionb % Yieldc 
1 AgOAc (2.0) – 86 68 
2 AgOAc (2.0) K2CO3 (2.0) 37 19 
3 AgOAc (2.0) TFA (2.0) 34 24 
4 AgOAc (2.0) AcOH (2.0) 86 70 
5 AgOAc (2.0) PivOH (2.0) 96 77 
6 Ag2O (1.0) PivOH (2.0) 88 74 
a Reaction conditions: uracil 5.3 (0.2 M), acrylate 5.4 (2.0 equiv), Pd(TFA)2 (10 mol%), 
AgOAc (2.0 equiv), additive, DMF (0.5 mL) under air at 80 °C, 24 h. b 1H NMR % 
Consumption of the starting uracil with Ph3SiMe (1.0 equiv) as the internal standard. c  1H 
NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
 
The effectiveness of this Pd/Ag/PivOH combination, employed in many recent C–H 
activation reactions,130, 333, 409, 410 can be attributed to both lowered transition state 
energies and increased basicity of its conjugated base serving as a proton shuttle.124-126 
However, the concerted-metalation-deprotonation (CMD) mechanism125 is less likely 
because the uracil C6-proton is more acidic than the C5-proton,411 which would predict 
C6-alkenylation if this mechanism was at work, but does not correlate with the observed 
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exclusive C5-regioselectivity. Nonetheless, we cannot rule out the possibility of a Pd 1,2-
migration. 
 
5.3.3 Solvent effect 
An array of solvents was also examined (Table 5-3). DMSO showed significant 
coupling inhibition (entry 1). Possibly, its strong coordinating ability decreased the 
electrophilicity of the PdII catalyst and impeded the electrophilic palladation process. 
Other polar solvents gave better but similar yields, while less polar solvents (e.g. 
dioxane) gave slightly lower yields (entries 2–7). Among all the solvents, the initially 
chosen DMF turned out to be optimal (entry 4). 
 
Table 5-3. Solvent effect on the dehydrogenative alkenylation 
N
N
O
O
N
N
O
CO2tBu
CO2tBu
Pd(TFA)2 (10 mol %)
AgOAc (2 equiv)
PivOH (2 equiv)
solvent, 80 ºC, 24 h O
+
5.3 5.4 5.5  
Entrya Solvent (0.5 mL) % Consumptionb % Yieldc 
1 DMSO 38 24 
2 MeCN 76 62 
3 NMP 92 64 
4 DMF 96 77 
8 DMA 90 72 
5 THF 94 66 
6 dioxane 100 58 
7 tBuOH 78 52 
a Reaction conditions: uracil 5.3 (0.2 M), acrylate 5.4 (2.0 equiv), Pd(TFA)2 (10 mol%), 
AgOAc (2.0 equiv), PivOH (3.0 equiv), solvent, under air at 80 °C, 24 h. b 1H NMR % 
Consumption of the starting uracil with Ph3SiMe (1.0 equiv) as the internal standard. c  1H 
NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
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5.3.4 Catalyst choice  
Table 5-4. Catalyst efficiency on the dehydrogenative alkenylationa 
N
N
O
O
N
N
O
CO2tBu
CO2tBu
Catalyst
AgOAc, PivOH
DMF, 80 ºC, 24 h O
+
5.3 5.4 5.5  
Entry Catalyst (mol%) AgOAc (equiv) PivOH (equiv) % Consumptionb % Yieldc 
1 Pd(TFA)2 (10) 2.0 2.0 96 77 
2 Pd(OAc)2 (10) 1.1 2.0 76 58 
3 Pd(OAc)2 (10) 2.0 2.0 95 80 
4 Pd(OAc)2 (10) 2.5 2.0 100 85 
5 Pd(OAc)2 (10) 3.0 2.0 100 85 
6 Pd(OAc)2 (1) 2.5 2.0 73 66 
7 Pd(OAc)2 (1) 4.0 2.0 65 57 
8 Pd(OAc)2 (5) 1.5 2.0 79 67 
9 Pd(OAc)2 (5) 2.0 2.0 93 83 
10 Pd(OAc)2 (5) 2.5 2.0 100 84 
11 Pd(OAc)2 (5) 3.0 2.0 100 82 
12 Pd(OAc)2 (5) 2.5 0.5 94 79 
13 Pd(OAc)2 (5) 2.5 2.5 100 83 
14 Pd(OAc)2 (5) 2.5 3.0 100 83 
15d [Cp*RhCl2]2 (5) – – 20 0 
a Reaction conditions: uracil 5.3 (0.2 M), acrylate 5.4 (2.0 equiv), catalyst, AgOAc, 
PivOH, DMF (0.5 mL) under air at 80 °C, 24 h. b 1H NMR % Consumption of the starting 
uracil with Ph3SiMe (1.0 equiv) as the internal standard. c  1H NMR % yield with 
Ph3SiMe (1.0 equiv) as the internal standard. d With AgSbF6 (20 mol%) and Cu(OAc)2 
(2.0 equiv) in THF. 
 
The reason we chose Pd(TFA)2 as the initial catalyst was because of the beneficial 
effect of KTFA in our C–H alkenylation protocol for cyclic enaminones (Table 4-3, entry 
12). We assumed that the anionic ligand exchange between Pd(OAc)2 and KTFA would 
form Pd(TFA)2 in situ, producing a more electron-deficient thus more reactive PdII center 
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for electrophilic palladation. Our hypothesis was later supported by a tentative Pd(TFA)2-
catalyzed alkenylation of cyclic enaminone with a similar yield (83%) compared to 81% 
under the optimized Pd(OAc)2/KTFA conditions.  
As mentioned in Section 5.3.2, more basic anionic ligands were beneficial to the 
current alkenylation. We hence returned to Pd(OAc)2 as the catalyst, which indeed 
showed better catalytic efficacy (Table 5-4). With the same loading (10 mol %), 
Pd(OAc)2 afforded a slightly better yield (80%, entry 3) than Pd(TFA)2 (77%, entry 1). 
Increasing the concentration of oxidant AgOAc helped to increase the yield to 85% 
(entries 2–5).  
We then studied the effect of reduced Pd loadings. Alkenylation using only 1 mol % 
of Pd(OAc)2 gave significantly poorer outcome (66%, entry 6), and adding more oxidant 
(up to 4.0 equiv) failed to improve the yield (57%, entry 7). However, we were pleased to 
find that 5 mol % of Pd(OAc)2 exhibited equally excellent efficacy as that of 10 mol % of 
Pd(OAc)2 (entry 9 vs. entry 3). Fine-tuning the oxidant and additive concentrations 
(entries 8–14) revealed that 2.5 equiv of AgOAc and 2.0 equiv of PivOH could push the 
reaction to completion and produce the desired product in excellent yield (84%, entry 10). 
Additionally, we also tested a Rh-catalyzed protocol, which unfortunately failed to yield 
product, presumably due to the absence of a directing group (entry 15).412, 413 
 
5.3.5 Effect of reactant concentration 
The influence of reactant concentrations was probed as well (Table 5-5). First, the 
concentration of acrylate 5.4 was modified (entries 1–3). 2.0 equiv of acrylate 5.4 was 
found to be optimal (entry 2). Then we tested the concentration of 5.3 at 0.1 M and 0.5 M. 
Virtually the same outcome was observed (entries 2, 4–5), which indicates the robustness 
of the alkenylation reaction to substrate concentrations within this range.   
 
5.3.6 Temperature effect 
In the interest of green chemistry, we next explored the possibility of lowering the 
reaction temperature preset at 80 ºC (Table 5-6). At 50 ºC, excellent yields up to 87% 
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were achieved by manipulating the mixture ratio of AgOAc and PivOH (entries 1–3). 
However, the consumption of the starting uracil was never complete. Hence, we raised 
the temperature to 60 ºC. The extra 10 ºC heat combined with the similar tuning on 
AgOAc and PivOH concentrations enabled 100% consumption of 5.3 and afforded better 
yields up to 91% (entries 4–8). In addition, we also tested temperatures from 70 ºC up to 
100 ºC (entries 9–12). Although the starting uracil 5.3 was consumed, slightly lower 
yields (up to 88%) were obtained. Therefore, we determined that the optimal temperature 
was 60 ºC. 
 
Table 5-5. Reaction scale of the dehydrogenative alkenylation 
N
N
O
O
N
N
O
CO2tBu
CO2tBu
Pd(OAc)2 (5 mol %)
AgOAc (2.5 equiv)
PivOH (2 equiv)
DMF, 80 ºC, 24 h O
+
5.3 5.4 5.5  
Entrya 5.3 (M) 5.4 (equiv) % Consumptionb % Yieldc 
1 0.2 1.1 100 78 
2 0.2 2.0 100 84 
3 0.2 3.0 97 81 
4 0.1 2.0 100 84 
5 0.5 2.0 100 82 
a Reaction conditions: uracil 5.3 (0.1 mmol), acrylate 5.4, Pd(OAc)2 (5 mol%), AgOAc 
(2.5 equiv), PivOH (2.0 equiv), DMF (0.2–1.0 mL) under air at 80 °C, 24 h. b 1H NMR % 
Consumption of the starting uracil with Ph3SiMe (1.0 equiv) as the internal standard. c  1H 
NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
 
5.3.7 Reaction time 
Lastly, we monitored the reaction over a 24 h period. Figure 5-1 revealed that the 
reaction proceeded slowly in the course of the first 12 h. After that, only a minimum 
amount of catalytic activity was observed, which led to a merely 3% increase of the yield. 
Presumably, this could be attributed to the reduced concentration of 5.3 as well as the 
inactivation of the PdII catalyst by the aggregation of black Pd0 over time before 
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reoxidation. Nevertheless, the desired 5-alkenyluracil 5.5 was shown to be stable under 
the current conditions over the course of 24 h.   
 
Table 5-6. Temperature effect on the dehydrogenative alkenylation 
N
N
O
O
N
N
O
CO2tBu
CO2tBu
Pd(OAc)2 (5 mol %)
AgOAc, PivOH
temperature
DMF, 24 h O
+
5.3 5.4 5.5  
Entrya AgOAc (equiv) PivOH (equiv) Temp (ºC) % Consumptionb % Yieldc 
1 2.5 2.0 50 86 80 
2 2.5 2.0 50 86 78 
3 3.0 3.0 50 92 87 
4 2.5 2.0 60 100 86 
5 3.0 2.0 60 100 91 
6 2.5 2.5 60 100 87 
7 2.5 3.0 60 100 91 
8 3.0 3.0 60 100 91 
9 2.5 2.0 70 100 88 
10 3.0 3.0 70 100 87 
11 2.5 2.0 80 100 84 
12 2.5 2.0 100 100 74 
a Reaction conditions: uracil 5.3 (0.2 M), acrylate 5.4 (2.0 equiv), Pd(OAc)2 (5 mol%), 
AgOAc, PivOH, DMF (0.5 mL) under air, 24 h. b 1H NMR % Consumption of the 
starting uracil with Ph3SiMe (1.0 equiv) as the internal standard. c  1H NMR % yield with 
Ph3SiMe (1.0 equiv) as the internal standard. 
 
It is worth noting that all the above reactions proceeded in a capped vial under 
ambient air. In comparison, direct alkenylation under N2 afforded a marginally lower 
yield (87%), indicating that O2 might serve as a minor oxidant. 
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N
N
O
O
N
N
O
CO2tBu
CO2tBu
Pd(OAc)2 (5 mol %)
AgOAc (3 equiv)
PivOH (3 equiv)
DMF, 60 ºC, time O
+
5.3 5.4 5.5  
 
a Reaction conditions: uracil 5.3 (0.2 M), acrylate 5.4 (2.0 equiv), Pd(OAc)2 (5 mol%), 
AgOAc (3.0 equiv), PivOH (3.0 equiv), DMF (0.5 mL), under air at 60 °C, 0–24 h. 1H 
NMR % Consumption of the starting uracil with Ph3SiMe (1.0 equiv) as the internal 
standard. 1H NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 92% 
isolated yield. 
 Figure 5-1. Effect of reaction time on the dehydrogenative alkenylation.a 
 
5.4 Investigation of the scope  
5.4.1 Alkene scope 
Utilizing these optimized catalytic conditions, a broad range of alkenes was found to 
undergo dehydrogenative coupling with uracil 5.3 in good to excellent yields (Table 5-7). 
The newly formed 5-alkenyluracils were obtained with absolute regio- and 
stereoselectivity (E-isomers), and a variety of functionalities were tolerated. Acrylate 
esters and styrene furnished excellent yields (5.5–5.9). Remarkably, quantitative 
consumption was observed when acrylamide was employed (5.10). Acrolein, dimethyl 
vinylphosphonate, and methylvinylketone were also good alkenylating partners albeit 
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showing slightly lowered yields (5.11–5.13). Notably, acrolein and acrolein diethyl acetal 
furnished the same aldehyde 5.11/5.11’ with comparable yields, presumably due to in situ 
hydrolysis by PivOH of the acetal functional group. As for disubstituted alkenes, overall 
moderate yields were observed, possibly due to the steric repulsion exerted by the 
substituents (5.14–5.15 and 5.17–5.18). As expected, when more than one β-hydrogen 
was present, final products 5.16–5.18 showed double bond tautomerization with a 
preference for unconjugated (to uracil) 5-allyluracils 5.17b and 5.18b.341, 377-379 However, 
allyl acetate predominantly afforded the conjugated 5-alkenyluracil 5.16a. As 
documented previously,331, 414, 415 the coordination between O (from the acetyl) and Pd 
locks the conformation and subsequently favors Ha for syn-elimination (Scheme 5-6). In 
addition, double C–H activation was observed in by-product 5.18c to our surprise 
(Scheme 5-7). We speculate that 5.18b served as an alkene for subsequent coupling with 
uracil 5.3 to furnish 5.18c, albeit in a low yield.  
 
5.4.2 Uracil scope 
We next probed the scope of uracils416-423 under the optimized conditions (Table 5-8). 
In addition to N-methyl groups (5.5), uracil can be protected with other electron-donating 
groups, such as benzyl (5.19), methoxymethyl (MOM) (5.20), and p-methoxybenzyl 
(PMB) (5.22), and provide reaction products in good to excellent yields. The new 
protocol was also effectively applied to 1-benzyl-3-(3’,5’-dimethylbenzyl)uracil (to 
furnish 5.21), which has exhibited potent antiviral activity against the human 
immunodeficiency virus (HIV-1) and the human cytomegalovirus (HCMV).424, 425 On the 
other hand, electronically-attenuated uracils (with electron-withdrawing groups or 
without protecting groups) were unreactive in the alkenylation process (5.25–5.27). 
Although poor solubility may play a role, we presume that decreased nucleophilicity of 
the uracils is the reason for the observed lack of reactivity. In further investigations we 
found that protected uridine and 2’-deoxyuridine were also good substrates (5.23 and 
5.24), demonstrating the practicality of our reaction protocol to uracil-based nucleosides. 
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Table 5-7. Scope of alkenes for dehydrogenative alkenylationa 
N
N
O
+ N
N
O
R
RPd(OAc)2 (5 mol%)AgOAc (3 equiv)
PivOH (3 equiv)
DMF, 60 ºC, 24 h
H
O O
5.3  
N
N
O
O
CO2tBu N
N
O
O
CO2nBu N
N
O
O
CO2Me
N
N
O
O
CONMe2N
N
O
O
CO2Bn
N
N
O
O
N
N
O
O
Ph
N
N
O
O
COMe
N
N
O
O
N
N
O
O
PO(OMe)2
N
N
O
O
CO2tBu
N
N
O
O
CHO
5.7, 94%5.6, 91%5.5, 92%
5.10, 100%5.8, 52%
5.15, 56%
5.9, 98%
5.18, 47%
(a:b = 1:2.5)c
N
N
O
O
CO2Me
5.16, 53%
(a:b = 8.7:1)c
5.13, 75%5.12, 84%
5.14, 59%
5.17, 96%
(a:b = 1:4.3)c
5.11, 77%
5.11', 79%b
O
O OAca b
N
N
O
O
O
O
a
b
a
b
 
a Conditions: uracil 5.3 (0.2 M), alkene (2.0 equiv), Pd(OAc)2 (5 mol%), AgOAc (3.0 
equiv), PivOH (3.0 equiv), DMF (0.5 mL) under air at 60 °C, 24 h. Isolated yields. b 
Acrolein diethyl acetal (2.0 equiv) was used as the alkene. c Ratio determined by 1H 
NMR. 
 
Ha Pd
Ha'
U Hc
OAc
Hb
U = 1,3-dimethyluracil
O
O
O
Pd
OAc
U O 5.16a
(major)
insertion elimination
 
Scheme 5-6. Dehydrogenative alkenylation with allyl acetate. 
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N
N
O
O
NN
O
O
CO2tBu
N
N
O
O
CO2tBu
5.18b
5.18c, 24%
5.3
5.3
CO2tBu
 
Scheme 5-7. Double C–H activation of uracil 5.3. 
 
 
Table 5-8. Scope of uracils for dehydrogenative alkenylationa 
N
N
O
+ N
N
O
CO2tBu
CO2tBu
Pd(OAc)2 (5 mol %)
AgOAc (3 equiv)
PivOH (3 equiv)
DMF, 60 ºC, 24 h
H
O
R2
R1
R2
O
R15.4  
N
N
O
O
CO2tBuBn
Bn
N
N
O
O
CO2tBu
Bn
5.19, 94%
5.21, 76%
N
N
O
OO
HO
O
O
Me CO2tBu
5.23, 66%
N
N
O
O
MOM
MOM CO2tBu
5.20, 68%
N
N
O
O
O
O
O
Si
O
Si
iPr iPr
iPr
iPr
Me CO2tBu
5.24, 75%
N
N
O
O
CO2tBu
5.5, 92%
N
N
O
O
CO2tBu
PMB
PMB
5.22, 96%
HN
N
H
O
O
CO2tBu HN
N
O
O
CO2tBu
Bz
N
N
H
O
O
CO2tBuBz
Incompatible:
5.26, 0% 5.27, 0%5.25, 0%
 
a Conditions: uracil (0.2 M), acrylate 5.4 (2.0 equiv), Pd(OAc)2 (5 mol %), AgOAc (3.0 
equiv), PivOH (3.0 equiv), DMF (0.5 mL) under air at 60 °C, 24 h. Isolated yields.  
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5.5 Proposed mechanism 
In light of both the exclusive C5-regioselectivity and the lack of reactivity from 
electron-poor uracils, an electrophilic palladation pathway138 was envisaged (Figure 5-2). 
Similar to our previously investigated enaminone system,341 uracil’s nucleophilic C5-
position is most likely first attacked by the Pd(II) species, although prior coordination of 
Pd(II) to the carbonyl group or the double bond is a possibility as well.426, 427 
Deprotonation by the more basic pivalate ligand then forms a palladated uracil II, which 
then undergoes migratory alkene insertion. Subsequent β-H elimination delivers the 
desired 5-alkenyluracil IV. Reductive elimination and reoxidation by AgI regenerates PdII 
to resume the catalytic cycle. 
 
Pd0
Pd(OPiv)2
N
N
O
R1
H
N
N
O
R1
PdOPiv
R3
N
N
O
R1
R3
PdOPiv
N
N
O
R1
R3
PdH OPiv
PivOH
2 AgI 2 Ag0
PivOH
O
R2
R2R2
O
O
R2
Pd(OAc)2 + 2 PivOH
2 AcOH
I
III
IV
O
II
 
Figure 5-2. Proposed mechanism for the dehydrogenative alkenylation of uracils. 
 
5.6 Summary 
We have developed an efficient and highly atom-economical protocol for cross-
dehydrogenative coupling of uracils and alkenes. The generality of this transformation 
  105 
provides a promisingly direct route to synthesize 5-alkenyluracils, which are of 
importance in medicinal chemistry. 
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Chapter 6  Biomimetic Aerobic C–H Alkenylation of Cyclic Enaminones at Room 
Temperature: Development toward the Synthesis of 1,3,5-Trisubstituted Arenes 
 
6.1 Introduction 
An important task in modern organic chemistry is the development of green, mild, 
and efficient methods for broad synthetic applications. In the interests of sustainable 
chemistry, new methods that generate a minimal amount of waste are highly sought-
after.308, 309 In the field of transition metal-catalyzed C–C construction, dehydrogenative 
reactions are arguably the flagship of all cross-coupling reactions, because they activate 
two C–H bonds with no prefunctionalization, thus significantly reducing byproducts and 
wastes by releasing, in theory, a stoichiometric amount of hydrogen gas.92, 133, 137-139  
Since dehydrogenative reactions entail two C–H nucleophiles, an oxidant is required 
to achieve catalytic turnover (see discussion in Chapter 2.4). We recently developed an 
efficient Pd-catalyzed dehydrogenative alkenylation of cyclic enaminones,341 the 
distinctive reactivity profile of which has been exploited extensively for heterocycle 
synthesis (Chapter 4).59, 61, 65, 345-349 Despite the high-yielding feature and broad scope, our 
protocol requires stoichiometric amounts of a CuII oxidant and an additive at an elevated 
temperature (80 ºC). Unfortunately, this demand for stoichiometric amounts of sacrificial 
heavy metal oxidants is very common in current research and is ironically contradictory 
to the goal of C–H functionalization (e.g. reducing heavy metal waste).133, 137-139 In search 
of alternative green oxidants, molecular oxygen is regarded as the ideal candidate 
because of its inexpensive and eco-friendly nature.308, 309  
 
1/2 O2
H2O substract
product[cat.]
[cat.]red
ETMox
ETMred ETM'red
ETM'ox
 
Scheme 6-1. Biomimetic O2 activation with ETMs. 
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The obstacle of applying O2 as the sole oxidant is the high activation energy and low 
concentration of O2 in solutions which significantly impedes the direct oxidation of Pd0. 
Hence, in early development, the pressure of O2 was often applied much higher than 1 
atm.138, 308 To circumvent high pressure, new protocols have been devised with catalytic 
amounts of oxygen activators (i.e. electron transfer mediators, ETM), such as 
molybdovanadophosphoric acid (HPMoV) and benzoquinone, to facilitate oxidation in a 
biomimetic approach.138, 309, 428 Mechanistically, this biomimetic strategy divides the 
oxidation process into several interconnected redox cycles and therefore effectively 
reduces the initial high-energy barrier for electron transfer (Scheme 6-1).428 For example, 
Hosokawa and co-workers discovered that the use of catalytic amounts of inexpensive 
catechol and CuII under O2 could remarkably enhance PdII catalysis (Scheme 6-2).313, 429 
Because catechol was readily oxidized to o-quinone under O2 in the presence of the 
Pd(OAc)2–Cu(OAc)2 catalyst, the authors proposed that the o-quinone could serve as a 
CuII ligand.  
 
Pd0
PdII2 CuII
2 CuI
HO OH
O O
1/2 O2
H2O substract
product
R OH O R'
5 mol % Pd(OAc)2
5 mol %Cu(OAc)2
10 mol % catechol
O2, MeCN, rt O
R
O
R'+
72–96%
Hosokawa group
 
Scheme 6-2. Biomimetic O2 activation by catechol and CuII salt. 
 
The synthesis of 1,3-dienes and polyenes through dehydrogenative cross-coupling 
between alkenes surprisingly did not attract much attention until very recently, despite 
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their importance in organic and medicinal chemistry, and material science.136 The use of 
O2 as the terminal oxidant in this type of coupling is very rare, and to the best of our 
knowledge there has been no report yet about a dehydrogenative cross-coupling of 
alkenes proceeding at room temperature.328, 329, 332, 334, 430 Bäckvall and co-workers 
reported a versatile biomimetic aerobic reaction between two alkenyl C–H donors under 
low catalyst loading.430 Unfortunately, their protocol involving acidic media, failed to 
deliver a satisfactory outcome with cyclic enaminone substrates,430 which as piperidine 
surrogates are valuable synthetic intermediates.59, 61, 65, 345-349 In light of the recent 
advances in this field, we aimed at developing a greener and milder method for the 
dehydrogenative alkenylation of cyclic enaminones at room temperature. We envisioned 
the alkenylated enaminones (i.e. 1,3-dienes) undergoing a Diels-Alder reaction to gain 
rapid access to hydroquinolines, a key structural motif in several major classes of 
alkaloids.431-436 Serendipitously, we instead found a Diels-Alder tandem reaction to 
furnish a series of 1,3,5-trisubstituted arenes, including chalcones, which are a major 
class of flavonoids and exhibit a wide range of pharmacological activities, including 
antiproliferative, antioxidant, anti-inflammatory and anticancer effects.437-439 Herein, we 
disclose the development of a biomimetic aerobic C–H alkenylation of cyclic enaminones 
at room temperature using O2 as the terminal oxidant and its unexpected application for 
the synthesis of 1,3,5-trisubstituted arenes. 
 
6.2 Alkenylation optimization 
6.2.1 Initial trials 
We started probing the aerobic conditions under atmospheric pressure (Table 6-1). 
The initial reaction conditions were adapted from our first protocol: enaminone 6.1 and 
alkene 6.2 (2 equiv) were mixed with Pd(OAc)2 (10 mol %) and KTFA (1 equiv) in DMF 
under air for 24 h. Without CuII oxidants, the starting material consumption and product 
yield dropped significantly under air (entry 1). Changing the reaction atmosphere to pure 
O2 improved the yield to 44% (entry 2). Addition of 20 mol % of Cu(OAc)2 to the 
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reaction did not improve the yield (entry 3).  Amino acids as ligands were also examined, 
but did not improve the outcome of the reactions (entries 4–5).  
 
Table 6-1. Initial attempts of aerobic oxidative alkenylation of cyclic enaminones 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
KTFA (1.0 equiv)
oxidant, ligands
DMF, 80 °C, 24 h
6.1 6.2 6.3  
Entrya CuII (0.2) Oxidantb Ligand (0.2) % Consumptionc % Yieldd 
1 – air – 50 27 
2 – O2 – 71 44 
3 Cu(OAc)2 O2 – 91 41 
4 – O2 Boc-β-Ala-OH 85 49 
5 – O2 Boc-Phe-OH 76 45 
a Other conditions: 6.1 (0.2 M), 6.2 (2 equiv), Pd(OAc)2 (10 mol %), KTFA (1 equiv) in 
DMF (0.5 mL) at 80 ºC through 24 h. b The pressure was 1 atm. c NMR % conversion of 
the starting enaminone with Ph3SiMe (1.0 equiv) as the internal standard. d NMR % yield 
with Ph3SiMe (1.0 equiv) as the internal standard. 
 
6.2.2 Introduction of catechol 
In order to activate O2, catalytic amounts of catechol were added to the reaction 
mixture (Table 6-2). Initially, a 1:1:2 ratio of the Pd(OAc)2/Cu(OAc)2/catechol mixture 
was tested at 80 ºC, which failed to increase the yield (40% from entry 1 vs. 44% from 
Table 4.8, entry 2). We also ran the same reaction at room temperature but recorded an 
even lower yield (36%, entry 2). Thus, we modified the catalyst formula and used a 1:2:4 
ratio, but only observed a slight increase of yield to 47% (entry 3). A significant increase 
of yield to 78% was attained after the loading of Pd(OAc)2 was doubled to 10 mol % 
(entry 4). We saw a similar trend when the reactions were performed under air, albeit 
with lower yields respectively (entries 5–6). Additional tuning of the ratio of 
Pd(OAc)2/Cu(OAc)2/catechol did not afford higher yields (entries 7–8), which suggests 
that the optimal ratio is 1:1:2.  
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Table 6-2. Aerobic oxidative alkenylation of cyclic enaminones with catechol 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2, Cu(OAc)2 
catechol, O2
DMF, temp, 24 h
6.1 6.2 6.3  
Entrya 
Pd(OAc)2 
(mol %) 
Cu(OAc)2 
(mol %) 
Catechol 
(mol %) 
Oxidant 
(1 atm) 
Temp 
(ºC) 
% 
Consumptionb 
% 
Yieldc 
1 5 5 10 O2 80 69 40 
2 5 5 10 O2 rt 49 36 
3 5 10 20 O2 rt 47 47 
4 10 10 20 O2 rt 85 78 
5 5 10 20 air rt 49 44 
6 10 10 20 air rt 79 72 
7 10 10 10 O2 rt 78 72 
8 10 20 40 O2 rt 77 69 
a Other conditions: 6.1 (0.2 M), 6.2 (4 equiv) in DMF (0.5 mL) through 24 h. b NMR % 
conversion of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal standard. c 
NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
 
6.2.3 Solvent screen 
Then we screened a series of common solvents. Except for the initially chosen DMF, 
all the other solvents failed to improve the alkenylation outcome (Table 6-3). The 
relatively high yields from DMF, MeCN and DMSO (entries 1–3) indicate that the 
coordinating ability of the solvents may help extend the catalyst lifespan, as reflected by 
the higher coupling yields. 
 
6.2.4 Alkene concentration  
The concentration of alkenes also proved to be critical. tert-Butyl acrylate was 
investigated on a scale from 1 equiv to 8 equiv (Table 6-4). The most effective 
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concentration was recorded at 4 equiv (entry 4). Attempts to push the reaction to 
completion by adding more alkenes, did not improve yields. (entries 5–7). 
 
Table 6-3. Solvent effect on the aerobic oxidative alkenylation of cyclic enaminones 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (10 mol%)
catechol (20 mol%)
solvent
rt, 24 h
6.1 6.2 6.3  
Entrya Solvent % Consumptionb % Yieldc 
1 DMF 85 78 
2 MeCN 73 65 
3 DMSO 70 62 
4 NMP 51 43 
5 THF 42 39 
6 toluene 65 57 
a Other conditions: 6.1 (0.2 M), 6.2 (4 equiv), Pd(OAc)2 (10 mol %), Cu(OAc)2 (10 mol 
%), catechol (20 mol %) in DMF (0.5 mL) at rt under O2 (1 atm) through 24 h. b NMR % 
conversion of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal standard. c 
NMR % yield with Ph3SiMe (1.0 equiv) as the internal standard. 
 
6.2.5 Catalyst combination 
As Hosokawa had reported the importance of anionic ligands to catalyst efficacy,429 
we next examined the effect of a few anionic ligands (i.e. TFA–, OAc–, and Cl–, Table 6-
5). In single anion systems (entry 1–3), OAc– afforded a better yield (78%) than TFA– 
(63%) or Cl– (55%). Gratifyingly, the use of Pd(TFA)2 and Cu(OAc)2 improved the yield 
to 81% (entry 4). When the anionic ligands were switched, the use of Pd(OAc)2 and 
Cu(TFA)2 gave the same yield (81%, entry 5). This yield similarity was also observed in 
the combination of OAc–/Cl– and TFA–/Cl– systems (entry 6–9), albeit furnishing lower 
yields respectively. This similarity suggests that the anionic ligands shall be 
exchangeable between PdII and CuII in the solution.  
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Table 6-4. Alkene concentration on the aerobic oxidative alkenylation of cyclic 
enaminones 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (10 mol%)
catechol (20 mol%)
DMF, rt, 24 h
6.1 6.2 6.3  
Entrya 6.2 (equiv) % Consumptionb % Yieldc 
1 1.0 59 57 
2 2.0 72 69 
3 3.0 69 62 
4 4.0 85 78 
5 5.0 77 74 
6 6.0 82 74 
7 8.0 77 77 
a Other conditions: 6.1 (0.2 M), Pd(OAc)2 (10 mol %), Cu(OAc)2 (10 mol %), catechol 
(20 mol %) in DMF (0.5 mL) at rt under O2 (1 atm) through 24 h. b NMR % conversion 
of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal standard. c NMR % 
yield with Ph3SiMe (1.0 equiv) as the internal standard. 
 
6.2.6 Additional optimization 
We also investigated the role of bases, reactant ratios, and additives (Table 6-6). First, 
a few common bases were added to the reaction mixture (entry 1–5). It soon became clear 
that bases inhibited the dehydrogenative coupling by reducing the yield to 16%. Since 
bases will neutralize the stoichiometric amounts of AcOH/TFA formed as byproducts, it 
echoed our earlier findings that acids enhanced the coupling efficiency of cyclic 
enaminones presumably by assisting anionic ligand dissociation.79 Next, we adjusted the 
reaction concentration from 0.03 M to 0.4 M and found that more concentrated solutions 
were favorable in general (entries 6–9), which is not uncommon for intermolecular 
coupling reactions. Moreover, Stahl and co-workers had reported that the addition of 
molecular sieves was beneficial for Pd-catalyzed aerobic alcohol oxidation.440 They 
found molecular sieves could provide a heterogeneous surface that hindered bulk 
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aggregation of Pd0 metal to increase the catalyst stability. Indeed, the presence of 4Å MS 
in the current aerobic protocol promoted a full consumption of 6.1, as well as an optimal 
isolated yield at 89% (entry 10).  
 
Table 6-5. Catalyst screen for the aerobic oxidative alkenylation of cyclic enaminones 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
PdII (10 mol%)
CuII (10 mol%)
catechol (20 mol%)
DMF, rt, 24 h
6.1 6.2 6.3  
Entrya PdII (10 mol %) CuII (10 mol %) % Consumptionb % Yieldc 
1 Pd(OAc)2 Cu(OAc)2 85 78 
2 Pd(TFA)2 Cu(TFA)2 73 63 
3 PdCl2 CuCl2  53 55 
4 Pd(TFA)2 Cu(OAc)2  90 81 
5 Pd(OAc)2 Cu(TFA)2  86 81 
6 PdCl2 Cu(OAc)2  61 57 
7 Pd(OAc)2 CuCl2  48 37 
8 PdCl2 Cu(TFA)2  43 33 
9 Pd(TFA)2 CuCl2  38 27 
a Other conditions: 6.1 (0.2 M), 6.2 (4 equiv), catechol (20 mol %) in DMF (0.5 mL) at rt 
under O2 (1 atm) through 24 h. b NMR % conversion of the starting enaminone with 
Ph3SiMe (1.0 equiv) as the internal standard. c NMR % yield with Ph3SiMe (1.0 equiv) as 
the internal standard. 
 
6.3 Investigation of the scope of the dehydrogenative alkenylation 
With the optimal conditions in hand, we embarked on a study of the scope of the 
reaction (Table 6-7). Acrylates were excellent alkene sources with yields up to 89% (6.3–
6.6). Vinyl phosphonate, vinyl ketone, acrylamide, and styrene were all well tolerated 
(6.7–6.10). Disubstituted alkenes afforded significantly lower yields (6.11–6.13), 
possibly because the sterics exerted by the substituents hindered the migratory insertion. 
Interestingly, double bond isomerization was not observed when more than one β-hydride 
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was present in the alkenes. Only conjugated (to enaminone) diene isomers (6.12 and 
6.13) were isolated. This is in contrast to our first alkenylation protocol, where 
unconjugated (to enaminone) diene isomers were favored at an elevated temperature (80 
ºC). We postulate that β-hydride elimination is a kinetically controlled process to furnish 
the conjugated diene isomers, whereas the unconjugated diene isomers are 
thermodynamically more favorable.  
 
Table 6-6. Further study on the aerobic oxidative alkenylation of cyclic enaminones 
N
O
Bn
+
N
O
Bn
CO2tBu
CO2tBu
PMP PMP
Pd(TFA)2 (10 mol%)
Cu(OAc)2 (10 mol%)
catechol (20 mol%)
base, additive
DMF, rt, 24 h
6.1 6.2 6.3  
Entrya 6.1 (M) Base (0.2 equiv) Additive % Consumptionb % Yieldc 
1 0.2 – – 90 81 
2 0.2 pyridine – 20 16 
3 0.2 Et3N – 52 51 
4 0.2 Na2CO3 – 72 69 
5 0.2 NaHCO3 – 77 73 
6 0.4 – – 100 86 
7 0.1 – – 58 43 
8 0.05 – – 77 68 
9 0.03 – – 61 52 
10 0.2 – 4Å MS 100 91 (89d) 
a Other conditions: 6.2 (4 equiv), Pd(TFA)2 (10 mol %), Cu(OAc)2 (10 mol %), catechol 
(20 mol %) in DMF (0.5 mL) at rt under O2 (1 atm) through 24 h. b NMR % conversion 
of the starting enaminone with Ph3SiMe (1.0 equiv) as the internal standard. c NMR % 
yield with Ph3SiMe (1.0 equiv) as the internal standard. d Isolated yield. 
 
A collection of enaminones was assessed under the optimized conditions as well 
(Table 6-7). Bicyclic, electron-rich enaminones offered moderate yields (6.14–6.15). 
Remarkably, our new conditions do not compromise the preexisting stereocenters of 6.15. 
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Replacing the 2-aryl group (i.e. PMP) with an alkyl group (i.e. iPr) retained a good yield 
(83%, 6.16). Surprisingly, the removal of the 2-PMP group caused a significant decline in 
yield (to 57%, 6.17). The reason behind this observation is yet to be elucidated. As we 
reported earlier, N-phenylenaminone is a less effective substrate possibly due to its 
attenuated nucleophilicity. Indeed, it afforded a lower yield (32%, 6.18) compared to the 
N-benzyl analogue (57%, 6.19). It is worth mentioning that the E-enaminone, N-H 
enaminone, and N-Cbz enaminone were all incompatible under the current aerobic 
conditions (6.19–6.21), albeit consistent with our previous studies. Our attempts on the 
uracil scaffold (6.22) were unfortunately not successful either. 
 
6.4 Unexpected formation of chalcones 
6.4.1 Initial trials 
In our continuous efforts to synthesize enaminone-based pilot scale libraries, we 
hypothesized that the Diels-Alder reaction could be an effective approach to quickly 
transform the alkenylated products of cyclic enaminones to hydroquinoline analogues, a 
common structural feature in many alkaloids.431-436 In fact, amino-substituted dienes have 
been employed as substrates to construct the octahydroquinoline scaffold (Scheme 6-3). 
Comins and co-workers reported that cyclic enaminone 6.23 underwent the Diels-Alder 
transformation with a variety of dienophiles to afford novel octahydroquinolines 6.25 as 
single diastereomers.441, 442  
Because our dehydrogenative alkenylation method installed electron-deficient alkenes 
onto cyclic enaminones, two of the three substituents on enaminone dienes (e.g. 6.3) are 
electron-withdrawing. It is uncertain whether the proposed Diels-Alder reaction would be 
normal-electron-demand (NED) or inverse-electron-demand (IED). Accordingly, we 
treated the alkenylated enaminone 6.3 with both electron-rich and electron-deficient 
dienophiles (6.26 and 6.27, Scheme 6-4). To our disappointment, no desired product was 
observed in either scenario. Most of enaminone 6.3 was consumed when subjected to an 
electron-deficient dienophile, while it did not react in the presence of an electron-rich 
dienophile. These intriguing results led us to first investigate the electronic nature of 
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enaminone dienes affected by the unique substitution pattern. 
 
Table 6-7. Scope of aerobic dehydrogenative alkenylation of cyclic enaminonesa 
N
O
R1
+ R5
R2
Pd(TFA)2 (10 mol%)
Cu(OAc)2 (10 mol%)
catechol (20 mol%)
DMF, rt, 24 h, 4Å MS
N
O
R1
R2
R5
R3 R3
R4
R6
R4
R6
 
N
O
CO2tBu
N
O
CO2tBu
N
O
Ph CO2tBu
6.14, 59%
6.15, 59% 6.18, 32%
Me
N
O
Bn
PMP
CO2Me
N
O
Bn
PMP
CO2nBu
N
O
Bn
PMP
CO2Bn
N
O
Bn
PMP
COMe N
O
Bn
PMP
CONMe2
N
O
Bn
PMP
PO(OMe)2
N
O
Bn
PMP
Ph
N
O
Bn
PMP
N
O
Bn
PMP
CO2Me
N
O
Bn
PMP
CO2tBu
N
O
Bn
PMP
CO2tBu
N
O
Bn CO2tBu
6.3, 89% 6.4, 78%
6.9, 68%
6.5, 85%
6.10, 46%
6.6, 87%
6.13, 57%
6.7, 69%
6.11, 19%
6.8, 80%
6.12, 37%
6.17, 57%
O
O
N
O
Bn CO2tBu
6.16, 83%
H
H
Incompatible:
O
CO2tBu
N
N
O
CO2tBu
6.19, 0% 6.22, 0%
N
O
Cbz CO2tBu
6.21, 0%
HN
OPh
CO2tBu
6.20, 0%
NMe2
PMP O
 
a Conditions: enaminone (0.2 M), acrylate (4 equiv), catechol (20 mol %), Pd(OAc)2 (10 
mol %), Cu(OAc)2 (10 mol %), catechol (20 mol %) with 4Å MS in DMF (0.5 mL) at rt 
under O2 (1 atm) through 24 h. Isolated yield.  
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N
O
CO2Ph
Ph
R1 R2
N
O
PhO2C
Ph
R1
R2H
+
6.23 6.24 6.25, 44–93%
single diastereomer
Comins group
toluene
reflux
 
Scheme 6-3. Examples of the Diels-Alder reaction to prepare octahydroquinolines. 
 
N
O
OtBu
O
Bn
PMP
toluene
reflux, 12 h
+
OnBu
benzene
85 ºC, 12 h
+
O
O
O
no product,
starting material 
decomposed
no reaction
N
O
OtBu
O
Bn
PMP
6.3 6.26
6.276.3  
Scheme 6-4. Failed attempts toward Diels-Alder cycloaddition. 
 
6.4.2 Theoretical prediction on the nature of the Diels-Alder reaction 
We turned to computational chemistry to explore the nature of the proposed Diels-
Alder reaction. Computational chemistry has made tremendous progress in the past two 
decades. It has enabled chemists to understand fundamental correlation between 
structures and properties (e.g. QSAR) and also predicted unknown reactivities that assist 
experimental chemists in rational compound design (e.g. drug design and catalyst). In 
particular, for small- to medium-size organic compounds (<30 ﬁrst row atoms), 
computation using quantum chemical methods, such as the density functional theory, are 
now capable of predicting molecular properties with a precision approaching that of 
experiments.443-446 
A series of representative diene substrates were selected (Scheme 6-5). Dienes 6.28 
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and 6.23 are known to undergo NED cycloaddition,441, 442, 447 while dienes 6.29 and 6.30 
are reported to undergo IED cycloaddition.448-452 Ab initio calculations were performed 
with the Gaussian 09 program suite.453 Geometry optimizations were performed with the 
B3LYP/6-31G(d) method without any constraint. Frequency calculations were carried out 
at the same B3LYP/6-31G(d) level of theory to confirm convergence to appropriate local 
minima or saddle points on the energy surface. Single-point energies were calculated 
with the UB3LYP/6-31+G(d,p) method. The HOMO and LUMO energies are shown in 
Figure 6-1. 
 
N
O
Bn
PMP
CO2tBu
N
O
CO2Ph
Ph
N
O
Bn
PMP
CO2Me
N
O
Bn
PMP
CONMe2
N
OH
Bn
PMP
CO2Me
N
OH
Bn
PMP
CO2Me
O
CO2Et
O
O
CO2Et
inverse-electron-demandnormal-electron-demand
6.28 6.23 6.29 6.30
6.3 6.4 6.8
6.31 6.32  
Scheme 6-5. Representative diene substrates for computational calculation. 
 
The calculation results revealed that the alkenylated enaminones should 
thermodynamically favor NED Diels-Alder reactions. All the HOMO energies of selected 
enaminones (6.3, 6.4, 6.8, 6.31, and 6.32) are higher than those of electron-rich dienes 
(6.28 and 6.23 in the red dashed box) that undergo NED Diels-Alder reactions. In 
comparison, 6.29 and 6.30 (in the green dashed box) should have lowered LUMO 
energies because they undergo IED Diels-Alder reactions,448-452 which was indeed 
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confirmed by our calculation. Therefore, the reduced HOMO-LUMO energy gaps 
between enaminones and dienophile 6.26 predict that the Diels-Alder reaction of 
alkenylated enaminones would proceed in a NED manner. 
 
 
 
Figure 6-1. Calculated energies of HOMOs and LUMOs. 
 
6.4.3 Unexpected chalcone formation 
As we reexamined the NED Diels-Alder reaction between 6.33 and 6.34, we were 
surprised to isolate a large amount of much less polar compound 6.36 instead of the 
expected 6.35 (Scheme 6-6). Presumably, the multiple electron-withdrawing substituents 
and the amino leaving group in cycloadduct 6.35 promoted aromatization.441, 447, 450 
Afterwards a retro-Michael fragmentation released methylamine and afforded chalcone 
6.36. 
 
dienes                                                       dienophile 
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N
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O
Me
PMP
S+
O O
N
O
OMe
O
Me
PMP
S O
O
NH
O
OMe
O
Me
PMP
S O
O
O
OMe
O
PMP
S O
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O
O
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+ O O
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O
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O
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O
H
H
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O
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53%
6.35
6.376.36
6.33 6.34
 
Scheme 6-6. Proposed mechanism for unexpected chalcone formation. 
 
O
O O
HR1 R2+
R1 R2
R1
(HO)2B
R2+
O
R1 R2
Y
+R1 R2+ +CO
X
X = OTf, Br, I, B(OH)2
carbonylative Heck coupling
O
Cl
X
X = H, Y = I
X = CO2H, Y = Br, I, B(OH)2
(decarboxylative) Heck coupling
(a) (b)
(c) (d)
Suzuki coupling Claisen-Schmidt condensation
 
Scheme 6-7. Representative strategies for chalcone synthesis. 
 
Conventionally, chalcones have been synthesized by the Claisen-Schmidt 
condensation (Scheme 6-7, path b).454, 455 The reaction efficiency and functionality 
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tolerance are usually low due to the strongly basic conditions. Although new Pd-
catalyzed cross-coupling methods, such as Suzuki (path a),456 carbonylative Heck (path 
c),457-459 and (decarboxylative) Heck reactions (path d),460, 461 have been developed for 
chalcone syntheses, their utilization has mostly depended on the availability of aryl 
coupling precursors and the necessity for pressurized carbon monoxide. In order to 
diversify the chalcone scaffold for library production, chemo- and regioselective 
functionalization of the aryl rings requires innovative strategies.  
Hence, the task of diversifying the chalcone core ultimately relies on the methods of 
functionalizing arenes. In spite of the high efficiency of the classic functionalization 
methods, such as electrophilic, nucleophilic and radical aromatic substitution, it is still of 
fundamental importance to devise novel methods for regioselective functionalization of 
arenes.462 Transition metal-catalyzed coupling reactions have become highly effective,463 
and direct C–H functionalization of arenes has been heavily studied in recent years.88, 91, 
132, 161, 350, 464-466 In many of these couplings, a directing group is required to achieve 
excellent regioselectivity.  
In particular, 1,3,5-trisubstituted benzenes are important structural motifs in material 
science and medicinal chemistry because of their unique symmetry. The symmetrical 
1,3,5-trisubstituted benzenes have been used in liquid crystals,467, 468 macromolecules,469 
and organic light-emitting devices (OLEDs),470, 471 while the unsymmetrical counterparts 
have been studied as thrombin inhibitors,472 γ-turn mimics,473, 474 and anticancer agents,475 
etc. A majority of the methods for synthesizing 1,3,5-trisubstituted benzenes employ 
commercially available 1,3,5-trihalobenzenes or alike as precursors, where the 
substitution pattern is established in the beginning.467, 469, 470, 476, 477 The regioselectivity is 
often problematic in order to produce unsymmetrical 1,3,5-trisubstituted benzenes. The 
sequential functionalization of each position sometimes also requires protection schemes, 
which are undesirable with poor atom economy.472 With regard to the advanced C–H 
activation chemistry of arenes, ortho-functionalization prevails, while meta-
functionalization is still in its infancy.478-484 Due to the synthetic difficulty, there is a lack 
of a general, regioselective method for synthesizing unsymmetrical 1,3,5-trisubstituted 
benzenes. 
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Inspired by our preliminary results, we decided to explore the potential of the Diels-
Alder tandem reaction to devise an alternative useful method to synthesize 1,3,5-
trisubstituted benzenes, including polysubstituted chalconoids. 
 
6.5 Condition optimization for the Diels-Alder tandem reaction 
6.5.1 Solvent screen 
We first tested a series of solvents for the Diels-Alder tandem reaction (Table 6-8). 
Due to the incomplete conversion of enaminone 6.33, all the reactions were run for 5 
days. An extended reaction time however led to more side reactions. Nevertheless, less 
polar solvents such as toluene and DCE furnished better yields (entries 1–2). More polar 
solvents such as MeCN, THF, and DMAc did not measure up (entries 3–5), while no 
product 6.39 was formed in THF (entry 6). As toluene has a higher boiling point than 
DCE, we chose toluene as the solvent for the subsequent study. 
 
Table 6-8. Study of solvent effect on the Diels-Alder tandem reaction 
N
O
OMe
O
Me
PMP
solvent
130 ºC, 5 d
O
OMe
O
O
PMP
+
O
6.33 6.38 6.39  
Entrya Solvent (1 mL) % Yield 
1 toluene 44 
2 DCE 45 
3 MeCN 36 
4 dioxane 35 
5 DMAc 28 
6 THF 0 
a Conditions: Enaminone 6.33 (0.07 M), alkene 6.38 (2 equiv) at 130 °C for 5 d. 1H NMR 
yield based on 1.0 equiv of Ph3SiMe as the internal standard. 
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6.5.2 Reaction time and temperature 
Table 6-9. Study of reaction time and temperature 
N
O
OMe
O
Me
PMP
toluene
temp, time
O
OMe
O
O
PMP
+
O
6.33 6.38 6.39  
Entrya Time (h) Temp (ºC) % Yield 
1b 0.5 180 17 
2b 2 180 44 
3b 4 180 48 
4b 8 180 51 
5b 10 180 52 
6b 2 200 46 
7b 4 200 19 
8 24 150 31 
9 24 160 56 
10 24 170 40 
11 24 180 45 
12 15 180 43 
a Conditions: Enaminone 6.33 (0.07 M), alkene 6.38 (4 equiv) in toluene (1 mL). 1H 
NMR yield based on 1.0 equiv of Ph3SiMe as the internal standard. b Under microwave.  
 
Next, we explored the feasibility of applying the microwave technique to facilitate the 
reaction (Table 6-9). The reaction was first exposed to an elevated temperature (180 ºC) 
for 0.5 h. To our disappointment, only 17% of 6.39 was observed (entry 1). As we 
prolonged the reaction time, it quickly became clear that the tandem transformation 
proceeded slowly (entries 1–5) Attempts to accelerate the reaction by increasing the 
temperature to 200 ºC resulted in decomposition (entries 6–7). Hence, the microwave 
technique is not suitable for this transformation. The conventional heating technique was 
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then adopted and the reaction temperature was controlled from 150 ºC to 180 ºC in 10 ºC 
intervals (entries 8–12). 160 ºC was found to be the most suitable temperature (entry 9). 
 
6.5.3 Stoichiometry  
Lastly, the reagent stoichiometry was examined (Table 6-10). The concentration of 
dienophile 6.38 was controlled from 1.1 equiv up to 30.0 equiv (entries 1–6). Apparently, 
8.0 equiv of 6.38 reached the apparent “saturation” level and afforded the highest yield 
(entry 4). Adding more dienophile showed no beneficial effect (entries 5–6). Attempts to 
extend the reaction time to 48 h and to use less dienophile 6.38 (2.0 equiv) were not 
successful (entry 7). It was also found that an oxygen atmosphere was detrimental to the 
Diels-Alder tandem reaction (entry 8).  
 
Table 6-10. Study of reagent stoichiometry 
N
O
OMe
O
Me
PMP
toluene
160 ºC
O
OMe
O
O
PMP
+
O
6.33 6.38 6.39  
Entrya  6.37 (equiv) Time (h) % Yield 
1 1.1 24 27 
2 2.0 24 42 
3 4.0 24 56 
4 8.0 24 63 (66b) 
5 15.0 24 59 
6 30.0 24 61 
7 2.0 48 43 
8c 2.0 24 17 
a Other conditions: Enaminone 6.33 (0.07 M) in toluene (1 mL) at 160 ºC. 1H NMR yield 
based on 1.0 equiv of Ph3SiMe as the internal standard. b Isolated yield. c Under 1 atm O2. 
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6.6 Study of the scope of the 1,3,5-trisubstituted arene synthesis 
The scope of the tandem reaction was then explored (Table 6-11). The Diels-Alder 
reaction exhibited excellent regioselectivity, furnishing a distinctive 1,3,5-trisubstitution 
pattern. A wide range of electron-deficient dienophiles (e.g. vinyl sulfone, vinyl ketone, 
acrylates, acrylonitrile, vinyl phosphonate) were compatible with yields up to 86% (6.36, 
6.39–6.44). Surprisingly, maleimide was not well tolerated, generating 6.45 in a low yield 
(16%). When acrylic acid was used, decarboxylation occurred to form 6.46 (Scheme 6-8). 
Although styrene was not reactive as a dienophile, the flexibility of our protocols allowed 
us to install styrene (as R3) beforehand via dehydrogenative alkenylation, and the tandem 
reaction thereafter could furnish the phenylated chalcones (6.47–6.48). Surprisingly, 
diene 6.14 generated a distinct benzene 6.49. A structural search of 1,3,5-trisubstituted 
benzenes bearing ketone, ester and cyano functionalities obtained only one precedence.474 
Due to the unique structural feature in 6.56, we presume that a retro-Mannich reaction 
took place instead of a retro-Michael fragmentation (Scheme 6-9). It is worth noting that 
no octahydroquinoline products (as 6.35) were left after any of these transformations. 
The advantages of this new tandem reaction in regioselectively functionalizing 
benzenes are four-fold: 
(1) The new protocol provides a straightforward pathway to synthesize 
unsymmetrical 1,3,5-electron-withdrawing-group-substituted benzenes. The synthesis of 
this type of arenes is not simple via conventional approaches. For instance, the classics 
electrophilic substitution could work in theory, but the deactivation of reactivity by every 
additional electron-withdrawing group significantly devalues this strategy. Metal-
catalyzed/mediated functionalization would require meticulously prefunctionalized 
benzenes with different (pseudo)halogens on 1,3,5-positions respectively;473-475 
Otherwise, regioselectivity is difficult to control. As to C–H functionalization, meta-
selectivity has very few reports so far with a limited substrate scope.478-484  
(2) The tandem reaction tolerates a series of electron-withdrawing functionalities. 
Due to the nature of the dehydrogenative alkenylation and NED Diels-Alder reaction, a 
variety of electron-deficient alkenes are compatible in both reactions (Tables 6-6 and 6-
11). In particular, functionalities such as sulfone (6.36) and phosphonate (6.44) can be 
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installed onto the phenyl ring in one step from commercially available vinyl reagents, 
which eliminates the prefunctionalization step (e.g. halogenation) required in previous 
methods.485-491 
 
Table 6-11. Scope of the Diels-Alder tandem reactiona 
N
O
R3
R1
R2
toluene
160 ºC, 24 h
R3
R4
O
R2
+ R4
 
O
OMe
S(O)2Me
O
PMP
O
OMe
COMe
O
PMP
O
OMe
CO2Me
O
PMP
O
OMe
CO2nBu
O
PMP
O
OMe
CO2Bn
O
PMP
O
OMe
CN
O
PMP
O
OMe
O
PMP
O
OMe
PO(OMe)2
O
PMP
O
OMe
O
PMP
6.36, 82% 6.39, 66% 6.40, 73%
6.41, 75% 6.42, 86% 6.43, 80%
6.46, 33%6.44, 23% (57%b) 6.45, 16%
Ph
CN
O
PMP
6.47, 46%c
Ph
CO2Me
O
PMP
6.48, 52%c
CN
O
Me
6.49, 48%d
OtBu
O
NH
O
O
 
a Conditions: Enaminone 6.33 (0.07 M), alkene (8.0 equiv) in toluene at 160 °C for 24 h. 
Isolated yield. b Based on recovered starting material 6.33. c Enaminone 6.10 was used. d 
Enaminone 6.14 was used. 
 
(3) This two-step scheme (i.e. the dehydrogenative alkenylation and Diels-Alder 
tandem reaction) is complementary and flexible. As mentioned above, compounds 6.47 
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and 6.48 have demonstrated the feasibility of changing the sequence of alkenes used in 
each step to afford satisfactory yield. In addition, the choice of alkenes in each step can 
simply construct symmetrical and unsymmetrical 1,3,5-trisubstituted benzenes (e.g. 
symmetrical 6.40 vs. unsymmetrical 6.43). Thus, the distribution of functional groups can 
be easily manipulated. Remarkably, several products, such as 6.49, have three different 
functional groups that might be modified in a chemoselective manner.  
 
N
O
OMe
O
Me
PMP
N
O
OMe
O
Me
PMP
CO2H
NH
O
OMe
O
Me
PMP
CO2H
O
OMe
O
Diels-Alder
retro-Michaelaromatization
6.51 6.536.52
H
6.33
6.50CO2H
PMP
O
OMe
O
33%
6.46
PMP
OO H
decarboxylation
toluene
160 ºC
H
 
Scheme 6-8. A tandem sequence with decarboxylation. 
 
N
O
OtBu
O
N
O
OtBu
O
CN
NH
O
OtBu
O
CN
Me
O
OtBu
O
CN
Diels-Alder retro-Mannicharomatization
6.55 6.496.56
H
6.14
6.54CN
 
Scheme 6-9. A tandem sequence with retro-Mannich fragmentation. 
 
(4) With respect to chalcone synthesis, the current approach focuses on the 
diversification of chalcone aryl rings, contrary to previous methods that paid most 
attention to the construction of the vinylketone linkage in chalcones (Scheme 6-7). Since 
the tandem reaction construct one of the two phenyl rings in chalcones, our approach 
does not depend as heavily as other methods on the availability of aryl precursors. In 
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addition, all the aforementioned advantages for the 1,3,5-trisubstituted benzene synthesis 
can facilitate the generation of unique chalcone libraries for medicinal study. 
 
6.7 Conclusion 
In this study, we successfully improved our dehydrogenative alkenylation method for 
cyclic enaminones in a biomimetic approach by adopting catechol as an O2 activator. The 
current protocol uses using O2 as a green oxidant and significantly reduces the heavy 
metal oxidant Cu(OAc)2 to a catalytic level. Remarkably, the new aerobic C–H 
alkenylation reaction shows comparable scope and proceeds efficiently at room 
temperature, which we believe is the first example in the field of dehydrogenative cross-
coupling. Interestingly, our synthetic development on alkenylated cyclic enaminones 
discovered a tandem reaction, which constructed a series of unique 1,3,5-trisubstituted 
benzenes through a Diels-Alder/aromatization/retro-Michael sequence. This unexpected 
transformation can provide an alternative approach to synthesize multisubstituted 
chalconoids in good yields.  
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Chapter 7  Progress on C–H Trifluoromethylation of Cyclic Enaminones 
 
7.1 Introduction 
Even though inorganic fluorides are abundant on Earth, no more than a dozen of the 
compounds created by nature contain fluorine atom(s).492 In contrast, 30–40% of all 
commercial agrochemicals and 20–30% of all pharmaceuticals are decorated with at least 
one fluorine atom.493 Among all the fluorinated compounds, molecules bearing a 
trifluoromethyl (CF3) group constitute an important class of compounds and have 
attracted broad attention because of their unique properties such as elevated 
electronegativity, hydrophobicity, and metabolic stability, etc.493, 494 Hence, molecular 
modification with a CF3 group is now common in the pharmaceutical and agrochemical 
industries (Scheme 7-1).493, 495  Classic methods to synthesize trifluoromethylated 
compounds largely undergo Lewis acid-promoted exchange of chloride by fluoride via 
the Swarts-type reaction (Scheme 7-2).496, 497 The harsh conditions significantly limit 
their synthetic application. With the increasing importance of fluorinated compounds, 
new synthetic methods are urgently needed. 
 
O
Cl
F3C
CO2H
NO2
Acifluorfen
O
N
iPr CF3
Oxaflozane
N
NO2
NO2F3C
Cl
Fluchloralin
H
N
N
NO2
NO2
Cl
F3C
Cl
CF3
N
H
Me2N
O
CF3
N
H
O
Br
Br
OH
CF3
Fluazinam
Fluometuron Fluorosalan  
Scheme 7-1. Examples of CF3-containing pharmaceuticals. 
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Cl2
R
CCl3
R
CF3
R
F–
 
Scheme 7-2. Traditional methods for trifluoromethylation.  
 
Transition metal-catalyzed trifluoromethylation in this regard is very promising in 
terms of regioselectivity, functionality tolerance, and reaction efficiency.498-504 
Palladium- and copper-catalyzed cross-coupling reactions in particular have proven to be 
an efficient strategy to introduce the CF3 functionality.498-504 These reactions often require 
substrate prefunctionalization with halogen or boron substituents. Although these 
reactions could afford excellent regioselectivity due to prefunctionalization, their low 
atom-economy would confine their industrial applications. A more desirable approach for 
trifluoromethylation via direct C–H activation would bypass the prefunctionalization step 
and offer a more straightforward and economical pathway. Unfortunately, direct C–H 
trifluoromethylation is very challenging. Mild and robust methods had not been available 
until very recently.505-508 
 
7.2 Recent development  
7.2.1 Direct trifluoromethylation of sp2 C–H bonds 
Due to the wide application of trifluoromethylated (hetero)arenes in pharmaceuticals, 
agrochemicals and advanced materials, direct trifluoromethylation of sp2 C–H bonds is 
currently the most studied and in fact the most straightforward method to synthesize CF3-
containing (hetero)arenes.498, 501, 503, 506, 508 The developed protocols can be categorized 
into three classes based on the three CF3 sources used: CF3+, CF3–, and CF3•.509  
 
7.2.1.1 Trifluoromethylation involving CF3+ reagents 
Yu and co-workers first reported a directed electrophilic ortho-trifluoromethylation 
reaction of arenes using Umemoto’s reagent (7.1, a trifluoromethyl sulfonium salt, 
Scheme 7-3, top).510 N-heterocycles, such as pyridine, pyrimidine, imidazole, and 
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thiazole, could be used as the directing groups. This pioneering work was catalyzed via a 
proposed PdII/PdIV cycle, and therefore a stoichiometric amount of Cu(OAc)2 as the 
oxidant was required. Subsequently, the same group developed a similar electrophilic 
trifluoromethylation reaction using an amido group as the directing group.511 In 
particular, N-methylformamide as an additive was crucial for the coupling process. 
Similarly, Shi and co-workers successfully applied the acetamino group as an alternative 
directing group to achieve regioselective ortho-trifluoromethylation of arenes (Scheme 7-
3, bottom).512  
Mechanistically, Sanford and co-workers later reported that the oxidation of the 
cyclometalated PdII dimer with CF3+ reagents could produce a monomeric CF3–PdIV 
intermediate, which would underwent selective reductive elimination to form a C–CF3 
bond.513 
 
R
DG
+
S
CF3
BF4
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (1–2 equiv)
DCE/TFA
110–130 ºC
R
DG
CF3H
53–88%
Yu group
DG =
N
N
N N
N
N
S
N
H
O
F
F
CF3
F
F
Shi group
R1
H
N
+
S
CF3
BF4
Pd(OAc)2 (10 mol%)
Cu(OAc)2 (2.2 equiv)
PivOH (5 equiv)
DCE, N2, 110 ºC
R1
H
N
CF3H
41–83%
R2
O
R2
O
7.1
7.1  
Scheme 7-3. Electrophilic ortho-trifluoromethylation using Umemoto’s reagent. 
 
Another class of CF3+ sources is Togni’s reagent (7.2, a hypervalent iodine 
compound). Initially, Togni and co-workers reported that no catalysts were needed for 
electrophilic aromatic trifluoromethylation on a broad range of arenes and N-
heteroarenes, although 7.2 showed increased electrophilicity in the presence of a Lewis 
  132 
acid.514 Hence, Sodeoka and co-workers later developed a CuOAc-catalyzed 
regioselective trifluoromethylation of indole derivatives using Togni’s reagent under very 
mild conditions (Scheme 7-4, top).515 Very recently, Sodeoka reported a 
difunctionalization-type trifluoromethylation reaction of activated alkenes bearing allylic 
protons using Togni’s reagent.516 This CuI-catalyzed protocol provides 
trifluoromethylated carbocycles and heterocycles in good to excellent yields. As for C–H 
trifluoromethylation of alkenes, Loh and co-workers reported the first example of this 
reaction (Scheme 7-4, bottom).517 A series of enamides was converted with Togni’s 
reagent to their β-trifluoromethyl substituted derivatives by CuI catalysis in good to 
excellent yields. 
 
Sodeoka group
N
R2
R3
R1 H + O
I
CF3
O
CuOAc (10 mol%)
MeOH, rt N
R2
R3
R1 CF3
5–90%7.2
Loh group
R1
NHAc
R2
+ O
I
CF3
O
Cu(MeCN)4PF6 (10 mol%)
THF, rt
7.2
H
R1
NHAc
R2
CF3
40–92%  
Scheme 7-4. Electrophilic trifluoromethylation using Togni’s reagent. 
 
7.2.1.2 Trifluoromethylation involving CF3– reagents 
The most used CF3– reagent is TMSCF3 (the Ruppert-Prakash reagent). Liu and co-
workers developed a Pd-catalyzed oxidative trifluoromethylation of indoles using 
TMSCF3 (Scheme 7-5, top).518 PhI(OAc)2 was used as an oxidant as this reaction was 
proposed to take place via a PdII/PdIV mechanism. Using very similar conditions, the 
same group continued to develop a tandem oxidative aryltrifluoromethylation of activated 
alkenes.519 This difunctionalization reaction afforded a variety of CF3-containing 
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oxindoles in good yields. More recently, Qing and co-workers described a Cu-catalyzed 
C–H trifluoromethylation reaction of heteroarenes and electron-deficient arenes with 
TMSCF3 (Scheme 7-5, bottom).520 The acidity of the targeted C–H proton is the key to 
this regioselective transformation.  A wide range of aromatic compounds, including 
oxadiazoles, benzoxazoles, benzothiazoles, benzoimidazoles, indoles, and 
perfluoroarenes, were compatible under the optimized conditions.  
 
 
Liu group
N
R2
R3
R1 H +
Pd(OAc)2 (10 mol%)/L
PhI(OAc)2 (2 equiv)
CsF (4 equiv)
TEMPO (0.5 equiv)
MeCN, rt
N
R2
R3
R1 CF3
33–83%
TMSCF3
Qing group
X
Y
N
R H +
CuX2 (10–40 mol%)
Phen (10–40 mol%)
base, additive
DCE, 80 ºC
X
Y
N
R CF3
32–93%
TMSCF3
X = C, N
Y = O, S, N  
Scheme 7-5. Nucleophilic trifluoromethylation using TMSCF3. 
 
7.2.1.3 Trifluoromethylation involving CF3• reagents 
In 2010, Yamakawa and co-workers demonstrated the use of CF3I in the presence of a 
FeII catalyst, H2O2 and DMSO in trifluoromethylating various (hetero)aromatic 
compounds.521 The regioselectivity is largely directed by the general trend of aromatic 
electrophilic substitution. Later, the Sanford group reported a silver-mediated direct 
trifluoromethylation of arenes with TMSCF3 (Scheme 7-6, top).522 An Ag–CF3 species 
was proposed as a key intermediate to produce the CF3• radical. Although a wide scope 
of substrates was tolerated, this protocol has a few drawbacks including the use of 
stoichiometric amounts of Ag salts and problematic regioselectivity. Bräse and co-
workers extended this silver-mediated protocol to aryl triazene substrates and achieved 
good ortho-selectivity (Scheme 7-6, bottom).523 Thanks to the versatility of triazenes, a 
variety of CF3–containing building blocks are therefore available.  
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Bräse group
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Scheme 7-6. Silver-mediated C–H trifluoromethylation. 
 
R +
Ru(phen)3Cl2 (1–2 mol%)
K2HPO4, MeCN, rt
26 W light source
R
CF3H
70–94%
MacMillan group
CF3SO2Cl
*Ru(phen)32+
reductant
Ru(phen)32+
photocatalyst
Ru(phen)33+
oxidant
household
light
S ClF3C
O
O
CF3SO2Cl
H
CF3
SO2 + Cl–
H
CF3
H
CF3
H+
CF3
R
R R
R
 
Scheme 7-7. MacMillan’s radical-based trifluoromethylation protocol. 
 
A recent breakthrough in direct C–H trifluoromethylation is the advance of radical 
approaches with inexpensive reagents and mild conditions.499, 524 MacMillan and co-
workers devised a novel photoredox protocol that promoted RuII-catalyzed direct C–H 
trifluoromethylation on an array of arenes and heteroarenes (Scheme 7-7).407 CF3SO2Cl 
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(i.e. TfCl) was used as the CF3• source. The low cost of TfCl and the mild conditions 
rendered this protocol very promising. Since then, a series of subsequent developments 
based on this photoredox protocol was achieved. For instance, Cho and co-workers used 
CF3I as the CF3• source in the direct trifluoromethylation of a wide range of heteroarenes 
with good to excellent yields.525  
 
+
tBuOOH (5–10 equiv)
DCM/H2O (2.5:1), rt
33–96%
Baran group
NaSO2CF3Het
H
Het
CF3
tBuOOH
trace metal CF3SO2
OH
tBuO tBuO    +  CF3SO2
SO2
CF3
Ar–H
F3C ArHH2O  +  Ar–CF3
tBuOOH  
Scheme 7-8. Baran’s radical-based trifluoromethylation protocol. 
 
Meanwhile, Baran’s group successfully employed CF3SO2Na (the Langlois reagent), 
a benchtop-stable and inexpensive solid, in a metal-free trifluoromethylation reaction 
with peroxides as radical initiators (Scheme 7-8).106 Both electron-rich and electron-
deficient heteroarenes can be used efficiently and with high functional group tolerance. 
However, the regioselectivity was modest, but the choice of solvent sometimes could 
help tune the innate substrate reactivity. These two methods are very beneficial for 
medicinal chemistry because their robust conditions and wide functional group tolerance 
allow late stage trifluoromethylation to diversify drug candidates.524 
 
7.2.2 Direct trifluoromethylation of sp C–H bonds 
The examples of direct C–H trifluoromethylation on sp carbon centers are very 
limited. As mentioned in Chapter 2, the dimerization of alkynes is a main problem. In 
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2010, Qing and co-workers reported the fist example of a Cu-mediated oxidative 
trifluoromethylation of terminal alkynes with TMSCF3 (Scheme 7-9).526 Stoichiometric 
amounts of CuI were needed for the reaction to proceed efficiently. Remarkably, the 
same group later reduced the usage of CuI to a catalytic amount by slow addition of 
reagents through a syringe pump.527 Subsequently, the Qing group reported an improved 
procedure for trifluoromethylation of terminal alkynes. This protocol used (phen)Cu(CF3) 
generated in situ and proceeded smoothly at room temperature with a smaller amount of 
TMSCF3.528  
 
Qing group
R
+
CuI (1 equiv)
Phen (1 equiv)
KF (5 equiv)
DMF, 100 ºC, air
R
41–97%
TMSCF3 CF3H
 
Scheme 7-9. First example of a C–H trifluoromethylation of alkynes. 
 
7.2.3 Direct trifluoromethylation of sp3 C–H bonds 
Similar to its sp counterpart, direct trifluoromethylation of sp3 C–H bonds is 
extremely challenging. The current available methods are applicable to only a few 
substrate prototypes, e.g. allylic C–H bonds and α-carbonyl C–H bonds.529-538 
Liu and Fu first reported a CuI-catalyzed C–H trifluoromethylation of terminal 
alkenes via allylic C–H activation using Umemoto’s reagent (Scheme 7-10, top).532 Their 
mechanistic calculation showed that the reaction might proceed through a Heck-like four-
membered transition state. This method can work on a variety of terminal alkenes without 
2-substitutents, whereas 2-substituted terminal alkenes or internal (including cyclic) 
alkenes were not viable. Meanwhile, Buchwald533 and Wang534 independently reported 
CuI-catalyzed allylic C–H trifluoromethylation reactions using Togni’s reagent (Scheme 
7-10, middle). These methods tolerate a wide range of functional groups and proceed 
with good yields. Interestingly, branched terminal alkenes and cyclic alkenes were not 
compatible with Buchwald’s method, but worked well using Wang’s conditions, albeit 
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requiring a higher temperature. In addition, Qing and co-workers developed a Cu-
catalyzed oxidative trifluoromethylation of terminal alkenes using TMSCF3 (Scheme 7-
10, bottom).535 This method provides a complementary pathway for direct allylic 
trifluoromethylations without using Umemoto’s reagent or Togni’s reagent.   
 
Fu & Liu groups
R H +
S
CF3
OHTf
CuTc (20 mol%)/L
DMAc, 40 ºC
R CF3
32–78%
Buchwald group
R H +
Cu(MeCN)4PF6 (15 mol%)
MeOH, 0 ºC to rt, 24 h
R CF3
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O
I
CF3
O
Wang group
R H +
CuCl (10 mol%)
MeOH, 70–90 ºC, 1 h
R CF3
44–97%
O
I
CF3
O
Qing group
R H +
CuTc (30 mol%)
PhI(OAc)2 (2 equiv)
K2CO3 (4 equiv)
NMP, 80 ºC
R CF3
31–87%
TMSCF3
 
Scheme 7-10. Allylic C–H trifluoromethylation. 
 
MacMillan and co-workers pioneered the direct trifluoromethylation of α-carbonyl 
C–H bonds using their aforementioned photoredox chemistry. They first reported their 
discovery in 2009 using CF3I as a CF3• source (Scheme 7-11).536 A series of aldehydes 
were α-trifluoromethylated enantioselectively. Later, they applied Togni’s reagents to 
replace CF3I in a non-photolytic approach to achieve enantioselective α-
trifluoromethylation of aldehydes.537 Recently, they expanded the substrate scope from 
aldehydes to ketones, esters, and amides with very good yields, which further enhanced 
the utility of this novel protocol.538  
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Scheme 7-11. Enantioselective α-trifluoromethylation of aldehydes. 
 
Despite the rapid advance in this field, existing methods and substrates are still 
inadequate. In particular, direct trifluoromethylation of alkenyl C–H bonds is very rare. 
Only one method involving enamides was reported so far by Loh and co-workers 
(Scheme 7-4, bottom).517 Trifluoromethylation of internal or cyclic alkenes has not been 
developed. With the innate nucleophilicity that favors Pd-catalysis, non-aromatic cyclic 
enaminones offer a promising platform to assess the feasibility of direct 
trifluoromethylation of cyclic alkenyl C–H bonds, which would potentially furnish a 
straightforward path to access 3-trifluoromethylpiperidine derivatives.  
 
Table 7-1. Trifluoromethylation of cyclic enaminone 7.3 using Umemoto’s reagent 
N
O
+ conditions
N
OPMP
Bn CF3
PMP
Bn H
7.3
S
CF3
BF4
7.1 7.4  
Entrya Pd(OAc)2 (mol%) 
Cu(OAc)2   
(equiv) 
Additive 
(equiv) Solvent 
Temp. 
(ºC) 
Time 
(h) 
% 
Yieldb 
1 10 2 KTFA (1) DMF 100 24 0 
2 10 2 TFA (10) DCE 100 24 0 
3 10 2 TFA (10) dioxane 100 24 0 
4 10 2 TFA (1) DCE 100 24 0 
5 — — — DMF rt 3 0 
6 — — — DMF 80 3 0 
a Conditions: enaminone 7.3 (0.1 mmol), 7.1 (2.0 equiv), Pd(OAc)2, Cu(OAc)2, additive, 
in solvent (1 mL). b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard.  
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Table 7-2. Trifluoromethylation of cyclic enaminone 7.3 using Togni’s reagent 
OI
F3C
N
O
+ conditions
N
OPMP
Bn CF3
PMP
Bn H
7.3 7.5 7.4  
Entrya Lewis Acid  (equiv) 
Additive 
(equiv) Solvent 
Temp 
(ºC) 
Time 
(h) 
% SM 
Consumptionb 
% 
Yieldb 
1 – Bu4NI (0.5) MeCN rt 24 26 12 
2 – Bu4NI (0.5) MeCN 80 24 54 15 
3 – Bu4NI (0.5) DMF rt 24 28 11 
4 – Bu4NI (0.5) MeOH rt 24 30 15 
5 Cu(OAc)2 (2) – MeOH rt 3 68 25 
a Conditions: enaminone 7.3 (0.1 mmol), 7.5 (2.0 equiv), Lewis acid, additive, in solvent 
(1 mL). b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard.  
 
7.3 Reaction optimization 
7.3.1 Screen of existing protocols 
We first subjected cyclic enaminone 7.3 to the existing methods in order to determine 
the most effective protocol. Electrophilic trifluoromethylation using Umemoto’s reagent 
failed to proceed in the desired manner (Table 7-1). Altering the additives and solvents 
did not yield any trifluoromethylated product 7.4 (entries 1–4). Our attempts to use 
metal-free conditions were not successful either (entries 5–6). Therefore, we turned to 
Togni’s reagent (7.5) as the alternative CF3+ source (Table 7-2). We first tested metal-
free conditions, which afforded the desired product 7.4 in only 12% (entry 1). As the 
consumption of the starting material 7.3 was low, we increased the temperature to 80 ºC, 
which unfortunately failed to provide a satisfactory conversion (entry 2). We also 
changed the solvent to DMF and MeOH, only the latter of which furnished a marginally 
higher yield (entries 3–4). As Cu salts were reported to catalyze trifluoromethylation 
reactions involving Togni’s reagent, Cu(OAc)2 was added to the reaction, which afforded 
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7.4 in 25% yield (entry 5). Overall, the electrophilic trifluoromethylation protocols did 
not meet our expectation.  
  
N
O
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+
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Ru(phen)3Cl2 (2 mol %)
K2HPO4⋅3H2O (3 equiv)
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H
7.3
N
O
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+
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K2HPO4⋅3H2O (3 equiv)
MeCN, rt, 24 h
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N
O
Cbz CF3
CF3SO2Cl
7.7, 62%
H
7.6  
Scheme 7-12. Radical trifluoromethylation of cyclic enaminone by photoredox catalysis. 
 
Table 7-3. Trifluoromethylation of cyclic enaminone 7.3 using tBuOOH 
NaSO2CF3N
O
+ conditions
N
OPMP
Bn CF3
PMP
Bn H
7.3 7.4  
Entrya Catalyst (equiv) Solvent Time (h) % Yieldb 
1 — DCM/H2O (2.5:1) 48 1 
2 — DMSO/H2O (2.5:1) 48 40 
3 AgNO3 (0.1) DMSO/H2O (2.5:1) 21 8 
4 CuSO4 (0.1) DMSO/H2O (2.5:1) 21 44 
5 Fe2(SO4)3 (0.1) DMSO/H2O (2.5:1) 21 37 
a Conditions: enaminone 7.3 (0.1 mmol), NaSO2CF3 (3.0 equiv), catalyst, tBuOOH (5 
equiv) in solvent (1 mL) at rt. b 19F NMR yields with C6F6 (1.0 equiv) as the internal 
standard.  
 
Next, we examined the existing radical-based protocols. MacMillan’s photoredox 
chemistry showed discrete results (Scheme 7-12). Electron-rich enaminone 7.3 only 
produced 12% of the desired product 7.4. In contrast, electron-deficient enaminone 7.6 
afforded a much better yield (62%). It is the first example of an electron-deficient 
enaminone being compatible with C–H functionalization at the C5 position. We presume 
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that the electron-withdrawing Cbz group may contribute to stabilizing the enaminone 
radical intermediate formed in the reaction (Scheme 7-7), thus averting decomposition 
and increasing the yield.  
Meanwhile, Baran’s radical protocol also gave varied yields (Table 7-3). The reported 
solvent mixture (DCM/H2O) only generated a trace amount of product 7.4 over an 
extended period of time (entry 1). Replacing DCM with a more polar solvent (DMSO) 
increased the yield to 40% (entry 2). As several reports showed beneficial effects from 
catalytic metal salts, we then introduced AgI, CuII, and FeIII salts to the reactions. It 
quickly became apparent that metal additives were not required for a productive reaction 
(entries 3–5). 
 
N
O
Bn
+
PMP
Cu(OAc)2 ( 40 mol%)
phen (40 mol%)
KF (3 equiv)
Ag2CO3 (2 equiv)
DCE, 80 ºC, 24 h
N
O
Bn
PMP
CF3
TMSCF3
AgOTf (4 equiv)
KF (4 equiv)
DCE, 80 ºC, 24 hN
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.4
no product
H
7.3
7.3 7.4
no product  
Scheme 7-13. Failed trifluoromethylation of cyclic enaminone using TMSCF3. 
 
Next, we tested a few TMSCF3-based protocols. Unfortunately, Cu-catalyzed 
trifluoromethylation of 7.3 failed to furnish any desired product (Scheme 7-13, top). 
Attempts to adopt Sanford’s protocol involving stoichiometric amounts of AgOTf did not 
yield any desired product either (Scheme 7-13, bottom). Lastly, we tried a Pd-catalyzed, 
PIDA-mediated protocol developed by Liu and coworkers (Table 7-4). The addition of 
TEMPO improved the yield of 7.4 by 10% (entry 2), while using PIFA instead of PIDA 
inhibited trifluoromethylation (entry 3).  
In all, two existing protocols afforded satisfactory yields after our preliminary 
investigation: 1) Baran’s tBuOOH-mediated radical trifluoromethylation (Table 7-3), and 
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2) Liu’s PIDA-mediated nucleophilic trifluoromethylation (Table 7-4). Although both 
methods use operationally easy procedures and readily available reagents, Liu’s protocol 
offers more variables for optimization. Hence, we decided to pursue a C–H 
trifluoromethylation method for cyclic enaminones based on Liu’s protocol.  
 
Table 7-4. Nucleophilic trifluoromethylation of cyclic enaminone 7.3 using TMSCF3 
 
Pd(OAc)2
PhIX2, TEMPO
CsF, CH3CN, rtN
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entry a PhIX2 (equiv) TEMPO (equiv) % SM Consumptionb % Yieldb 
1 PhI(OAc)2 (2.0) – 64 32 
2 PhI(OAc)2 (2.0) TEMPO (0.5) 60 41 
3 PhI(TFA)2 (2.0) TEMPO (0.5) 84 0 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), 
CsF (4.0 equiv), PhIX2, TEMPO in MeCN (1 mL) at rt for 24 h. b 1H NMR yields with 
Ph3SiMe (1.0 equiv) as the internal standard. 
 
7.3.2 Further optimization 
7.3.2.1 Ligand selection 
We first surveyed a series of N-containing ligands (Table 7-5). The yields of 7.4 
revealed the beneficial effect of ligands compared to the ligandless conditions (32%, 
entry 12). Although these data do not provide definitive information on the best class of 
ligands, oxazole-based bidentate ligands (L4–L7) showed relatively higher yields (entries 
4–7). In particular, indenooxazole ligand L4 offered the highest yield at 61% (entry 4).  
 
7.3.2.2 Solvent survey 
Table 7-6 shows the survey results of nine solvents. To our surprise, more polar 
solvents, such as DMSO and NMP, only furnished a trace amount of 7.4 (entries 1–2). 
DMF and acetone (entries 3–4) did not provide comparable yields to that of MeCN (61%, 
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entry 5). Interestingly, using EtOAc as a medium offer a better yield (68%, entry 6). 
Further attempts involving dioxane, THF and DCM did not increase the formation of 7.4 
(entries 7–9).  
 
Table 7-5. Ligand effect on C–H trifluoromethylation of cyclic enaminone 7.3 
Pd(OAc)2 (10 mol%)/L
PhI(OAc)2 (2 equiv)
TEMPO (0.5 equiv)
CsF (4 equiv)
CH3CN, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entry a L (15 mol%) % SM Consumptionb % Yieldb 
1 L1  75 46 
2 L2  41 6 
3 L3  41 8 
4 L4  69 61 
5 L5  71 51 
6 L6  68 57 
7 L7  72 55 
8 L8  69 51 
9 L9  67 49 
10 L10  69 56 
11 L11  72 54 
12 – 64 32 
N N
O O H
HH
H
N N
O O
Ph Ph
N N
O O
Bn Bn
N N
O O
Ph Ph
N N NN NN
Ph Ph
NN
Ph Ph
L4 L5 L6
L7 L8 L9 L10 L11
N N N NN
L3L1 L2
 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), 
ligand (15 mol %), PhI(OAc)2 (2 equiv), CsF (4.0 equiv), TEMPO (0.5 equiv) in MeCN 
(1 mL) at rt for 24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. 
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Table 7-6. Solvent effect on C–H trifluoromethylation of cyclic enaminone 7.3 
Pd(OAc)2 (10 mol%)/L4
PhI(OAc)2 (2 equiv)
TEMPO (0.5 equiv)
CsF (4 equiv)
solvent, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entrya Solvent (1 mL) % SM Consumptionb % Yieldb 
1 DMSO 17 3 
2 NMP 22 3 
3 DMF 43 31 
4 acetone 22 11 
5 MeCN 69 61 
6 EtOAc 76 68 
7 dioxane 48 19 
8 THF 33 9 
9 DCM 70 37 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), L4 
(15 mol %), PhI(OAc)2 (2 equiv), CsF (4.0 equiv), TEMPO (0.5 equiv) in solvent (1 mL) 
at rt for 24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. 
 
7.3.2.3 Oxidant screen 
In addition to phenyliodine diacetate (PIDA), seven other oxidants were examined for 
their effectiveness (Table 7-7). Unfortunately, no other oxidant showed any reactivity. 
Strongly oxidizing reagents like PIFA and Selectfluor largely decomposed 7.3 without 
any conversion to 7.4 (entries 2–3). The other oxidants showed total reaction inhibition 
(entries 4–8). 
 
7.3.2.4 Base effect 
We also found that the choice of the metal cation for the F– sources was crucial 
(Table 7-8). Main group I metals (i.e. Na+, K+ and Cs+) were examined and only KF and 
CsF afforded 7.4 (entries 1–3). Other fluoride salts, such as AgF, CuF2, ZnF2 and NiF2, 
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were not effective either (entries 4–7). The commonly used TBAF also proved to be 
unsuitable (entry 8). We also tested a few non-fluoride metal salts (entries 9–11), and 
only K3PO4 provided 7.4 but with an inferior yield of 20% (entry 9).  
 
Table 7-7. Oxidant screen for C–H trifluoromethylation of cyclic enaminone 7.3 
Pd(OAc)2 (10 mol%)/L4
oxidant (2 equiv)
TEMPO (0.5 equiv)
CsF (4 equiv)
EtOAc, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entrya Oxidant (2.0 equiv) % SM Consumptionb % Yieldb 
1 PhI(OAc)2 86 69 
2 PhI(TFA)2 89 0 
3 Selectfluor 100 0 
4 duroquinone 5 0 
5 K2S2O8 4 0 
6 Oxone 5 0 
7 Cu(OAc)2 6 0 
8 AgOAc 5 0 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), L4 
(15 mol %), oxidant (2 equiv), CsF (4.0 equiv), TEMPO (0.5 equiv) in EtOAc (1 mL) at 
rt for 24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. 
 
7.3.2.5 Additive effect 
Next, a series of additives were introduced to the reaction conditions (Table 7-9). 
Yb(OTf)3 presented a beneficial effect in an earlier example of aryltrifluoromethylation 
of alkenes,519 but significantly inhibited the current trifluoromethylation of 7.3 (14%, 
entry 2). Weak carboxylic acids, especially benzoic acid, increased the yield to 68% 
(entries 3–4). As reported earlier, radical side reactions were observed with indoles.519 
We thus tested a few radical scavengers, such as TEMPO and 2,6-di-t-butyl-4-
methylphenol (entries 5–6). Intriguingly, 2,6-di-t-butyl-4-methylphenol failed to improve 
the yield, while TEMPO increased the yield to 69%. Following attempts to find the most 
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effective concentration of TEMPO quickly revealed a deleterious effect from TEMPO, 
whereby 2.0 equiv of TEMPO caused a total inhibition of trifluoromethylation (entry 6–
9). Therefore, 0.5 equiv of TEMPO turned out to be the most effective additive. 
 
Table 7-8. Base screen for C–H trifluoromethylation of cyclic enaminone 7.3 
Pd(OAc)2 (10 mol%)/L4
PhI(OAc)2 (2 equiv)
TEMPO (0.5 equiv)
base (4 equiv)
EtOAc, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entrya Base (4.0 equiv) % SM Consumptionb % Yieldb 
1 NaF 73 0 
2 KF 87 61 
3 CsF 86 69 
4 AgF 43 0 
5 ZnF2 64 0 
6 NiF2 70 0 
7 CuF2 70 0 
8 TBAF 26 0 
9 K3PO4 83 20 
10 K2CO3 64 0 
11 NaOAc 77 0 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), L4 
(15 mol %), PhI(OAc)2 (2 equiv), base (4.0 equiv), TEMPO (0.5 equiv) in EtOAc (1 mL) 
at rt for 24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. 
 
7.3.2.6 Temperature effect 
Given the incomplete consumption of 7.3, the reaction temperature was raised from 
room temperature to 80 ºC (Table 7-10). Unexpectedly, both the consumption rates and 
product yields were affected adversely. We presumed that the higher temperatures might 
weaken the stability of the palladated intermediate and cause more side reactions. Thus, 
reaction at room temperature proved to be the best of the conditions examined. 
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Table 7-9. Additive effect on C–H trifluoromethylation of cyclic enaminone 7.3 
Pd(OAc)2 (10 mol%)/L4
PhI(OAc)2 (2 equiv)
additive (0.5 equiv)
CsF (4 equiv)
EtOAc, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entrya Additive (equiv) % SM Consumptionb % Yieldb 
1 – 86 58 
2 Yb(OTf)3 (0.5) 76 14 
3 benzoic acid (0.5) 84 68 
4 pivalic acid (0.5) 84 57 
5 2,6-di-t-butyl-4-methylphenol (0.5) 70 49 
6 TEMPO (0.5) 86 69 
7 TEMPO (0.2) 89 60 
8 TEMPO (1.0) 76 52 
9 TEMPO (2.0) 27 0 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), L4 
(15 mol %), PhI(OAc)2 (2 equiv), CsF (4.0 equiv) and additive in EtOAc (1 mL) at rt for 
24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. 
 
Table 7-10. Temperature effect on C–H trifluoromethylation of cyclic enaminone 7.3  
Pd(OAc)2 (10 mol%)/L4
PhI(OAc)2 (2 equiv)
TEMPO (0.5 equiv)
CsF (4 equiv)
EtOAc, temp, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entrya Temp (ºC) % SM Consumptionb % Yieldb 
1 rt 86 69 
2 40 85 59 
3 60 83 51 
4 80 77 47 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd(OAc)2 (10 mol %), L4 
(15 mol %), PhI(OAc)2 (2 equiv), CsF (4.0 equiv) and TEMPO (0.5 equiv) in EtOAc (1 
mL) for 24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. 
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7.3.2.7 Choice of catalyst 
Table 7-11. Catalyst choice for C–H trifluoromethylation of cyclic enaminone 7.3 
Pd catalyst/L4
PhI(OAc)2 (2 equiv)
TEMPO (0.5 equiv)
CsF (4 equiv)
EtOAc, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
7.3 7.4  
Entrya Pd Catalyst/L (mol %) % SM Consumptionb % Yieldb 
1 PdCl2/L4 (10/15) 77 61 
2 Pd(TFA)2/L4 (10/15) 84 67 
3 Pd(OAc)2/L4 (10/15) 86 69 (70c) 
4 Pd(OAc)2/L4 (5/7.5) 80 60 
5 Pd(OAc)2/L4 (15/22.5) 84 62 
6 Pd(OAc)2/L4 (20/30) 80 60 
7 – 78 60 
a Conditions: enaminone 7.3 (0.1 mmol), TMSCF3 (4.0 equiv), Pd catalyst and L4 (1:1.5) 
PhI(OAc)2 (2 equiv), CsF (4.0 equiv) and TEMPO (0.5 equiv) in EtOAc (1 mL) at rt for 
24 h. b 1H NMR yields with Ph3SiMe (1.0 equiv) as the internal standard. c Isolated yield. 
 
Lastly, we screened a few common PdII catalysts in addition to Pd(OAc)2 (Table 7-
11). According to the yields, PdCl2 showed inferior catalytic efficacy, while Pd(TFA)2 
afforded comparable outcome to reaction with Pd(OAc)2 (entries 1–3). Attempts to 
manipulate the Pd loading indicated no or little correlation between the yield and the Pd 
loading (entries 3–6). This prompted us to evaluate the feasibility of metal-free 
conditions (entry 7). As anticipated, a moderate yield (60%) was recorded in the absence 
of the catalyst and ligand.  
 
7.4 Mechanistic implication 
The comparable yield (60%) from the metal-free conditions (Table 7-11, entry 7) 
prompted us to reevaluate our results. We propose two competing pathways (Figure 7-1). 
Alongside with the PdII/PdIV catalysis (path a), a PIDA-mediated process (path b) is also 
feasible.  However, the almost identical results from Table 7-11 entry 1 and entry 7 
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suggest that PdCl2 essentially had no catalytic activity towards 7.3. The beneficial effect 
from adding Pd(TFA)2 and Pd(OAc)2 is not significant either (within 10% yield increase, 
Table 7-11, entries 2–3), indicating that Pd catalysis only played a minor role in the C–H 
trifluoromethylation. Path b is likely to be more favorable in the competing processes. 
 
N
O
R
H PdIILn
N
O
R
PdLn
N
O
R
Pd
N
O
R
CF3CF3
II IV
– PdIILn
N
O
R
I
OAc
Ph
OAc
N
O
R
CF3–
CF3– N
O
R
CF3
PhI(OAc)2
PhI(OAc)2
"SET"
N
O
R
CF3
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V
VII
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IV
path a
path b
H
CF3–
 
Figure 7-1. Plausible mechanisms for C–H trifluoromethylation of cyclic enaminones. 
 
Under ligandless conditions we observed a 32% yield of 7.4 (Table 7-5, entry 12), 
lower than that (61%) from the equivalent conditions in the presence of ligand L4 (Table 
7-5, entry 4).  We presume that the lack of ligands significantly destabilized the active 
PdIV intermediate III, whose decomposition resulted in decreased formation of IV.  
On the other hand, although ligands are essential to stabilize intermediate III, they 
unfortunately seem to retard the palladation process to form II. The mechanistic study in 
Chapter 4 (section 4.5) revealed fast palladation between Pd(OAc)2 and enaminone 7.3 in 
the absence of ligands. We postulate that ligands would reduce the electrophilicity of the 
PdII center and thus hamper the fast palladation, resulting in impeding path a and 
directing trifluoromethylation towards path b. This detrimental effect of ligands was also 
seen in our C–H arylation project (Chapter 3, section 3.3.2). Hence, the direct 
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trifluoromethylation of cyclic enaminones by Pd catalysis is overall not favored 
compared to the metal-free PIDA-mediated protocol. 
The key for the high reactivity of PIDA is the strong electrophilicity of the 
hypervalent iodine(III) center, which is complementary in nature to the strong 
nucleophilicity of the cyclic enaminones. Two tentative mechanisms are plausible for the 
metal-free protocol (path b). One is the nucleophilic substitution via intermediate VI, 
while the other is a single-electron-transfer (SET) process via intermediate VII.539-543 
Although the mechanism is yet to be elucidated, the total reaction inhibition caused by 
2.0 equiv of TEMPO may indicate a radical-based process (Table 7-9, entry 9). 
It is worth noting that metal-free PhI(OAc)2-mediated C–H trifluoromethylation of 
arenes has been reported very recently.539 We reckon it is more advantageous to devise a 
green and mild trifluoromethylation method for cyclic enaminones under metal-free 
conditions at room temperature. The ensuing development is being conducted by Adwait 
Ranade in our laboratory. 
 
7.5 Summary 
Our preliminary study on C–H trifluoromethylation has showed good yields from 
both electron-rich and electron-deficient cyclic enaminones. A PdIV-catalyzed protocol 
was initially studied employing electron-rich enaminones. However, we later found that 
the key effective ingredient was PdI(OAc)2, which led to the discovery of a metal-free 
protocol with comparable yields. In addition, a Ru-catalyzed photoredox protocol was 
found very effective for electron-deficient enaminones. It is the first time that we are able 
to functionalize the C5–H bond on electron-deficient enaminones. Further studies are 
underway. 
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Chapter 8  Experimental Data 
 
8.1 General information 
All reactions were carried out in clear vials used without drying the vial. All 
chemicals were purchased and were directly used without further purification. Anhydrous 
solvents were used as purchased without further drying. Flash column chromatography 
was carried out on silica gel (230–400 mesh). TLC was conducted on 250 micron, F254 
silica gel plates. 1H NMR spectra were recorded at 400 MHz and 13C NMR spectra at 100 
MHz with complete proton decoupling. Chemical shifts are reported as ppm relative to 
chloroform (CHCl3: 7.26 ppm for 1H, 77.16 ppm for 13C). Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m 
= multiplet), coupling constants (Hz) and integration. IR Spectra of liquids were directly 
taken on a NaCl plate. IR spectra of solids were obtained by dissolving the sample in 
CH2Cl2 on a NaCl plate. High-resolution mass spectrometry was performed on an ESI-
TOF instrument. Melting points were uncorrected. 
 
8.2 Preparation of starting materials  
8.2.1 Synthesis of N-benzyl-2-(p-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one 
Step 1) Preparation of N-benzyl-4-pyridone 
N
OMe
N
O
Bn
NaOH/MeOH
THF
Bn–Br+
 
To a solution of 4-methoxypyridine (10.2 mL, 100 mmol) in THF (50 mL) was added 
benzyl bromide (11.9 mL, 100 mmol). After the reaction was stirred for 2 h, a 10% w/w 
solution of NaOH in MeOH (125 mL) was added into the reaction vessel over 30 min at 0 
°C. The reaction mixture was stirred for another 2 h at ambient temperature. The reaction 
mixture was then concentrated under reduced pressure. To the residue was added water 
(30 mL) and the product was extracted with CH2Cl2 (15 mL × 4). The combined organic 
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layers were dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
crude product was purified using flash column chromatography (5% MeOH in CH2Cl2) to 
yield 8.71 g (47%) of N-benzyl-4-pyridone as a light yellow solid (mp 115–119 °C). 1H 
NMR (400 MHz, CDCl3) δ 7.38–7.40 (m, 3H), 7.31 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.0 
Hz, 2H), 6.38 (d, J = 8.0 Hz, 2H), 4.93 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 178.6, 
140.1, 134.7, 129.4, 129.0, 127.4, 118.8, 60.2; FTIR (Film, cm-1) 3049, 2977, 1640, 
1567, 1454, 1405, 1179, 851; HRMS (ESI+) m/z calculated for [M+H]+ C12H12NO: 
186.0919, found 186.0906. 
 
Step 2) Preparation of N-benzyl-2-(p-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one 
N
O
Bn
N
O
Bn
2,6-lutidine
TMSOTf, DCM
MgBr
OMe
+
MeO  
N-Benzyl-4-pyridone (5.0 g, 26.99 mmol) in dry CH2Cl2 (50 mL) was treated with 
TMSOTf (10.5 mL, 53.97 mmol) at room temperature under a N2 atmosphere. After the 
reaction was stirred for 1 h, 2,6-lutidine (6.3 mL, 53.97 mmol) was added, followed by 
slow addition of a 0.5 M solution of p-methoxyphenylmagnesium bromide in THF (81.0 
mL, 40.49 mmol) with a syringe pump. The reaction was stirred for another 2 h and then 
quenched with saturated NH4Cl (15 mL). The mixture was extracted with CH2Cl2 (15 mL 
× 4). The combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. Further purification was carried out by flash column 
chromatography (3:2 EtOAc/hexanes) to produce 4.0 g (51%) of N-benzyl-2-(para-
methoxyphenyl)-2,3-dihydropyridin-4(1H)-one as an orange oil. 1H NMR (400 MHz, 
CDCl3) δ 7.31–7.37  (m, 3H), 7.27 (d, J = 8.0 Hz, 1H), 7.16 (d, J = 8.0 Hz, 2H), 7.11 (d, 
J = 8.0 Hz, 2H), 6.87 (d, J = 8.0 Hz, 2H), 5.08 (d, J = 8.0 Hz, 1H), 4.45 (t, J = 8.0 Hz, 
1H), 4.31 (d, J = 16.0 Hz, 1H), 4.11 (d, J = 16.0 Hz, 1H), 3.81 (s, 3H), 2.79 (dd, J = 
16.0, 8.0 Hz, 1H), 2.68 (dd, J = 16.0, 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 190.6, 
159.5, 154.3, 135.9, 130.5, 128.9, 128.4, 128.2, 127.7, 114.3, 98.5, 60.2, 57.0, 55.3, 43.7; 
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FTIR (Film, cm-1) 3031, 2931, 2837, 1637, 1590, 1512, 1251, 1174, 1032, 834; HRMS 
(ESI+) m/z calculated for [M+H]+ C19H20NO2: 294.1494, found 294.1476. 
 
8.2.2 Synthesis of N-benzyl-2-isopropyl-2,3-dihydropyridin-4(1H)-one 
Step 1) Preparation of N-benzyl-4-pyridone (the same as in Section 8.2.1) 
Step 2) Preparation of N-benzyl-2-isopropyl-2,3-dihydropyridin-4(1H)-one 
N
O
Bn
MgBr
+
2,6-lutidine
TMSOTf, DCM N
O
Bn  
N-Benzyl-4-pyridone (3.0 g, 16.20 mmol) in dry CH2Cl2 (30 mL) was treated with 
TMSOTf (6.3 mL, 32.39 mmol) at room temperature under a N2 atmosphere. After the 
reaction was stirred for 1 h, 2,6-lutidine (3.8 mL, 32.39 mmol) was added, followed by 
slow addition of a 2.0 M solution of isopropylmagnesium bromide in THF (12.2 mL, 
24.29 mmol) with a syringe pump. The reaction was stirred for another 2 h and then 
quenched with saturated NH4Cl (15 mL). The mixture was extracted with CH2Cl2 (15 mL 
× 4). The combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. Further purification was carried out by flash column 
chromatography (3:1 EtOAc/hexanes) to produce 2.1 g (57%) of N-benzyl-2-isopropyl-
2,3-dihydropyridin-4(1H)-one as an orange oil. 1H NMR (400 MHz, CDCl3) δ 7.41–7.30 
(m, 3H), 7.29–7.24 (m, 2H), 7.12 (d, J = 7.4 Hz, 1H), 4.91 (d, J = 7.4 Hz, 1H), 4.47 (d, J 
= 15.4 Hz, 1H), 4.39 (d, J = 15.4 Hz, 1H), 3.22 (td, J = 6.9, 4.0 Hz, 1H), 2.60 (dd, J = 
16.7, 7.5 Hz, 1H), 2.39 (dd, J = 16.7, 3.8 Hz, 1H), 2.28 (dq, J = 13.4, 6.7 Hz, 1H), 0.95 
(d, J = 6.8 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 191.3, 153.7, 137.0, 129.2, 128.4, 
127.4, 97.5, 61.4, 58.8, 36.5, 29.1, 19.8, 18.1; FTIR (Film, cm-1) 3054, 2984, 2876, 1635, 
1591, 1496, 1455, 1441, 1421, 1387, 1357, 1344, 1204, 1166, 1094, 1077, 1029, 1014, 
1002, 955, 896; HRMS (ESI+) m/z calculated for [M+Na]+ C15H19NONa: 252.1359, 
found 252.1354. 
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8.2.3 Synthesis of other cyclic enaminones 
Other cyclic enaminones were prepared according to the reported procedures 
(Scheme 8-1).24, 50, 51, 79-81, 544-546 
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Scheme 8-1. References for enaminone preparation. 
 
8.2.4 Synthesis of uracils 
Uracil and 1,3-dimethyluracil are commercially available. Other uracil derivatives 
were prepared according to the corresponding procedures (Scheme 8-2).416-423, 425 
 
N
N
O
O
Bn
Bn
N
N
O
O
Bn
N
N
O
OO
HO
O
O
Me
N
N
O
O
MOM
MOM
N
N
O
O
O
O
O
Si
O
Si
iPr iPr
iPr
iPr
Me
N
N
O
O
PMB
PMB HN
N
O
O
Bz
N
N
H
O
O
Bz
Ref. 418 Ref. 419 Ref. 416 Ref. 417 Ref. 417
Ref. 425 Ref. 423 Ref. 421  
Scheme 8-2. References for uracil preparation. 
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8.3 Chapter 3 
8.3.1 General procedure for the direct C–H arylation of cyclic enaminones  
N
O
+
Pd(OAc)2 (20 mol%)
Bu4NCl (0.5 equiv)
AgCl (1.2 equiv)
NaHCO3 (1.0 equiv)
DMSO, 80 ºC, 24 h
R3
R2
R1 N
O
R3
R2
R1 ArH
ArI
 
In a clear 1-dram vial, cyclic enaminone (0.1 mmol), aryl iodide (0.3 mmol, 3.0 equiv), 
Pd(OAc)2 (4.5 mg, 0.02 mmol, 20 mol %), Bu4NCl (13.9 mg, 0.05 mmol, 0.5 equiv), 
NaHCO3 (8.4 mg, 0.1 mmol, 1.0 equiv), and AgCl (17.2 mg, 0.12 mmol, 1.2 equiv) were 
mixed in DMSO (0.5 mL). The reaction vessel was then capped and stirred at 80 °C for 
24 h, and then cooled to room temperature. The mixture was filtered through a pad of 
Celite (washed with EtOAc). The filtrate was concentrated under reduced pressure and 
purified by flash column chromatography. 
 
8.3.2 Compound characterization 
N
OPMP
Bn
Me  
1-Benzyl-2-(4-methoxyphenyl)-5-(p-tolyl)-2,3-dihydropyridin-4(1H)-one (3.8). 
Prepared by the general procedure described above and purified by flash column 
chromatography (30% EtOAc in hexanes) on silica gel to provide 27.3 mg (72%) as an 
orange wax. Spectroscopic data are consistent with those from our previous report.81 
 
N
O
Bn
PMP
Me  
1-Benzyl-2-(4-methoxyphenyl)-6-(p-tolyl)-2,3-dihydropyridin-4(1H)-one (3.9). A side 
product (2–18%) during the optimization study and purified by flash column 
chromatography (25% EtOAc in hexanes) on silica gel as a yellow wax. 1H NMR (400 
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MHz, CDCl3) δ 7.40–7.20 (m, 9H overlapping with CHCl3), 7.15 (d, J = 6.8 Hz, 2H), 
6.89 (d, J = 8.7 Hz, 2H), 5.17 (s, 1H), 4.76 (d, J = 15.7 Hz, 1H), 4.61 (dd, J = 7.3, 4.0 Hz, 
1H), 3.99 (d, J = 15.7 Hz, 1H), 3.81 (s, 3H), 2.97 (dd, J = 16.5, 7.4 Hz, 1H), 2.61 (dd, J = 
16.7, 3.9 Hz, 1H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 190.1, 164.9, 159.4, 
140.0, 137.8, 133.6, 131.3, 129.6, 129.0, 128.0, 128.0, 127.8, 127.2, 114.4, 102.8, 59.4, 
55.5, 53.9, 42.6, 21.5; FTIR (NaCl, cm-1) 3054, 2987, 1639, 1598, 1513, 1442, 1179, 
1032, 896; HRMS (ESI+) m/z calculated for [M+H]+ C26H26NO2: 384.1963, found 
384.1969. 
 
N
OPMP
Bn
Me
 
1-Benzyl-2-(4-methoxyphenyl)-5-(o-tolyl)-2,3-dihydropyridin-4(1H)-one (3.10). 
Prepared by the general procedure described above and purified by flash column 
chromatography (25% EtOAc in hexanes) on silica gel to provide 16.9 mg (43%) as a 
yellow solid (mp 139–142 °C). 1H NMR (400 MHz, CDCl3) δ 7.32–7.22 (m, 4H 
overlapping with CHCl3), 7.18–7.03 (m, 8H), 6.83 (d, J = 8.6 Hz, 2H), 4.48 (t, J = 7.6 
Hz, 1H), 4.27 (d, J = 15.1 Hz, 1H), 4.10 (d, J = 15.1 Hz, 1H), 3.75 (s, 3H), 2.85 (dd, J = 
16.3, 6.7 Hz, 1H), 2.76 (dd, J = 16.3, 8.7 Hz, 1H), 2.16 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 187.7, 159.7, 154.0, 138.2, 136.2, 136.0, 130.6, 130.2, 129.1, 128.6, 128.5, 
128.3, 127.9, 127.2, 125.8, 114.5, 112.6, 60.7, 57.3, 55.5, 44.4, 20.7; FTIR (NaCl, cm-1) 
3054, 2987, 1638, 1596, 1551, 1422, 1157, 1029, 896; HRMS (ESI+) m/z calculated for 
[M+Na]+ C26H25NO2Na: 406.1783, found 406.1779. 
 
N
OPMP
Bn Me
 
1-Benzyl-2-(4-methoxyphenyl)-5-(m-tolyl)-2,3-dihydropyridin-4(1H)-one (3.11). 
Prepared by the general procedure described above and purified by flash column 
chromatography (30% EtOAc in hexanes) on silica gel to provide 27.2 mg (72%) as a 
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yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.53 (s, 1H), 7.34 (td, J = 18.5, 15.9, 9.5 Hz, 
4H), 7.25–7.14 (m, 6H), 7.07–6.99 (m, 1H), 6.89 (d, J = 8.5 Hz, 2H), 4.52 (t, J = 7.5 Hz, 
1H), 4.41 (d, J = 15.1 Hz, 1H), 4.21 (d, J = 15.1 Hz, 1H), 3.82 (s, 3H), 2.95 (dd, J = 16.2, 
6.8 Hz, 1H), 2.82 (dd, J = 16.2, 8.3 Hz, 1H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
188.0, 159.7, 153.3, 137.8, 136.1, 130.6, 129.1, 128.6, 128.6, 128.5, 128.3, 128.3, 127.8, 
126.7, 124.8, 114.5, 111.4, 60.4, 57.5, 55.5, 44.6, 21.7; FTIR (NaCl, cm-1) 3054, 2987, 
1639, 1598, 1513, 1422, 1179, 1035, 896; HRMS (ESI+) m/z calculated for [M+Na]+ 
C26H25NO2Na: 406.1783, found 406.1779. 
 
N
OPMP
Bn
 
1-Benzyl-2-(4-methoxyphenyl)-5-phenyl-2,3-dihydropyridin-4(1H)-one (3.12). 
Prepared by the general procedure described above and purified by flash column 
chromatography (30% EtOAc in hexanes) on silica gel to provide 24.8 mg (68%) as a 
yellow oil. Spectroscopic data are consistent with those from our previous report.81 
 
N
OPMP
Bn
tBu  
1-Benzyl-5-(4-(tert-butyl)phenyl)-2-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-
one (3.13). Prepared by the general procedure described above and purified by flash 
column chromatography (25% EtOAc in hexanes) on silica gel to provide 27.9 mg (66%) 
as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.53 (s, 1H), 7.43–7.29 (m, 7H), 7.24–
7.14 (m, 4H), 6.88 (d, J = 8.7 Hz, 2H), 4.52 (t, J = 7.5 Hz, 1H), 4.40 (d, J = 15.1 Hz, 1H), 
4.20 (d, J = 15.1 Hz, 1H), 3.82 (s, 3H), 2.96 (dd, J = 16.2, 6.8 Hz, 1H), 2.83 (dd, J = 16.2, 
8.4 Hz, 1H), 1.33 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 188.1, 159.7, 153.1, 148.7, 
136.1, 133.2, 130.7, 129.1, 128.5, 128.3, 127.9, 127.4, 125.3, 114.5, 111.3, 60.5, 57.5, 
55.5, 44.6, 34.5, 31.5; FTIR (NaCl, cm-1) 3054, 2986, 1637, 1598, 1513, 1422, 1376, 
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1358, 1306, 1179, 1130, 1034, 896, 837; HRMS (ESI+) m/z calculated for [M+Na]+ 
C29H31NO2Na: 448.2252, found 448.2259. 
 
N
OPMP
Bn
OMe  
1-Benzyl-2,5-bis(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one (3.14). Prepared by 
the general procedure described above and purified by flash column chromatography 
(50% EtOAc in hexanes) on silica gel to provide 29.2 mg (74%) as a yellow oil. 
Spectroscopic data are consistent with those from our previous report.81 
 
N
OPMP
Bn OMe
 
1-Benzyl-5-(3-methoxyphenyl)-2-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one 
(3.15). Prepared by the general procedure described above and purified by flash column 
chromatography (35% EtOAc in hexanes) on silica gel to provide 31.2 mg (79%) as a red 
oil. Spectroscopic data are consistent with those from our previous report.81 
 
N
OPMP
Bn
OMe
OMe
OMe  
1-Benzyl-2-(4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2,3-dihydropyridin-
4(1H)-one (3.16). Prepared by the general procedure described above and purified by 
flash column chromatography (50% EtOAc in hexanes) on silica gel to provide 36.5 mg 
(80%) as a yellow solid (mp 125–128 °C). 1H NMR (400 MHz, CDCl3) δ 7.51 (s, 1H), 
7.39–7.31 (m, 3H), 7.23–7.14 (m, 4H), 6.89 (d, J = 8.6 Hz, 2H), 6.67 (s, 2H), 4.52 (t, J = 
7.5 Hz, 1H), 4.42 (d, J = 15.1 Hz, 1H), 4.22 (d, J = 15.1 Hz, 1H), 3.87 (s, 6H), 3.83 (s, 
3H), 3.81 (s, 3H), 2.95 (dd, J = 16.2, 6.8 Hz, 1H), 2.81 (dd, J = 16.2, 8.2 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 188.0, 159.8, 153.1, 136.5, 136.0, 131.9, 130.5, 129.1, 128.5, 
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128.5, 128.4, 127.9, 114.6, 111.0, 105.2, 61.0, 60.4, 57.5, 56.3, 55.5, 44.6; FTIR (NaCl, 
cm-1) 3054, 2987, 2840, 1639, 1598, 1583, 1512, 1422, 1357, 1327, 1129, 1034, 1005, 
896; HRMS (ESI+) m/z calculated for [M+H]+ C28H30NO5: 460.2118, found 460.2126. 
 
N
OPMP
Bn
O
O
 
1-Benzyl-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (3.17). Prepared by the general procedure described above 
and purified by flash column chromatography (40% EtOAc in hexanes) on silica gel to 
provide 35.4 mg (83%) as an orange wax. 1H NMR (400 MHz, CDCl3) δ 7.46 (s, 1H), 
7.39–7.30 (m, 3H), 7.20–7.14 (m, 4H), 6.98–6.81 (m, 5H), 4.50 (dd, J = 8.4, 6.8 Hz, 1H), 
4.37 (d, J = 15.1 Hz, 1H), 4.24 (s, 4H), 4.17 (d, J = 15.1 Hz, 1H), 3.81 (s, 3H), 2.92 (dd, J 
= 16.2, 6.7 Hz, 1H), 2.80 (dd, J = 16.2, 8.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
188.1, 159.7, 152.9, 143.3, 142.0, 136.1, 130.6, 129.7, 129.1, 128.5, 128.3, 127.8, 121.1, 
117.0, 116.7, 114.5, 111.0, 108.8, 64.5, 60.5, 57.4, 55.5, 44.6; FTIR (NaCl, cm-1) 3155, 
2935, 1635, 1597, 1583, 1511, 1459, 1442, 1377, 1357, 1315, 1298, 1282, 1250, 1178, 
1127, 1071, 1036, 834; HRMS (ESI+) m/z calculated for [M+Na]+ C27H25NO4Na: 
450.1681, found 450.1684. 
 
N
OPMP
Bn
N
O  
1-Benzyl-2-(4-methoxyphenyl)-5-(4-morpholinophenyl)-2,3-dihydropyridin-4(1H)-
one (3.18). Prepared by the general procedure described above and purified by flash 
column chromatography (70% EtOAc in hexanes) on silica gel to provide 33.9 mg (75%) 
as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.47 (s, 1H), 7.38–7.30 (m, 5H), 7.23–7.12 
(m, 4H), 6.92–6.86 (m, 4H), 4.51 (t, J = 7.6 Hz, 1H), 4.38 (d, J = 15.1 Hz, 1H), 4.18 (d, J 
= 15.1 Hz, 1H), 3.86 (t, J = 4.6 Hz, 4H), 3.81 (s, 3H), 3.14 (t, J = 4.0 Hz, 4H), 2.93 (dd, J 
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= 16.3, 6.6 Hz, 1H), 2.82 (dd, J = 16.2, 8.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
188.3, 159.7, 152.7, 149.6, 136.2, 130.7, 129.1, 128.6, 128.6, 128.3, 127.8, 116.0, 114.5, 
114.5, 111.3, 67.1, 60.6, 57.4, 55.4, 49.8, 44.7; FTIR (NaCl, cm-1) 3155, 2967, 2901, 
2839, 1794, 1634, 1595, 1514, 1452, 1380, 1307, 1231, 1177, 1121, 1035, 907; HRMS 
(ESI+) m/z calculated for [M+H]+ C29H31N2O3: 455.2329, found 455.2324. 
 
N
OPMP
Bn
 
1-Benzyl-2-(4-methoxyphenyl)-5-(naphthalen-1-yl)-2,3-dihydropyridin-4(1H)-one 
(3.19). Prepared by the general procedure described above and purified by flash column 
chromatography (40% EtOAc in hexanes) on silica gel to provide 33.3 mg (80%) as a red 
wax. 1H NMR (400 MHz, CDCl3) δ 7.89–7.75 (m, 3H), 7.50–7.28 (m, 10H), 7.19 (d, J = 
6.5 Hz, 2H), 6.95 (d, J = 8.5 Hz, 2H), 4.66 (t, J = 7.7 Hz, 1H), 4.38 (d, J = 15.1 Hz, 1H), 
4.23 (d, J = 15.1 Hz, 1H), 3.86 (s, 3H), 3.06 (dd, J = 16.3, 6.5 Hz, 1H), 2.97 (dd, J = 16.2, 
8.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 188.3, 159.8, 154.8, 136.1, 134.3, 134.0, 
133.2, 130.5, 129.1, 128.6, 128.6, 128.4, 128.0, 128.0, 127.9, 127.7, 126.3, 125.7, 125.7, 
114.6, 111.1, 60.7, 57.4, 55.6, 44.5; FTIR (NaCl, cm-1) 3155, 3035, 2936, 2840, 1794, 
1637, 1599, 1513, 1464, 1442, 1388, 1376, 1359, 1306, 1253, 1178, 1137, 1096, 1035, 
834, 796; HRMS (ESI+) m/z calculated for [M+Na]+ C29H25NO2Na: 442.1783, found 
442.1783. 
 
N
OPMP
Bn
Ph  
5-([1,1'-Biphenyl]-4-yl)-1-benzyl-2-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-
one (3.20). Prepared by the general procedure described above and purified by flash 
column chromatography (30% EtOAc in hexanes) on silica gel to provide 32.2 mg (73%) 
as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.68–7.51 (m, 7H), 7.46–7.31 (m, 6H), 
7.23–7.18 (m, 4H), 6.90 (d, J = 8.6 Hz, 2H), 4.55 (t, J = 7.5 Hz, 1H), 4.44 (d, J = 15.1 
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Hz, 1H), 4.23 (d, J = 15.1 Hz, 1H), 3.82 (s, 3H), 2.99 (dd, J = 16.2, 6.8 Hz, 1H), 2.86 (dd, 
J = 16.2, 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 188.0, 159.8, 153.1, 141.3, 138.6, 
136.0, 135.3, 130.5, 129.1, 128.8, 128.5, 128.5, 128.4, 128.0, 127.9, 127.1, 127.1, 114.6, 
110.9, 60.5, 57.6, 55.5, 44.6; FTIR (NaCl, cm-1) 3054, 2087, 1638, 1597, 1513, 1488, 
1421, 1357, 1179, 1126, 1035, 896; HRMS (ESI+) m/z calculated for [M+Na]+ 
C31H27NO2Na: 468.1939, found 468.1937. 
 
N
OPMP
Bn
CO2Et  
1-Benzyl-5-(4-(ethoxycarbonyl)phenyl)-2-(4-methoxyphenyl)-2,3-dihydropyridin-
4(1H)-one (3.21). Prepared by the general procedure described above and purified by 
flash column chromatography (30% EtOAc in hexanes) on silica gel to provide 21.9 mg 
(50%) as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 8.4 Hz, 2H), 7.64 (s, 
1H), 7.55 (d, J = 8.4 Hz, 2H), 7.42–7.32 (m, 3H), 7.22–7.14 (m, 4H), 6.88 (d, J = 8.6 Hz, 
2H), 4.55 (t, J = 7.3 Hz, 1H), 4.46 (d, J = 15.1 Hz, 1H), 4.36 (q, J = 7.1 Hz, 2H), 4.25 (d, 
J = 15.1 Hz, 1H), 3.81 (s, 3H), 2.98 (dd, J = 16.2, 6.9 Hz, 1H), 2.82 (dd, J = 16.2, 7.8 Hz, 
1H), 1.39 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 13C 187.7, 166.9, 159.9, 
153.5, 141.1, 135.7, 130.2, 129.7, 129.2, 128.6, 128.4, 127.89, 127.4, 126.9, 114.6, 110.0, 
60.8, 60.3, 57.8, 55.4, 44.5, 14.5; FTIR (NaCl, cm-1) 3054, 2987, 1707, 1642, 1597, 1513, 
1422, 1368, 1180, 1127, 1107, 1034, 896; HRMS (ESI+) m/z calculated for [M+Na]+ 
C28H27NO4Na: 464.1838, found 464.1832. 
 
N
OPMP
Bn
Cl  
1-Benzyl-5-(4-chlorophenyl)-2-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one 
(3.22). Prepared by the general procedure described above and purified by flash column 
chromatography (25% EtOAc in hexanes) on silica gel to provide 20.3 mg (51%) as a 
yellow wax. Spectroscopic data are consistent with those from our previous report.81 
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NO2  
1-Benzyl-2-(4-methoxyphenyl)-5-(4-nitrophenyl)-2,3-dihydropyridin-4(1H)-one 
(3.23). Prepared by the general procedure described above and purified by flash column 
chromatography (30% EtOAc in hexanes) on silica gel to provide 13.0 mg (32%) as a 
bright yellow solid (mp 98–100 °C). Spectroscopic data are consistent with those from 
our previous report.81 
 
N
OPMP
Bn
CF3  
1-Benzyl-2-(4-methoxyphenyl)-5-(4-(trifluoromethyl)phenyl)-2,3-dihydropyridin-
4(1H)-one (3.24). Prepared by the general procedure described above and purified by 
flash column chromatography (25% EtOAc in hexanes) on silica gel to provide 12.8 mg 
(30%) as a yellow wax. Spectroscopic data are consistent with those from our previous 
report.81 
 
N
O
OMe
Bn
 
1-Benzyl-5-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one (3.26). Prepared by the 
general procedure described above and purified by flash column chromatography (70% 
EtOAc in hexanes) on silica gel to provide 22.6 mg (78%) as a yellow oil. Spectroscopic 
data are consistent with those from our previous report.81 
 
N
O
OMe
Ph
 
5-(4-Methoxyphenyl)-1-phenyl-2,3-dihydropyridin-4(1H)-one (3.27). Prepared by the 
general procedure described above and purified by flash column chromatography (50% 
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EtOAc in hexanes) on silica gel to provide 14.1 mg (50%) as an orange solid (mp 129–
132 °C). Spectroscopic data are consistent with those from our previous report.81 
 
 
N
O
OMe
TBSO Ph
 
1-(3-((tert-Butyldimethylsilyl)oxy)propyl)-5-(4-methoxyphenyl)-2-phenyl-2,3-
dihydropyridin-4(1H)-one (3.28). Prepared by the general procedure described above 
and purified by flash column chromatography (30% EtOAc in hexanes) on silica gel to 
provide 20.3 mg (45%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.40 (s, 1H), 
7.39–7.28 (m, 7H), 6.87 (d, J = 8.7 Hz, 2H), 4.67 (t, J = 7.4 Hz, 1H), 3.80 (s, 3H), 3.64 (t, 
J = 5.6 Hz, 2H), 3.37 (dt, J = 14.6, 7.4 Hz, 1H), 3.23 (dt, J = 13.6, 6.4 Hz, 1H), 3.01 (dd, 
J = 16.2, 6.7 Hz, 1H), 2.82 (dd, J = 16.2, 8.0 Hz, 1H), 1.72 (p, J = 6.3 Hz, 2H), 0.85 (s, 
9H), 0.01 (s, 3H), -0.01 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 187.6, 157.9, 153.3, 
138.9, 129.2, 128.9, 128.9, 128.4, 127.0, 113.8, 110.8, 61.4, 59.4, 55.5, 50.5, 44.6, 31.7, 
26.0, 18.3, -5.3; FTIR (NaCl, cm-1) 3054, 2987, 2930, 2857, 1635, 1596, 1512, 1422, 
1178, 1156, 1101, 1036, 896, 836; HRMS (ESI+) m/z calculated for [M+Na]+ 
C27H37NO3SiNa: 474.2440, found 474.2440. 
 
 
N
O
OMe  
3-(4-Methoxyphenyl)-7,8,9,9a-tetrahydro-1H-quinolizin-2(6H)-one (3.29). Prepared 
by the general procedure described above and purified by flash column chromatography 
(50% EtOAc in hexanes) on silica gel to provide 16.0 mg (63%) as a yellow oil. 
Spectroscopic data are consistent with those from our previous report.81 
 
 
  164 
N
O
Me
OMe
H
H
 
(4aR,8aR)-3-(4-Methoxyphenyl)-1-methyl-4a,5,6,7,8,8a-hexahydroquinolin-4(1H)-
one (3.30). Prepared by the general procedure described above and purified by flash 
column chromatography (30% EtOAc in hexanes) on silica gel to provide 12.9 mg (48%) 
as a yellow wax. Spectroscopic data are consistent with those from our previous report.81 
 
N
O
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(4aS,8aR)-3-(4-Methoxyphenyl)-1-methyl-4a,5,6,7,8,8a-hexahydroquinolin-4(1H)-
one (3.31). Prepared by the general procedure described above and purified by flash 
column chromatography (50% EtOAc in hexanes) on silica gel to provide 16.3 mg (60%) 
as a yellow wax. Spectroscopic data are consistent with those from our previous report.81 
 
 
N
O
Cbz OMe  
1-(Benzoxycarbonyl)-6-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one (3.37). 
Prepared by the general procedure described above and purified by flash column 
chromatography (30% EtOAc in hexanes) on silica gel to provide 20.3 mg (60%) as a 
yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.35–7.18 (m, 5H), 6.92 (d, J = 6.7 Hz, 2H), 
6.84 (d, J = 8.7 Hz, 2H), 5.71 (s, 1H), 5.00 (s, 2H), 4.28 (t, J = 6.4 Hz, 2H), 3.84 (s, 3H), 
2.62 (t, J = 6.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 195.1, 161.6, 157.2, 154.1, 
134.9, 129.2, 128.4, 128.2, 128.2, 128.1, 114.1, 113.4, 68.7, 55.6, 47.1, 38.4; FTIR 
(NaCl, cm-1) 3155, 2983, 1794, 1714, 1659, 1607, 1589, 1568, 1511, 1464, 1384, 1341, 
1318, 1256, 1242, 1219, 1176, 1144, 1097, 1033, 989, 834; HRMS (ESI+) m/z calculated 
for [M+Na]+ C20H19NO4Na: 360.1212, found 360.1207. 
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1-(tert-Butoxycarbonyl)-6-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one (3.39). 
Prepared by the general procedure described above and purified by flash column 
chromatography (25% EtOAc in hexanes) on silica gel to provide 9.4 mg (31%) as a 
yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.7 Hz, 2H), 6.91 (d, J = 8.7 Hz, 
2H), 5.63 (s, 1H), 4.20 (t, J = 6.4 Hz, 2H), 3.85 (s, 3H), 2.60 (t, J = 6.4 Hz, 2H), 1.15 (s, 
9H); 13C NMR (100 MHz, CDCl3) δ 195.3, 161.3, 157.7, 152.7, 130.1, 128.1, 113.7, 
112.6, 82.4, 55.5, 46.4, 38.2, 27.6; FTIR (NaCl, cm-1) 3155, 2983, 1793, 1706, 1654, 
1607, 1587, 1567, 1510, 1465, 1386, 1350, 1354, 1226, 1177, 1146, 1097, 988, 830; 
HRMS (ESI+) m/z calculated for [M+Na]+ C17H21NO4Na: 326.1368, found 326.1364. 
 
8.4 Chapter 4 
8.4.1 General procedure for the dehydrogenative alkenylation of cyclic enaminones 
N
O
R3
+
R2 Pd(OAc)2 (10 mol %)Cu(OAc)2 (2.0 equiv)
N
O
R3
R2
R6KTFA (1.0 equiv)DMF, 80 °C, 3 h
R1 R1
R4 R4
R6
R5
R7
R5
R7
H
H
 
Cyclic enaminone (0.40 mmol) was mixed with Pd(OAc)2 (9.0 mg, 0.04 mmol), 
Cu(OAc)2 (145.3 mg, 0.80 mmol), and KTFA (60.8 mg, 0.40 mmol). To the mixture was 
added alkene (0.80 mmol), followed by DMF (2 mL). The reaction vessel was purged 
with N2 and then sealed. After being stirred for 5 min, the reaction was heated at 80 °C 
for 3 h. The reaction was diluted with EtOAc (4 mL), neutralized with excess K2CO3 (1 
g), and stirred for another 5 min. The mixture was filtered through Celite, and the filter 
cake was washed with EtOAc (25 mL). The filtrate was then concentrated under reduced 
pressure and purified by flash chromatography on silica gel.  
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8.4.2 Compound characterization 
N
O
Bn
PMP
CO2tBu  
(E)-1-Benzyl-5-(2-(t-butoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.3). Prepared by the general procedure described above and 
140 mg (81%) was isolated as a light yellow solid (mp 64–68 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.52 (s, 1H), 7.42–7.34 (m, 3H), 7.09–7.15 (m, 5H), 6.86 (d, J = 8.8 Hz, 2H), 
6.60 (d, J = 15.6 Hz, 1H), 4.50 (t, J = 6.8 Hz, 1H), 4.43 (d, J = 14.9 Hz, 1H), 4.25 (d, J = 
14.9 Hz, 1H), 3.81 (s, 3H), 2.92 (dd, J = 16.3, 7.2 Hz, 1H), 2.71 (dd, J = 16.3, 6.4 Hz, 
1H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 188.1, 168.7, 160.0, 156.6, 138.8, 
135.0, 129.8, 129.4, 128.9, 128.3, 128.0, 114.7, 114.1, 106.5, 79.4, 60.1, 58.2, 55.5, 44.2, 
28.5; FTIR (Film, cm-1) 3066, 2972, 2854, 1690, 1656, 1595, 1511, 1428, 1316, 1254, 
1145, 1111, 1032, 790; HRMS (ESI+) m/z calculated for [M+H]+ C26H30NO4: 420.2175, 
found 420.2191. 
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(E)-1-Benzyl-5-(2-(methoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.4). Prepared by the general procedure described above and 
61.6 mg (82%) was isolated as a light yellow solid (mp 50–55 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.56 (s, 1H), 7.46–7.33 (m, 3H), 7.21 (d, J = 15.6 Hz, 1H), 7.14 (dd, J = 7.2, 
2.2 Hz, 2H), 7.11 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 6.70 (d, J = 15.6 Hz, 1H), 
4.52 (t, J = 6.8 Hz, 1H), 4.44 (d, J = 14.9 Hz, 1H), 4.27 (d, J = 14.9 Hz, 1H), 3.81 (s, 3H), 
3.73 (s, 3H), 2.93 (dd, J = 16.4, 7.3 Hz, 1H), 2.72 (dd, J = 16.4, 6.4 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 188.0, 169.7, 160.1, 157.0, 140.3, 134.8, 129.7, 129.4, 128.9, 128.3, 
128.0, 114.8, 111.5, 106.4, 60.1, 58.2, 55.5, 51.3, 44.2; FTIR (film, cm-1) 3055, 2987, 
2951, 1696, 1657, 1595, 1513, 1438, 1392, 1317, 1165, 1092, 1034, 989, 896, 835; 
HRMS (ESI+) m/z calculated for [M+H]+ C23H24NO4: 378.1705, found 378.1711. 
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(E)-1-Benzyl-5-(2-(n-butoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.5). Prepared by the general procedure described above and 
72.7 mg (87%) was isolated as a light yellow solid (mp 102–104 °C). 1H NMR (400 
MHz, CDCl3) δ 7.56 (s, 1H), 7.42–7.34 (m, 3H), 7.20 (d, J = 15.6 Hz, 1H), 7.14 (dd, J = 
7.2, 2.1 Hz, 2H), 7.11 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 6.69 (d, J = 15.6 Hz, 
1H), 4.51 (t, J = 6.8 Hz, 1H), 4.44 (d, J = 14.9 Hz, 1H), 4.26 (d, J = 14.9 Hz, 1H), 4.14 (t, 
J = 6.7 Hz, 2H), 3.81 (s, 3H), 2.93 (dd, J = 16.3, 7.3 Hz, 1H), 2.71 (dd, J = 16.4, 6.3 Hz, 
1H), 1.69–1.60 (m, 2H), 1.41 (dq, J = 14.6, 7.4 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 188.1, 169.4, 160.0, 156.9, 139.9, 134.9, 129.7, 129.4, 128.9, 
128.3, 128.0, 114.8, 112.1, 106.5, 63.8, 60.1, 58.2, 55.5, 44.2, 31.1, 19.4, 13.9; FTIR 
(film, cm-1) 3054, 2963, 2986, 1692, 1655, 1595, 1513, 1441, 1422, 1316, 1165, 1090, 
1033, 989, 896, 834; HRMS (ESI+) m/z calculated for [M+H]+ C26H30NO4: 420.2175, 
found 420.2170. 
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(E)-5-(2-(Benzoxycarbonyl)vinyl)-1-benzyl-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.6). Prepared by the general procedure described above and 
82.2 mg (91%) was isolated as a light yellow solid (mp 49–53 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.55 (s, 1H), 7.43–7.28 (m, 8H), 7.27–7.21 (m, 2H), 7.11 (d, J = 8.7 Hz, 2H), 
6.87 (d, J = 8.7 Hz, 2H), 6.76 (d, J = 15.6 Hz, 1H), 5.20 (s, 2H), 4.51 (t, J = 6.8 Hz, 1H), 
4.44 (d, J = 14.9 Hz, 1H), 4.26 (d, J = 14.9 Hz, 1H), 3.81 (s, 3H), 2.93 (dd, J = 16.4, 7.3 
Hz, 1H), 2.71 (dd, J = 16.4, 6.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 188.0, 169.1, 
160.0, 157.0, 140.6, 137.0, 134.8, 129.7, 129.4, 128.9, 128.6, 128.3, 128.2, 128.0, 128.0, 
114.8, 111.6, 106.4, 65.7, 60.1, 58.3, 55.5, 44.2; FTIR (film, cm-1) 3054, 2986, 1696, 
1655, 1594, 1513, 1441, 1392, 1316, 1179, 1156, 1090, 1029, 989, 896; HRMS (ESI+) 
m/z calculated for [M+H]+ C29H28NO4: 454.2018, found 454.2007. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-(3-oxobut-1-enyl)-2,3-dihydropyridin-4(1H)-
one (4.7). Prepared by the general procedure described above and 61.0 mg (85%) was 
isolated as a light yellow solid (mp 48–52 °C). 1H NMR (400 MHz, CDCl3) δ 7.66 (s, 
1H), 7.44–7.35 (m, 3H), 7.23 (d, J = 15.8 Hz, 1H), 7.15 (dd, J = 7.0, 2.3 Hz, 2H), 7.12 (d, 
J = 8.7 Hz, 2H), 6.89 (dd, J = 12.2, 9.6 Hz, 3H), 4.57–4.51 (m, 1H), 4.47 (d, J = 14.9 Hz, 
1H), 4.29 (d, J = 14.9 Hz, 1H), 3.81 (s, 3H), 2.95 (dd, J = 16.4, 7.4 Hz, 1H), 2.72 (dd, J = 
16.4, 6.0 Hz, 1H), 2.26 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 199.3, 188.0, 160.1, 
156.7, 138.6, 134.7, 129.5, 129.4, 129.0, 128.2, 128.0, 120.5, 114.8, 106.1, 60.1, 58.5, 
55.5, 44.0, 28.3; FTIR (film, cm-1) 3054, 2987, 1655, 1593, 1579, 1513, 1422, 1356, 
1179, 1033, 896; HRMS (ESI+) m/z calculated for [M+H]+ C23H24NO3: 362.1756, found 
362.1754. 
 
N
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(E)-1-Benzyl-5-(2-(dimethylcarbamoyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.8). Prepared by the general procedure described above and 
73.9 mg (95%) was isolated as a yellow solid (mp 50–54 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.51 (s, 1H), 7.41 (d, J = 14.8 Hz, 1H), 7.38–7.32 (m, 3H), 7.20–7.09 (m, 4H), 
7.07 (d, J = 14.8 Hz, 1H), 6.87 (d, J = 8.7 Hz, 2H), 4.49 (t, J = 7.0 Hz, 1H), 4.43 (d, J = 
14.9 Hz, 1H), 4.23 (d, J = 14.9 Hz, 1H), 3.80 (s, 3H), 3.11 (s, 3H), 3.02 (s, 3H), 2.93 (dd, 
J = 16.3, 7.2 Hz, 1H), 2.71 (dd, J = 16.3, 6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
188.6, 169.0, 160.0, 158.0, 138.0, 135.0, 129.9, 129.3, 128.8, 128.3, 128.0, 114.7, 112.4, 
107.0, 60.0, 58.1, 55.5, 44.6, 29.4; FTIR (film, cm-1) 3054, 2985, 1707, 1655, 1600, 
1513, 1442, 1395, 1357, 1179, 1089, 1034, 988, 896; HRMS (ESI+) m/z calculated for 
[M+H]+ C24H27N2O3: 391.2022, found 391.2013. 
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(E)-1-Benzyl-5-(2-(diethoxyphosphinyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.9). Prepared by the general procedure described above and 
61.7 mg (68%) was isolated as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.49 (s, 1H), 
7.44–7.32 (m, 3H), 7.12 (dd, J = 9.2, 6.1 Hz, 4H), 7.01–6.84 (m, 3H), 6.54 (dd, J = 21.9, 
17.1 Hz, 1H), 4.50 (t, J = 6.9 Hz, 1H), 4.41 (d, J = 14.9 Hz, 1H), 4.24 (d, J = 14.9 Hz, 
1H), 4.16–3.97 (m, 4H), 3.81 (s, 3H), 2.91 (dd, J = 16.3, 7.3 Hz, 1H), 2.70 (dd, J = 16.4, 
6.5 Hz, 1H), 1.32 (td, J = 7.1, 1.5 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 188.2, 160.0, 
157.2, 144.6 (d, J = 7.9 Hz), 134.8, 129.7, 129.4, 128.9, 128.3, 128.1, 114.8, 107.0 (d, J = 
27.4 Hz), 106.0 (d, J = 139.7 Hz), 61.5 (d, J = 5.2 Hz), 60.1, 58.1, 55.5, 44.3, 16.6 (d, J = 
5.7 Hz); FTIR (film, cm-1) 3054, 2987, 1654, 1600, 1422, 1393, 1030, 961, 896; HRMS 
(ESI+) m/z calculated for [M+H]+ C25H31NO5P: 456.1940, found 456.1940. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-styryl-2,3-dihydropyridin-4(1H)-one (4.10). 
Prepared by the general procedure described above and 52.4 mg (66%) was isolated as a 
yellow solid (mp 53–57 °C). 1H NMR (400 MHz, CDCl3) δ 7.57 (s, 1H), 7.38 (dt, J = 
13.9, 6.9 Hz, 5H), 7.29 (d, J = 7.5 Hz, 2H), 7.23–7.11 (m, 5H), 7.08 (d, J = 16.3 Hz, 1H), 
6.87 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 16.3 Hz, 1H), 4.55–4.39 (m, 2H), 4.23 (d, J = 15.1 
Hz, 1H), 3.81 (s, 3H), 2.92 (dd, J = 16.3, 7.0 Hz, 1H), 2.75 (dd, J = 16.3, 7.5 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 188.5, 159.8, 152.8, 139.1, 135.9, 130.3, 129.2, 128.6, 128.5, 
128.5, 127.8, 126.3, 125.8, 123.2, 122.8, 114.6, 108.5, 60.0, 57.9, 55.5, 44.4; FTIR (film, 
cm-1) 3054, 2987, 1646, 1592, 1513, 1422, 1179, 969; HRMS (ESI+) m/z calculated for 
[M+H]+ C27H26NO2: 396.1964, found 396.1970. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-(2-(methylsulfonyl)vinyl)-2,3-dihydropyridin-
4(1H)-one (4.11). Prepared by the general procedure described above and 44.7 mg (56%) 
was isolated as a light yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.62 (s, 1H), 7.46–7.33 
(m, 4H), 7.20–7.12 (m, 2H), 7.10 (d, J = 8.8 Hz, 2H), 6.96 (d, J = 14.7 Hz, 1H), 6.87 (d, J 
= 8.8 Hz, 2H), 4.59–4.45 (m, 2H), 4.28 (d, J = 14.8 Hz, 1H), 3.79 (s, 3H), 3.01–2.90 (m, 
4H), 2.69 (dd, J = 16.4, 5.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 187.9, 160.1, 158.4, 
138.8, 134.4, 129.5, 129.2, 129.1, 128.2, 128.1, 119.7, 114.9, 104.2, 60.0, 58.4, 55.5, 
44.0, 43.9; FTIR (film, cm-1) 3055, 2987, 1656, 1602, 1513, 1442, 1301, 1176, 1124, 
1033, 962, 909; HRMS (ESI+) m/z calculated for [M+H]+ C22H24NO4S: 398.1426, found 
398.1430. 
 
 
N
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(E)-1-Benzyl-5-(2-(methoxycarbonyl)1-methyl-vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (4.14). Prepared by the general procedure described above 
and 32.8 mg (42%) was isolated as a waxy solid. 1H NMR (400 MHz, CDCl3) δ 7.59 (s, 
1H), 7.44–7.29 (m, 3H), 7.18–7.05 (m, 4H), 6.86 (d, J = 8.8 Hz, 2H), 6.45 (d, J = 1.2 Hz, 
1H), 4.44 (m, 2H), 4.23 (d, J = 15.1 Hz, 1H), 3.80 (s, 4H), 3.67 (s, 3H), 2.89 (dd, J = 
16.0, 7.1 Hz, 1H), 2.69 (dd, J = 16.0, 7.0 Hz, 1H), 2.40 (d, J = 1.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 187.9, 168.5, 159.9, 153.5, 151.7, 135.5, 130.0, 129.3, 128.7, 128.3, 
127.8 114.7, 113.3, 111.7, 59.8, 58.1, 55.5, 50.9, 44.8, 17.4; FTIR (film, cm-1) 3055, 
2987, 1648, 1579, 1513, 1422, 1170, 1034, 896; HRMS (ESI+) m/z calculated for 
[M+H]+ C24H26NO4: 392.1862, found 392.1865. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-((2-oxodihydrofuran-3(2H)-ylidene)methyl)-
2,3-dihydropyridin-4(1H)-one (4.15a). Prepared by the general procedure described 
above and 18.4 mg (24%) was isolated as a light yellow solid (mp 57–63 °C). 1H NMR 
(400 MHz, CDCl3) δ 7.63 (s, 1H), 7.45–7.32 (m, 4H), 7.20–7.07 (m, 4H), 6.88 (d, J = 8.7 
Hz, 2H), 4.58 (t, J = 6.8 Hz, 1H), 4.46 (d, J = 14.7 Hz, 1H), 4.34–4.24 (m, 3H), 3.80 (s, 
3H), 2.93 (m, 3H), 2.73 (dd, J = 16.3, 6.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 187.5, 
173.7, 160.0, 155.7, 134.7, 131.2, 129.6, 129.4, 128.9, 128.3, 128.2, 114.8, 114.3, 106.8, 
65.2, 60.4, 58.3, 55.5, 43.7, 28.2; FTIR (film, cm-1) 3055, 2987, 1738, 1658, 1594, 1581, 
1513, 1422, 1194, 1033, 896; HRMS (ESI+) m/z calculated for [M+H]+ C24H24NO4: 
390.1705, found 390.1693. 
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1-Benzyl-2-(4-methoxyphenyl)-5-((2-oxo-2,5-dihydrofuran-3-yl)methyl)-2,3-
dihydropyridin-4(1H)-one (4.15b). Prepared by the general procedure described above 
and 46.1 mg (59%) was isolated as a light yellow solid (mp 59–66 °C). 1H NMR (400 
MHz, CDCl3) δ 7.50 (s, 1H), 7.37–7.27 (m, 3H), 7.18 (s, 1H), 7.10 (ddd, J = 9.4, 4.9, 2.4 
Hz, 4H), 6.89–6.81 (m, 2H), 4.71 (d, J = 1.5 Hz, 2H), 4.43–4.30 (m, 2H), 4.08 (d, J = 
15.1 Hz, 1H), 3.79 (s, 3H), 3.16 (dd, J = 15.0, 1.2 Hz, 1H), 3.09 (dd, J = 15.0, 1.1 Hz, 
1H), 2.73 (dd, J = 16.5, 6.7 Hz, 1H), 2.63 (dd, J = 16.5, 8.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 189.0, 174.8, 159.6, 154.5, 145.6, 136.0, 132.6 130.2, 128.9, 128.4, 
128.2, 127.9, 114.4, 105.3, 70.2, 60.3, 57.3, 55.4, 44.1, 23.8; FTIR (film, cm-1) 3054, 
2987, 1753, 1602, 1512, 1422, 1195, 1063, 896; HRMS (ESI+) m/z calculated for 
[M+H]+ C24H24NO4: 390.1705, found 390.1706. 
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1-Benzyl-5-(2-cyclohexene)-2-(4-methoxyphenyl)-2,3-dihydropyridin-4(1H)-one 
(4.16a) and 1-benzyl-5-(3-cyclohexene)-2-(4-methoxyphenyl)-2,3-dihydropyridin-
4(1H)-one (4.16b). Prepared by the general procedure described above and 36.3 mg 
(49%) were isolated as a light yellow oil. Two constitutional isomers were inseparable. 
The ratio was determined by 1H NMR. 1H NMR (400 MHz, CDCl3) δ 7.36–7.28 (m, 6H, 
4.16a, 4.16b), 7.17–7.01 (m, 10H, 4.16a, 4.16b), 6.90–6.82 (m, 4H, 4.16a, 4.16b), 5.92–
5.76 (m, 2H, 4.16a, 4.16b), 5.58–5.50 (m, 2H, 4.16a, 4.16b), 4.41–4.22 (m, 4H, 4.16a, 
4.16b), 4.14–4.02 (m, 2H, 4.16a, 4.16b), 3.81 (m, 6H, 4.16a, 4.16b), 3.51 (br, 2H, 
4.16a), 2.77 (dd, J = 16.3, 6.7 Hz, 1H, 4.16a), 2.73–2.60 (m, 3H, 4.16a, 4.16b), 2.03–
1.95 (m, 4H, 4.16a, 4.16b), 1.92–1.83 (m, 2H, 4.16a, 4.16b), 1.68–1.50 (m, 4H, 4.16a, 
4.16b), 1.50–1.35 (m, 2H, 4.16b); 13C NMR (100 MHz, CDCl3) δ 189.4 (4.16b), 189.1 
(4.16a), 159.6 (4.16b), 159.5 (4.16a), 153.5 (4.16b), 153.2 (4.16a), 136.6 (4.16a), 136.5 
(4.16b), 131.0 (4.16a), 130.0 (4.16b), 129.9 (4.16a), 129.1 (4.16a), 128.9 (4.16b), 128.9 
(4.16b), 128.8 (4.16a), 128.7 (4.16a), 128.5 (4.16b), 128.0 (4.16a), 128.0 (4.16b), 127.7 
(4.16b), 114.4 (4.16b), 114.3 (4.16a), 114.2 (4.16b), 113.8 (4.16a), 60.7 (4.16b), 60.2 
(4.16a), 57.3 (4.16a), 57.0 (4.16b), 55.4 (4.16a, 4.16b), 44.7 (4.16b), 44.3 (4.16a), 31.6 
(4.16a), 31.5 (4.16b), 30.0 (4.16b), 29.7 (4.16a), 25.3 (4.16a), 25.3 (4.16b), 20.1 (4.16a), 
20.1 (4.16b); FTIR (film, cm-1) 3016, 2927, 1636, 1598, 1512, 1443, 1380, 1360, 1298, 
1178, 1032, 834; HRMS (ESI+) m/z calculated for [M+H]+ C25H28NO2: 374.2120, found 
374.2125.  
 
N
O
Ph CO2tBu  
(E)-5-(2-(tert-Butoxycarbonyl)vinyl)-1-phenyl-2,3-dihydropyridin-4(1H)-one (4.17). 
Prepared by the general procedure described above and 45.1 mg (76%) was isolated as a 
light yellow solid (mp 150–152 °C). 1H NMR (400 MHz, CDCl3) δ 7.69 (s, 1H), 7.43 
(dd, J = 8.4, 7.6 Hz, 2H), 7.26–7.12 (m, 4H), 6.60 (d, J = 15.7 Hz, 1H), 4.10–4.02 (m, 
  173 
2H), 2.78–2.70 (m, 2H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 189.3, 168.1, 152.0, 
144.7, 138.4, 130.1, 125.9, 119.2, 115.9, 109.5, 79.6, 47.8, 36.5, 28.4; FTIR (film, cm-1) 
3155, 2982, 1794, 1691, 1578, 1493, 1390, 1316, 1281, 1153, 1110, 986; HRMS (ESI+) 
m/z calculated for [M+Na]+ C18H21NO3Na: 322.1419, found 322.1425. 
 
 
N
O
Me CO2tBu  
(E)-5-(2-(tert-Butoxycarbonyl)vinyl)-1-methyl-2,3-dihydropyridin-4(1H)-one (4.18). 
Prepared by the general procedure described above and 40.0 mg (84%) was isolated as a 
light yellow solid (mp 128–134 °C). 1H NMR (400 MHz, CDCl3) δ 7.25 (s, 1H), 7.08 (d, 
J = 15.6 Hz, 1H), 6.51 (d, J = 15.6 Hz, 1H), 3.51 (t, J = 7.8 Hz, 2H), 3.18 (s, 3H), 2.62–
2.53 (m, 2H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 188.4, 168.7, 157.2, 138.9, 
113.4, 106.1, 79.3, 48.6, 44.0, 35.9, 28.5; FTIR (film, cm-1) 3155, 2982, 1794, 1689, 
1651, 1604, 1473, 1392, 1317, 1152, 1101, 986; HRMS (ESI+) m/z calculated for 
[M+H]+ C13H20NO3: 238.1443, found 238.1436. 
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(E)-1-Benzyl-5-(2-(tert-butoxycarbonyl)vinyl)-2,3-dihydropyridin-4(1H)-one (4.19). 
Prepared by the general procedure described above and 43.1 mg (92%) was isolated as a 
light yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.47–7.35 (m, 4H), 7.26–7.23 (m, 2H), 
7.11 (d, J = 15.6 Hz, 1H), 6.56 (d, J = 15.6 Hz, 1H), 4.48 (s, 2H), 3.45 (t, J = 7.6 Hz, 2H), 
2.54 (t, J = 7.9 Hz, 2H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 188.7, 168.6, 156.5, 
139.0, 134.6, 129.4, 129.0, 127.9, 114.0, 106.5, 79.4, 60.8, 46.5, 36.1, 28.5; FTIR (film, 
cm-1) 3055, 2987, 1689, 1597, 1422, 1150, 896; HRMS (ESI+) m/z calculated for 
[M+H]+ C19H24NO3: 314.1756, found 314.1742. 
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(E)-6-(2-(tert-Butoxycarbonyl)vinyl)-2,3,8,8a-tetrahydroindolizin-7(1H)-one (4.20). 
Prepared by the general procedure described above and 38.3 mg (73%) was isolated as a 
light yellow solid (mp 122–126 °C). 1H NMR (400 MHz, CDCl3) δ 7.51 (s, 1H), 7.17 (d, 
J = 15.6 Hz, 1H), 6.44 (d, J = 15.6 Hz, 1H), 3.78 (ddd, J = 21.0, 10.5, 5.4 Hz, 1H), 3.72–
3.54 (m, 2H), 2.57 (dd, J = 15.9, 4.7 Hz, 1H), 2.46–2.28 (m, 2H), 2.16 (dt, J = 14.0, 7.1 
Hz, 1H), 2.05–1.90 (m, 1H), 1.79–1.66 (m, 1H), 1.47 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 189.3, 168.7, 152.4, 139.1, 112.4, 105.8, 79.2, 58.0, 50.5, 42.1, 32.9, 28.5, 24.4; 
FTIR (film, cm-1) 3155, 2981, 1794, 1687, 1652, 1590.0, 1476, 1430, 1369, 1319, 1249, 
1150, 1097, 990; HRMS (ESI+) m/z calculated for [M+H]+ C15H22NO3: 264.1600, found 
264.1602. 
 
 
N
O
CO2tBu  
(E)-3-(2-(tert-Butoxycarbonyl)vinyl)-7,8,9,9a-tetrahydro-1H-quinolizin-2(6H)-one 
(4.21). Prepared by the general procedure described above and 47.1 mg (86%) was 
isolated as a light yellow solid (mp 122–124 °C). 1H NMR (400 MHz, CDCl3) δ 7.16 (s, 
1H), 7.05 (d, J = 15.6 Hz, 1H), 6.57 (d, J = 15.6 Hz, 1H), 3.57–3.49 (m, 1H), 3.49–3.39 
(m, 1H), 3.18 (td, J = 12.9, 2.9 Hz, 1H), 2.62 (dd, J = 16.4, 5.8 Hz, 1H), 2.43 (dd, J = 
16.4, 11.7 Hz, 1H), 1.94–1.86 (m, 1H), 1.86–1.76 (m, 2H), 1.68–1.42 (m, 12H); 13C 
NMR (100 MHz, CDCl3) δ 189.3, 168.6, 157.0, 138.9, 114.1, 106.7, 79.3, 56.9, 54.0, 
43.6, 31.8, 28.5, 25.9, 23.2; FTIR (film, cm-1) 3155, 2981, 1793, 1688, 1654, 1593, 1450, 
1392, 1321, 1246, 1155, 1107, 987; HRMS (ESI+) m/z calculated for [M+H]+ 
C26H24NO3: 278.1756, found 278.1759. 
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(E)-(cis)-3-(2-(tert-Butoxycarbonyl)vinyl)-1-methyl-4a,5,6,7,8,8a-hexahydroquinolin-
4(1H)-one (4.22). Prepared by the general procedure described above and 45.1 mg (77%) 
was isolated as a light yellow solid (mp 182–184 °C). 1H NMR (400 MHz, CDCl3) δ 7.15 
(s, 1H), 7.09 (d, J = 15.6 Hz, 1H), 6.53 (d, J = 15.6 Hz, 1H), 3.44 (dd, J = 14.1, 6.2 Hz, 
1H), 3.16 (s, 3H), 2.84–2.73 (m, 1H), 2.40 (d, J = 11.0 Hz, 1H), 1.78–1.65 (m, 3H), 1.46 
(s, 9H), 1.43–1.21 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 190.5, 168.8, 155.5, 139.3, 
112.6, 105.0, 79.1, 60.8, 45.0, 41.7, 28.5, 24.5, 24.0, 23.6, 22.2; FTIR (film, cm-1) 3155, 
2939, 1794, 1687, 1653, 1597, 1478, 1384, 1329, 1254, 1156, 1144, 1095, 993; HRMS 
(ESI+) m/z calculated for [M+H]+ C17H26NO3: 292.1913, found 292.1920. 
 
N
O
Bn CO2tBu
 
(E)-1-Benzyl-5-(2-(tert-butoxycarbonyl)vinyl)-6-methyl-2,3-dihydropyridin-4(1H)-
one (4.23). Prepared by the general procedure described above and 14.2 mg (22%) was 
isolated as a light yellow solid (mp 118–120 °C). 1H NMR (400 MHz, CDCl3) δ 7.50 (d, 
J = 15.4 Hz, 1H), 7.37 (m, 3H), 7.18 (d, J = 7.0 Hz, 2H), 6.84 (d, J = 15.4 Hz, 1H), 4.69 
(s, 2H), 3.64–3.53 (m, 2H), 2.59–2.49 (m, 2H), 2.33 (s, 3H), 1.49 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 189.2, 169.4, 164.6, 137.6, 135.7, 129.5, 128.4, 126.3, 116.1, 107.3, 
79.3, 56.4, 49.3, 36.5, 28.5, 17.4; FTIR (film, cm-1) 3155, 2981, 1794, 1686, 1642, 1590, 
1535, 1471, 1388, 1305, 1154, 1096, 985; HRMS (ESI+) m/z calculated for [M+H]+ 
C20H26NO3: 328.1913, found 328.1923. 
 
N
N
OO
CO2tBu  
(E)-1,3-Dimethyl-5-(2’-t-butoxycarbonylvinyl)uracil (4.24). Prepared by the general 
procedure described above and purified by flash chromatography (30–40% EtOAc in 
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hexanes) on silica gel to provide 35.1 mg (33%) as an off-white solid (mp 140–142 °C). 
1H NMR (400 MHz, CDCl3) δ 7.37 (s, 1H), 7.19 (d, J = 15.8 Hz, 1H), 6.89 (d, J = 16.6 
Hz, 1H), 3.47 (s, 3H), 3.38 (s, 3H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 166.9, 
161.5, 150.9, 144.2, 135.1, 121.4, 109.3, 80.5, 37.6, 28.3, 28.3; FTIR (NaCl, cm-1) 3155, 
2953, 1710, 1665, 1629, 1457, 1437, 1370, 1301, 1263, 1194, 1172, 1091, 984, 907; 
HRMS (ESI+) m/z calculated for [M+Na]+ C13H18N2O4Na: 289.1159, found 289.1158. 
 
N
O
Me CO2tBu
H
H
 
(E)-(trans)-3-(2-(tert-Butoxycarbonyl)vinyl)-1-methyl-4a,5,6,7,8,8a-hexahydroquino-
lin-4(1H)-one (4.25). Prepared by the general procedure described above and 43.5 mg 
(75%) was isolated as a light yellow solid (mp 146–148 °C). 1H NMR (400 MHz, CDCl3) 
δ 7.27 (s, 1H), 7.09 (d, J = 15.6 Hz, 1H), 6.55 (d, J = 15.6 Hz, 1H), 3.20–3.05 (m, 4H), 
2.44 (ddd, J = 11.1, 5.6, 2.7 Hz, 1H), 2.29–2.20 (m, 1H), 2.14 (ddd, J = 14.8, 11.4, 3.7 
Hz, 1H), 1.94–1.79 (m, 2H), 1.50–1.36 (m, 10H), 1.35–1.04 (m, 3H); 13C NMR (100 
MHz, CDCl3) δ 191.2, 168.7, 157.6, 139.2, 113.5, 106.2, 79.2, 61.3, 48.7, 40.1, 30.2, 
28.5, 24.8, 24.7, 24.5; FTIR (film, cm-1) 3155, 2939, 1794, 1687, 1602, 1474, 1392, 
1297, 1154, 1136, 1095, 987; HRMS (ESI+) m/z calculated for [M+H]+ C17H26NO3: 
292.1913, found 292.1913. 
 
N
O
Bn CO2tBu  
(E)-1-Benzyl-3-(2-(tert-butoxycarbonyl)vinyl)pyridin-4(1H)-one (4.26). Prepared by 
the general procedure described above and 4.4 mg (7%) was isolated as a waxy solid. 1H 
NMR (400 MHz, CDCl3) δ 7.50 (d, J = 2.4 Hz, 1H), 7.45–7.37 (m, 3H), 7.33–7.23 (m, 
2H), 7.22–7.14 (m, 3H), 6.45 (d, J = 7.5 Hz, 1H), 4.97 (s, 2H), 1.49 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 177.2, 167.5, 141.8, 138.4, 137.2, 134.4, 129.7, 129.4, 127.6, 124.2, 
122.8, 120.2, 80.3, 60.7, 28.3; FTIR (film, cm-1) 3155, 2982, 1794, 1697, 1643, 1578, 
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1482, 1382, 1317, 1163, 1096, 987; HRMS (ESI+) m/z calculated for [M+H]+ 
C19H22NO3: 312.1600, found 312.1588. 
 
HN
OPh
CO2tBu  
(E)-2-Phenyl-5-(2-(tert-butoxycarbonyl)vinyl)-2,3-dihydropyridin-4(1H)-one (4.27). 
Prepared by the general procedure described above and 3.5 mg (6%) was isolated as a 
light yellow solid (mp 193–196 °C). 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 6.9 Hz, 
1H), 7.46–7.34 (m, 5H), 7.14 (d, J = 15.7 Hz, 1H), 6.62 (d, J = 15.7 Hz, 1H), 5.52 (dd, J 
= 21.3, 9.5 Hz, 1H), 4.83 (dd, J = 13.7, 5.1 Hz, 1H), 2.85 (dd, J = 16.2, 13.8 Hz, 1H), 
2.69 (dd, J = 16.2, 5.0 Hz, 1H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 189.4, 
153.4, 138.5, 129.5, 129.1, 126.6, 118.8, 115.3, 110.3, 107.8, 79.6, 58.2, 44.9, 28.5; FTIR 
(film, cm-1) 3426, 3155, 2983, 1794, 1710, 1595, 1471, 1382, 1224, 1152, 1095, 988; 
HRMS (ESI+) m/z calculated for [M+H]+ C18H22NO3: 300.1600, found 300.1593. 
 
8.5 Chapter 5 
8.5.1 General procedure for the dehydrogenative alkenylation of uracils 
N
N
O
+ N
N
O
R4
R4
Pd(OAc)2 (5 mol %)
AgOAc (3 equiv)
PivOH (3 equiv)
DMF, 60 ºC, 24 h
H
O
R2
R1
R2
O
R1
H
R3
R5
R3
R5
 
Uracil (0.1 mmol) was mixed in a clear 1-dram vial with Pd(OAc)2 (0.005 mmol), 
AgOAc (0.3 mmol), and PivOH (0.3 mmol). To the mixture was added alkene (0.2 
mmol), followed by DMF (0.5 mL). The reaction vessel was then capped. After being 
stirred for 2 min, the reaction was heated at 60 °C for 24 h in dark. The reaction was then 
cooled, diluted with EtOAc (1 mL), and pressure-filtered over Celite. The filter cake was 
washed with EtOAc (20 mL). The filtrate was then concentrated under reduced pressure 
and purified by flash chromatography on silica gel.  
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8.5.2 Compound characterization 
N
N
O
O
CO2tBu
 
(E)-1,3-Dimethyl-5-(2’-t-butoxycarbonylvinyl)uracil (5.5). Prepared by the general 
procedure described above and purified by flash chromatography (30–40% EtOAc in 
hexanes) on silica gel to provide 24.3 mg (92%) as an off-white solid (mp 140–142 °C). 
1H NMR (400 MHz, CDCl3) δ 7.37 (s, 1H), 7.19 (d, J = 15.8 Hz, 1H), 6.89 (d, J = 16.6 
Hz, 1H), 3.47 (s, 3H), 3.38 (s, 3H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 166.9, 
161.5, 150.9, 144.2, 135.1, 121.4, 109.3, 80.5, 37.6, 28.3, 28.3; FTIR (NaCl, cm-1) 3155, 
2953, 1710, 1665, 1629, 1457, 1437, 1370, 1301, 1263, 1194, 1172, 1091, 984, 907; 
HRMS (ESI+) m/z calculated for [M+Na]+ C13H18N2O4Na: 289.1159, found 289.1158. 
 
 
N
N
O
O
CO2nBu
 
(E)-1,3-Dimethyl-5-(2’-n-butoxycarbonylvinyl)uracil (5.6). Prepared by the general 
procedure described above and purified by flash chromatography (40% EtOAc in 
hexanes) on silica gel to provide 24.1 mg (91%) as a colorless solid (mp 138–140 °C). 1H 
NMR (400 MHz, CDCl3) δ 7.41 (s, 1H), 7.28 (d, J = 16.3 Hz, 1H), 6.99 (d, J = 15.8 Hz, 
1H), 4.16 (t, J = 6.6 Hz, 2H), 3.47 (s, 3H), 3.38 (s, 3H), 1.65 (m, 2H), 1.41 (m, 2H), 0.94 
(t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 167.8, 161.4, 150.8, 144.8, 136.3, 
119.3, 109.0, 64.4, 37.6, 30.9, 28.3, 19.3, 13.8; FTIR (NaCl, cm-1) 3055, 2987, 2963, 
1708, 1665, 1628, 1454, 1422, 1355, 1299, 1173, 1090, 1063, 985, 867; HRMS (ESI+) 
m/z calculated for [M+Na]+ C13H18N2O4Na: 289.1159, found 289.1159. 
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(E)-5-(2’-Methoxycarbonylvinyl)-1,3-dimethyluracil (5.7). Prepared by the general 
procedure described above and purified by flash chromatography (50% EtOAc in 
hexanes) on silica gel to provide 21.0 mg (94%) as a colorless solid (mp 163–165 °C). 1H 
NMR (400 MHz, CDCl3) δ 7.41 (s, 1H), 7.30 (d, J = 15.8 Hz, 1H), 7.00 (d, J = 15.8 Hz, 
1H), 3.77 (s, 3H), 3.48 (s, 3H), 3.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 168.2, 161.4, 
150.8, 144.9, 136.6, 118.9, 109.0, 51.8, 37.7, 28.3; FTIR (NaCl, cm-1) 3124, 2953, 1710, 
1666, 1630, 1456, 1437, 1369, 1301, 1262, 1172, 1091, 984, 908; HRMS (ESI+) m/z 
calculated for [M+Na]+ C10H12N2O4Na: 247.0689, found 247.0695. 
 
N
N
O
O
CO2Bn
 
(E)-5-(2’-Benzoxycarbonylvinyl)-1,3-dimethyluracil (5.8). Prepared by the general 
procedure described above and purified by flash chromatography (50% EtOAc in 
hexanes) on silica gel to provide 15.7 mg (52%) as a colorless solid (mp 180–182 °C). 1H 
NMR (400 MHz, CDCl3) δ 7.42—7.30 (m, 7H), 7.06 (d, J = 15.7 Hz, 1H), 5.22 (s, 2H), 
3.47 (s, 3H), 3.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 167.5, 161.4, 150.8, 145.0, 
136.9, 136.3, 128.7, 128.3, 128.2, 119.0, 109.0, 66.4, 37.7, 28.3; FTIR (NaCl, cm-1) 3167, 
2956, 1710, 1666, 1629, 1456, 1380, 1299, 1166, 1093, 985, 907; HRMS (ESI+) m/z 
calculated for [M+Na]+ C16H16N2O4Na: 323.1002, found 323.1003. 
 
N
N
O
O
Ph
 
(E)-1,3-Dimethyl-5-styryluracil (5.9). Prepared by the general procedure described 
above and purified by flash chromatography (40% EtOAc in hexanes) on silica gel to 
provide 24.0 mg (98%) as a light yellow solid (mp 139–141 °C). 1H NMR (400 MHz, 
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CDCl3) δ 7.45 (d, J = 7.6 Hz, 2H), 7.38 (d, J = 16.4 Hz, 1H), 7.28 (m, 4H), 6.84 (d, J = 
16.3 Hz, 1H), 3.46 (s, 3H), 3.41 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 162.4, 151.2, 
139.4, 137.5, 129.5, 128.8, 127.8, 126.5, 120.1, 111.6, 37.4, 28.3; FTIR (NaCl, cm-1) 
3055, 2987, 1702, 1659, 1459, 1369, 1087, 968; HRMS (ESI+) m/z calculated for 
[M+Na]+ C14H14N2O2Na: 265.0947, found 265.0943. 
 
N
N
O
O
CONMe2
 
(E)-1,3-Dimethyl-5-(2’-dimethylcarbamoylvinyl)uracil (5.10). Prepared by the general 
procedure described above and purified by flash chromatography (100% acetone) on 
silica gel to provide 23.5 mg (100%) as a light yellow solid (mp 208–210 °C). 1H NMR 
(400 MHz, CDCl3) δ 7.58 (d, J = 15.0 Hz, 1H), 7.13 (s, 1H), 7.07 (d, J = 15.0 Hz, 1H), 
3.33 (s, 3H), 3.25 (s, 3H), 3.01 (s, 3H), 2.90 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
167.3, 161.9, 150.8, 145.3, 134.3, 118.8, 109.5, 37.5, 36.0, 28.2; FTIR (NaCl, cm-1) 3155, 
2929, 1709, 1663, 1599, 1454, 1398, 1354, 1146, 1090, 980, 908; HRMS (ESI+) m/z 
calculated for [M+Na]+ C11H15N3O3Na: 260.1006, found 260.1011. 
 
N
N
O
O
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(E)-5-(2’-Formylvinyl)-1,3-dimethyluracil (5.11/5.11’). Prepared by the general 
procedure described above and purified by flash chromatography (100% EtOAc) on silica 
gel to provide 15.3 mg (79%) as a colorless solid (mp 175–177 °C). 1H NMR (400 MHz, 
CDCl3) δ 9.59 (d, J = 7.6 Hz, 1H), 7.57 (s, 1H), 7.23 (d, J = 15.9 Hz, 1H), 7.02 (dd, J = 
15.9, 7.6 Hz, 1H), 3.52 (s, 3H), 3.41 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 193.9, 
161.1, 150.8, 144.6, 144.2, 128.5, 108.8, 37.9, 28.4; FTIR (NaCl, cm-1) 3155, 2949, 2847, 
1716, 1665, 1630, 1455, 1372, 1127, 1092, 908; HRMS (ESI+) m/z calculated for 
[M+Na]+ C9H10N2O3Na: 217.0584, found 217.0580. 
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(E)-5-(2’-Dimethoxyphosphinylvinyl)-1,3-dimethyluracil (5.12). Prepared by the 
general procedure described above and purified by flash chromatography (100% acetone) 
on silica gel to provide 23.0 mg (84%) as a yellow solid (mp 155–157 °C). 1H NMR (400 
MHz, CDCl3) δ 7.42 (s, 1H), 7.10 (dd, J = 24.1, 17.3 Hz, 1H), 6.91 (dd, J = 17.3, 20.1 
Hz, 1H), 3.73 (d, J = 11.1 Hz, 6H), 3.47 (s, 3H), 3.36 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 161.6, 150.7, 145.6, 141.7 (d, J = 7.1 Hz), 113.6 (d, J = 185.8 Hz), 109.0 (d, J = 
23.2 Hz), 52.6 (d, J = 13.9 Hz), 37.7, 28.2; FTIR (NaCl, cm-1) 3055, 2987, 2954, 1711, 
1664, 1454, 1422, 1356, 1266, 1196, 1057, 1034, 989, 863, 838; HRMS (ESI+) m/z 
calculated for [M+Na]+ C10H15N2O5PNa: 297.0611, found 297.0607. 
 
N
N
O
O
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(E)-1,3-Dimethyl-5-(3’-oxobut-1’-enyl)uracil (5.13). Prepared by the general procedure 
described above and purified by flash chromatography (100% EtOAc) on silica gel to 
provide 15.8 mg (75%) as an off-white solid (mp 164–166 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.48 (s, 1H), 7.22 (s, 2H), 3.49 (s, 3H), 3.39 (s, 3H), 2.31 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 198.6, 161.6, 150.8, 145.0, 134.7, 126.7, 109.0, 37.8, 28.9, 28.3; 
FTIR (NaCl, cm-1) 3155, 2980, 2938, 2834, 1727, 1703, 1676, 1634, 1456, 1393, 1368, 
1318, 1288, 1155, 1100, 1057, 983, 908, 870; HRMS (ESI+) m/z calculated for [M+Na]+ 
C10H12N2O3Na: 231.0740, found 231.0742. 
 
N
N
O
O
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(E)-5-(2’-Methoxycarbonyl-1’-methylvinyl)-1,3-dimethyluracil (5.14). Prepared by 
the general procedure described above and purified by flash chromatography (40% 
  182 
EtOAc in hexanes) on silica gel to provide 13.9 mg (59%) as a colorless solid (mp 108–
110 °C). 1H NMR (400 MHz, CDCl3) δ 7.28 (s, 1H), 6.39 (s, 1H), 3.72 (s, 3H), 3.45 (s, 
3H), 3.36 (s, 3H), 2.43 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 167.2, 161.5, 151.2, 
148.5, 141.1, 118.8, 115.5, 51.4, 37.5, 28.3, 17.7; FTIR (NaCl, cm-1) 3208, 2951, 1702, 
1655, 1450, 1363, 1341, 1291, 1214, 1175, 1040; HRMS (ESI+) m/z calculated for 
[M+Na]+ C11H14N2O4Na: 261.0846, found 261.0852. 
 
N
N
O
O O
O
 
1,3-Dimethyl-5-p-quinonyluracil (5.15). Prepared by the general procedure described 
above and purified by flash chromatography (50% EtOAc in hexanes) on silica gel to 
provide 13.7 mg (56%) as an orange solid (mp 159–161 °C). 1H NMR (400 MHz, 
CDCl3) δ 7.84 (s, 1H), 7.46 (d, J = 2.1 Hz, 1H), 6.83–6.76 (m, 2H), 3.51 (s, 3H), 3.40 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 187.4, 186.7, 161.4, 150.7, 146.2, 137.0, 136.9, 
136.6, 134.1, 104.3, 38.0, 28.6; FTIR (NaCl, cm-1) 3055, 2087, 1710, 1655, 1422, 1357, 
1109, 996; HRMS (ESI+) m/z calculated for [M+Na]+ C12H10N2O4Na: 269.0533, found 
269.0536. 
 
N
N
O
O
OAca b
 
(E)-5-(3’-Acetoxyprop-1’-enyl)-1,3-dimethyluracil (5.16a) and (E)-5-(3’-
Acetoxyprop-2’-enyl)-1,3-dimethyluracil (5.16b). Prepared by the general procedure 
described above and purified by flash chromatography (60% EtOAc in hexanes) on silica 
gel to provide 12.5 mg (53%) of an inseparable mixture as a colorless solid (mp 108–110 
°C). 1H NMR (400 MHz, CDCl3) δ 7.27 (s, 1H, 5.16b), 7.22 (s, 1H, 5.16a), 6.58 (dt, J = 
15.8, 6.3 Hz, 1H, 5.16a), 6.43 (d, J = 12.2 Hz, 1H, 5.16b), 6.35 (d, J = 15.9 Hz, 1H, 
5.16a), 5.83 (dt, J = 7.0, 11.6 Hz, 1H, 5.16b), 4.70 (d, J = 7.0 Hz, 2H, 5.16b), 4.65 (d, J = 
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6.3 Hz, 2H, 5.16a), 3.44 (s, 3H, 5.16b), 3.43 (s, 3H, 5.16a), 3.37 (s, 3H, 5.16a), 3.37 (s, 
3H, 5.16b), 2.08 (s, 3H, 5.16b), 2.07 (s, 3H, 5.16a); 13C NMR (100 MHz, CDCl3) δ 170.9 
(5.16a), 162.2 (5.16a), 151.2 (5.16a), 140.3 (5.16a), 125.3 (5.16a), 124.6 (5.16a), 110.4 
(5.16a), 65.3 (5.16a), 37.3 (5.16a), 28.2 (5.16a), 21.1 (5.16a); FTIR (NaCl, cm-1) 3055, 
2087, 1735, 1707, 1655, 1458, 1421, 1369, 1089, 1025, 970; HRMS (ESI+) m/z 
calculated for [M+Na]+ C11H14N2O4Na: 261.0846, found 261.0848. 
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(E)-1,3-Dimethyl-5-((2-oxodihydrofuran-3(2H)-ylidene)methyl)uracil (5.17a) and 
1,3-Dimethyl-5-((2-oxo-2,5-dihydrofuran-3-yl)methyl)uracil (5.17b). Prepared by the 
general procedure described above and purified by flash chromatography (60% acetone 
in hexanes) on silica gel to provide 22.4 mg (96%) of an inseparable mixture as a yellow 
solid (mp 130–132 °C). 1H NMR (400 MHz, CDCl3) δ 7.44 (t, J = 2.9 Hz, 1H, 5.17a), 
7.42 (s, 1H, 5.17a), 7.36 (s, 1H, 5.17b), 7.31 (s, 1H, 5.17b), 4.76 (d, J = 1.4 Hz, 2H, 
5.17b), 4.40 (t, J = 7.2 Hz, 2H, 5.17a), 3.49 (s, 3H, 5.17a), 3.38 (s, 3H, 5.17a), 3.38 (s, 
3H, 5.17b), 3.33 (s, 3H, 5.17b), 3.31 (s, 2H, 5.17b), 3.13 (td, J = 7.1, 2.7 Hz, 2H, 5.17a); 
13C NMR (100 MHz, CDCl3) δ 174.3 (5.17b), 171.9 (5.17a), 163.4 (5.17b), 161.4 
(5.17a), 151.7 (5.17b), 150.9 (5.17a), 147.2 (5.17b), 143.8 (5.17a), 141.6 (5.17b), 130.5 
(5.17b), 127.9 (5.17a), 123.3 (5.17a), 109.6 (5.17a), 108.8 (5.17b), 70.3 (5.17b), 65.3 
(5.17a), 37.9 (5.17a), 37.1 (5.17b), 28.5 (5.17a), 28.2 (5.17a), 28.1 (5.17b), 23.5 (5.17b); 
FTIR (NaCl, cm-1) 3224, 2930, 1752, 1702, 1664, 1459, 1375, 1343, 1205, 1171, 1081, 
1052, 907, 833, 312; HRMS (ESI+) m/z calculated for [M+Na]+ C11H12N2O4Na: 
259.0689, found 259.0686. 
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(E)-1,3-Dimethyl-5-(2’-t-butoxycarbonylpropenyl)uracil (5.18a) and 1,3-Dimethyl-5-
(2’-t-butoxycarbonylallyl)uracil (5.18b). Prepared by the general procedure described 
above and purified by flash chromatography (50% EtOAc in hexanes) on silica gel to 
provide 13.2 mg (47%) of an inseparable mixture as colorless crystals (mp 93–95 °C). 1H 
NMR (400 MHz, CDCl3) δ 7.41 (s, 1H, 5.18a), 7.28 (s, 1H, 5.18a), 7.10 (s, 1H, 5.18b), 
6.15 (s, 1H, 5.18b), 5.69 (s, 1H, 5.18b), 3.46 (s, 3H, 5.18a), 3.38 (s, 3H, 5.18a), 3.37 (s, 
3H, 5.18b), 3.35 (s, 3H, 5.18b), 3.29 (s, 2H, 5.18b), 1.98 (s, 3H, 5.18a), 1.51 (s, 9H, 
5.18a), 1.47 (s, 9H, 5.18b); 13C NMR (100 MHz, CDCl3) δ 167.1 (5.18a), 166.1 (5.18b), 
163.5 (5.18b), 162.5 (5.18a), 151.9 (5.18b), 151.2 (5.18a), 142.2 (5.18a), 140.8 (5.18b), 
138.6 (5.18b), 130.3 (5.18a), 128.6 (5.18a), 126.7 (5.18b), 111.0 (5.18b), 110.1 (5.18a), 
81.1 (5.18b), 81.0 (5.18a), 37.6 (5.18a), 37.0 (5.18a, 5.18b), 29.6 (5.18a, 5.18b), 28.2 
(5.18a, 5.18b), 14.9 (5.18a); FTIR (NaCl, cm-1) 3055, 2086, 1702, 1660, 1457, 1422, 
1369, 1341, 1143, 1085, 1049, 954, 849; HRMS (ESI+) m/z calculated for [M+Na]+ 
C14H20N2O4Na: 303.1315, found 303.1316. 
 
N
N
O
O
NN
O
O
CO2tBu
 
(E)-1,3-Dimethyl-5-(3’-(1,3-dimethyluracil-5-yl)-2’-t-butoxycarbonylallyl)uracil 
(5.18c). Prepared by the general procedure described above and purified by flash 
chromatography (100% EtOAc) on silica gel to provide 6.6 mg (24%) as a colorless wax. 
1H NMR (400 MHz, CDCl3) δ 8.56 (s, 1H), 7.50 (s, 1H), 7.37 (s, 1H), 3.50 (s, 3H), 3.44 
(s, 2H), 3.38 (s, 6H), 3.36 (s, 3H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 167.4, 
164.3, 162.8, 151.6, 151.4, 144.3, 143.1, 131.1, 130.7, 109.6, 108.5, 81.6, 37.6, 37.2, 
37.2, 28.3, 25.4; FTIR (NaCl, cm-1) 3054, 2987, 1702, 1659, 1552, 1422, 1370, 1344, 
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1157, 1102; HRMS (ESI+) m/z calculated for [M+Na]+ C20H26N4O6Na: 441.1745, found 
441.1751. 
 
N
N
O
O
CO2tBuBn
Bn  
(E)-1,3-Dibenzyl-5-(2’-t-butoxycarbonylvinyl)uracil (5.19). Prepared by the general 
procedure described above and purified by flash chromatography (20% EtOAc in 
hexanes) on silica gel to provide 38.4 mg (94%) as a colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 7.49 (d, J = 6.7 Hz, 2H), 7.42–7.26 (m, 9H), 7.12 (d, J = 15.8 Hz, 1H), 6.88 (d, 
J = 15.7 Hz, 1H), 5.18 (s, 2H), 4.97 (s, 2H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
166.9, 161.1, 150.8, 143.3, 136.6, 135.2, 134.7, 129.4, 129.3, 129.0, 128.6, 128.4, 127.9, 
121.6, 109.9, 80.5, 52.8, 45.0, 28.3; FTIR (NaCl, cm-1) 3055, 2983, 2933, 1708, 1664, 
1629, 1496, 1452, 1384, 1368, 1317, 1155, 1080, 1030, 984, 910; HRMS (ESI+) m/z 
calculated for [M+Na]+ C25H26N2O4Na: 441.1785, found 441.1790. 
 
N
N
O
O
MOM
MOM CO2tBu
 
(E)-1,3-Bis(methoxymethyl)-5-(2’-t-butoxycarbonylvinyl)uracil (5.20). Prepared by 
the general procedure described above and purified by flash chromatography (50% 
EtOAc in hexanes) on silica gel to provide 21.7 mg (68%) as a colorless oil. 1H NMR 
(400 MHz, CDCl3) δ 7.51 (s, 1H), 7.21 (d, J = 15.8 Hz, 1H), 6.88 (d, J = 15.8 Hz, 1H), 
5.42 (s, 2H), 5.18 (s, 2H), 3.45 (s, 3H), 3.41 (s, 3H), 1.49 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 166.6, 161.1, 150.9, 142.7, 134.7, 122.4, 110.4, 80.6, 79.3, 72.5, 58.2, 57.5, 
28.3; FTIR (NaCl, cm-1) 3155, 2980, 2938, 1724, 1676, 1634, 1456, 1368, 1318, 1288, 
1155, 1100, 984, 908; HRMS (ESI+) m/z calculated for [M+Na]+ C15H21N2O6Na: 
349.1370, found 349.1367. 
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(E)-1-Benzyl-3-(3’,5’-dimethylbenzyl)-5-(2’-t-butoxycarbonylvinyl)uracil (5.21). 
Prepared by the general procedure described above and purified by flash chromatography 
(20% EtOAc in hexanes) on silica gel to provide 33.3 mg (76%) as a colorless oil. 1H 
NMR (400 MHz, CDCl3) δ 7.40–7.27 (m, 6H), 7.13 (d, J = 15.8 Hz, 1H), 7.06 (s, 2H), 
6.90–6.87 (m, 2H), 5.11 (s, 2H), 4.98 (s, 2H), 2.28 (s, 6H), 1.48 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 166.9, 161.0, 150.8, 143.3, 138.1, 136.4, 135.3, 134.8, 129.5, 129.4, 
129.0, 128.3, 126.7, 121.5, 109.9, 80.5, 52.8, 44.9, 28.3, 21.4; FTIR (NaCl, cm-1) 3156, 
2079, 2948, 2869, 1704, 1660, 1466, 1368, 1329, 1297, 1153, 1116, 1041, 993, 908; 
HRMS (ESI+) m/z calculated for [M+Na]+ C27H30N2O4Na: 469.2098, found 469.2097. 
 
 
N
N
O
O
CO2tBu
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(E)-1,3-Bis(p-methoxybenzyl)-5-(2’-t-butoxycarbonylvinyl)uracil (5.22). Prepared by 
the general procedure described above and purified by flash chromatography (50% 
EtOAc in hexanes) on silica gel to provide 46.1 mg (96%) as a colorless oil. 1H NMR 
(400 MHz, CDCl3) δ 7.46 (d, J = 8.6 Hz, 2H), 7.28 (s, 1H), 7.22 (d, J = 8.6 Hz, 2H), 7.10 
(d, J = 15.8 Hz, 1H), 6.92–6.80 (m, 5H), 5.10 (s, 2H), 4.88 (s, 2H), 3.81 (s, 3H), 3.77 (s, 
3H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 166.9, 161.0, 160.1, 159.3, 150.8, 
143.1, 135.4, 130.9, 130.1, 128.9, 126.5, 121.3, 114.8, 113.8, 109.7, 80.4, 55.4, 52.3, 
44.4, 28.3; FTIR (NaCl, cm-1) 3055, 2987, 2839, 1706, 1663, 1628, 1623, 1514, 1456, 
1422, 1368, 1178, 1155, 1034, 985, 896; HRMS (ESI+) m/z calculated for [M+Na]+ 
C27H30N2O6Na: 501.1996, found 501.1995. 
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(E)-2′,3′-O-Isopropylidene-3-methyl-5-(2’-t-butoxycarbonylvinyl)uridine (5.23). 
Prepared by the general procedure described above and purified by flash chromatography 
(35% EtOAc in hexanes) on silica gel to provide 27.1 mg (66%) as a colorless wax. 1H 
NMR (400 MHz, CDCl3) δ 7.83 (s, 1H), 7.19 (d, J = 15.8 Hz, 1H), 6.81 (d, J = 15.8 Hz, 
1H), 5.76 (d, J = 1.4 Hz, 1H), 4.96–4.89 (m, 2H), 4.42–4.34 (m, 1H), 3.96 (dd, J = 11.8, 
2.3 Hz, 1H), 3.83 (dd, J = 11.8, 2.9 Hz, 1H), 3.34 (s, 3H), 2.95 (br, 1H), 1.58 (s, 3H), 
1.48 (s, 9H), 1.35 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 167.1, 161.1, 150.1, 141.2, 
135.4, 121.3, 114.4, 109.2, 96.0, 87.2, 84.9, 80.7, 62.8, 28.3, 28.1, 27.3, 25.4; FTIR 
(NaCl, cm-1) 3468, 3055, 2987, 1710, 1667, 1627, 1466, 1422, 1369, 1265, 1155, 1112, 
1084, 987, 855; HRMS (ESI+) m/z calculated for [M+Na]+ C20H28N2O8Na: 447.1738, 
found  447.1737. 
 
N
N
O
O
O
O
O
Si
O
Si
iPr iPr
iPr
iPr
Me CO2tBu
 
(E)-2’-Deoxy-3′,5′-O-(1’,1’,3’,3’-tetraisopropyldisiloxy)-3-methyl-5-(2’-t-
butoxycarbonylvinyl)uridine (5.24). Prepared by the general procedure described above 
and purified by flash chromatography (10–20% EtOAc in hexanes) on silica gel to 
provide 44.6 mg (75%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.94 (s, 1H), 
7.26 (d, J = 15.8 Hz, 1H), 6.84 (d, J = 15.9 Hz, 1H), 6.02 (d, J = 6.6 Hz, 1H), 4.44 (q, J = 
8.0 Hz, 1H), 4.16 (d, J = 13.1 Hz, 1H), 4.03 (dd, J = 13.2, 2.5 Hz, 1H), 3.81 (d, J = 8.2 
Hz, 1H), 3.35 (s, 3H), 2.54 (ddd, J = 13.4, 10.2, 7.2 Hz, 1H), 2.29 (dd, J = 13.4, 7.2 Hz, 
1H), 1.48 (s, 9H), 1.11–0.98 (m, 28H); 13C NMR (100 MHz, CDCl3) δ 166.7, 161.2, 
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149.9, 138.6, 135.7, 121.1, 108.8, 85.5, 80.2, 67.1, 60.1, 40.2, 28.3, 27.9, 17.5, 17.1, 13.6, 
13.1, 12.8, 12.6; FTIR (NaCl, cm-1) 3156, 2079, 2948, 2869, 1704, 1660, 1466, 1368, 
1320, 1297, 1153, 1116, 1041, 993, 908, 885; HRMS (ESI+) m/z calculated for [M+Na]+ 
C29H50N2O8Si2Na: 633.3003, found 633.2995. 
 
8.6 Chapter 6 
8.6.1 General procedure for the aerobic alkenylation of cyclic enaminones  
N
O
R1
+ R5
R2
Pd(TFA)2 (10 mol%)
Cu(OAc)2 (10 mol%)
catechol (20 mol%)
DMF, rt, 24 h, 4Å MS
N
O
R1
R2
R5
R3 R3
R4
R6
R4
R6
H
H
 
In a 2-dram vial, cyclic enaminone (0.10 mmol) was mixed with Pd(TFA)2 (3.3 mg, 0.01 
mmol), Cu(OAc)2 (1.8 mg, 0.01 mmol), catechol (2.2 mg, 0.02 mmol), and 4Å molecular 
sieves (ca. 30 mg). To the mixture was added alkene (0.40 mmol), followed by DMF (0.5 
mL). The vial was purged with O2 and then sealed with an O2 balloon attached. After 
stirring at room temperature for 24 h, the reaction was diluted with acetone (2 mL). The 
mixture was filtered through Celite, and the filter cake was washed with acetone (20 mL). 
The filtrate was then concentrated under reduced pressure and purified by flash 
chromatography on silica gel.  
 
8.6.2 General procedure for the synthesis of chalcones via the tandem reaction 
N
O
R3
R1
R2
toluene
160 ºC, 24 h
R3
R4
O
R2
+ R4
 
In a 2-dram vial, alkenylated cyclic enaminone (0.07 mmol) was mixed with alkene (0.56 
mmol) and toluene (1 mL). The vial was then sealed and stirred at 160 °C. After 24 h, the 
reaction mixture was cooled, concentrated under reduced pressure, and then purified by 
flash chromatography on silica gel. 
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8.6.3 Compound characterization 
N
O
Bn
PMP
CO2tBu  
(E)-1-Benzyl-5-(2-(t-butoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.3). Prepared by the general procedure described above and 
35.1 mg (89%) was isolated as a light yellow solid (mp 64–68 °C). Spectroscopic data are 
consistent with those from compound 4.3. 
 
N
O
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CO2Me  
(E)-1-Benzyl-5-(2-(methoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.4). Prepared by the general procedure described above and 
28.0 mg (78%) was isolated as a light yellow solid (mp 52–55 °C). Spectroscopic data are 
consistent with those from compound 4.4. 
 
N
O
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PMP
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(E)-1-Benzyl-5-(2-(n-butoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.5). Prepared by the general procedure described above and 
34.2 mg (85%) was isolated as a light yellow solid (mp 102–104 °C). Spectroscopic data 
are consistent with those from compound 4.5. 
 
N
O
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CO2Bn  
(E)-5-(2-(Benzoxycarbonyl)vinyl)-1-benzyl-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.6). Prepared by the general procedure described above and 
37.4 mg (87%) was isolated as a light yellow solid (mp 49–52 °C). Spectroscopic data are 
consistent with those from compound 4.6. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-(3-oxobut-1-enyl)-2,3-dihydropyridin-4(1H)-
one (6.7). Prepared by the general procedure described above and 23.7 mg (69%) was 
isolated as a light yellow solid (mp 49–52 °C). Spectroscopic data are consistent with 
those from compound 4.7. 
 
N
O
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CONMe2  
(E)-1-Benzyl-5-(2-(dimethylcarbamoyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.8). Prepared by the general procedure described above and 
29.4 mg (80%) was isolated as a yellow solid (mp 51–53 °C). Spectroscopic data are 
consistent with those from compound 4.8. 
 
 
N
O
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(E)-1-Benzyl-5-(2-(diethoxyphosphinyl)vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.9). Prepared by the general procedure described above and 
27.4 mg (68%) was isolated as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.50 (s, 1H), 
7.42–7.34 (m, 3H), 7.18–7.07 (m, 4H), 6.95 (dd, J = 24.7, 17.1 Hz, 1H), 6.87 (d, J = 8.5 
Hz, 2H), 6.52 (dd, J = 22.2, 17.0 Hz, 1H), 4.51 (t, J = 6.8 Hz, 1H), 4.42 (d, J = 14.9 Hz, 
1H), 4.25 (d, J = 14.9 Hz, 1H), 3.81 (s, 3H), 3.72 (d, J = 3.3 Hz, 3H), 3.69 (d, J = 3.2 Hz, 
3H), 2.92 (dd, J = 16.4, 7.3 Hz, 1H), 2.70 (dd, J = 16.3, 6.4 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 188.2, 160.0, 157.3, 145.4 (d, J = 8.0 Hz), 134.7, 129.6, 129.4, 128.9, 
128.3, 128.0, 114.8, 106.7 (d, J = 22.0 Hz) , 104.5 (d, J = 189.5 Hz), 60.1, 58.2, 55.5, 
52.3 (d, J = 5.3 Hz), 52.3 (d, J = 5.3 Hz), 44.3; FTIR (NaCl, cm-1) 3156, 2953, 2930, 
2851, 1654, 1600, 1513, 1457, 1442, 1392, 1358, 1298, 1194, 1179, 1059, 1035, 991, 
868, 832; HRMS (ESI+) m/z calculated for [M+Na]+ C23H26NO5PNa: 450.1441, found 
450.1447. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-styryl-2,3-dihydropyridin-4(1H)-one (6.10). 
Prepared by the general procedure described above and 17.0 mg (46%) was isolated as a 
yellow solid (mp 54–56 °C). Spectroscopic data are consistent with those from compound 
4.10. 
 
N
O
Bn
PMP
CO2Me
 
(E)-1-Benzyl-5-(2-(methoxycarbonyl)-1-methyl-vinyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.11). Prepared by the general procedure described above 
and 7.0 mg (19%) was isolated as a waxy solid. Spectroscopic data are consistent with 
those from compound 4.14. 
 
N
O
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CO2tBu  
(E)-1-Benzyl-5-(2-(tert-butoxycarbonyl)propenyl)-2-(4-methoxyphenyl)-2,3-
dihydropyridin-4(1H)-one (6.12). Prepared by the general procedure described above 
and 12.2 mg (37%) was isolated as a waxy solid. 1H NMR (400 MHz, CDCl3) δ 7.58 (s, 
1H), 7.50 (d, J = 0.9 Hz, 1H), 7.39–7.33 (m, 3H), 7.22–7.12 (m, 4H), 6.88 (d, J = 8.6 Hz, 
2H), 4.54 (t, J = 7.0 Hz, 1H), 4.41 (d, J = 14.9 Hz, 1H), 4.26 (d, J = 14.9 Hz, 1H), 3.81 (s, 
3H), 2.92 (dd, J = 16.4, 7.1 Hz, 1H), 2.73 (dd, J = 16.5, 6.9 Hz, 1H), 1.90 (d, J = 1.2 Hz, 
3H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 188.5, 168.4, 159.9, 154.5, 135.4, 
131.9, 130.0, 129.3, 128.7, 128.4, 128.0, 123.0, 114.7, 107.3, 80.0, 60.1, 58.1, 55.5, 43.5, 
28.4, 15.2; FTIR (NaCl, cm-1) 3035, 2981, 1640, 1594, 1513, 1466, 1442, 1391, 1368, 
1299, 1176, 1121, 1035, 833; HRMS (ESI+) m/z calculated for [M+Na]+ C27H31NO4Na: 
456.2145, found 456.2144. 
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(E)-1-Benzyl-2-(4-methoxyphenyl)-5-((2-oxodihydrofuran-3(2H)-ylidene)methyl)-
2,3-dihydropyridin-4(1H)-one (6.13). Prepared by the general procedure described 
above and 21.2 mg (57%) was isolated as a light yellow solid (mp 59–62 °C). 
Spectroscopic data are consistent with those from compound 4.15a. 
 
N
O
CO2tBu  
(E)-3-(2-(tert-Butoxycarbonyl)vinyl)-7,8,9,9a-tetrahydro-1H-quinolizin-2(6H)-one 
(6.14). Prepared by the general procedure described above and 15.5 mg (59%) was 
isolated as a light yellow solid (mp 122–124 °C). Spectroscopic data are consistent with 
those from compound 4.21. 
 
N
O
Me CO2tBu
H
H
 
(E)-(trans)-3-(2-(tert-Butoxycarbonyl)vinyl)-1-methyl-4a,5,6,7,8,8a-hexahydroquino-
lin-4(1H)-one (6.15). Prepared by the general procedure described above and 16.4 mg 
(59%) was isolated as a light yellow solid (mp 146–148 °C). Spectroscopic data are 
consistent with those from compound 4.25. 
 
N
O
Bn CO2tBu  
(E)-1-Benzyl-5-(2-(tert-butoxycarbonyl)vinyl)-2-isopropyl-2,3-dihydropyridin-
4(1H)-one (6.16). Prepared by the general procedure described above and 27.0 mg (83%) 
was isolated as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.43–7.35 (m, 4H), 7.25 (d, 
J = 7.0 Hz, 2H), 7.08 (d, J = 15.6 Hz, 1H), 6.50 (d, J = 15.6 Hz, 1H), 4.58 (d, J = 15.0 
Hz, 1H), 4.48 (d, J = 15.1 Hz, 1H), 3.32–3.22 (m, 1H), 2.63 (dd, J = 16.6, 7.6 Hz, 1H), 
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2.47 (dd, J = 16.6, 2.3 Hz, 1H), 2.22 (dq, J = 13.4, 6.7 Hz, 1H), 1.46 (s, 9H), 0.98 (d, J = 
6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 188.7, 168.6, 
155.9, 138.9, 135.6, 129.4, 128.9, 127.6, 113.1, 105.9, 79.2, 61.8, 59.8, 37.5, 29.7, 28.4, 
19.8, 18.1; FTIR (NaCl, cm-1) 3052, 2975, 2932, 1685, 1654, 1594, 1496, 1455, 1439, 
1391, 1367, 1319, 1271, 1241, 1151, 1093, 990, 859; HRMS (ESI+) m/z calculated for 
[M+Na]+ C22H29NO3Na: 378.2040, found 378.2038. 
 
N
O
Bn CO2tBu  
(E)-1-Benzyl-5-(2-(tert-butoxycarbonyl)vinyl)-2,3-dihydropyridin-4(1H)-one (6.17). 
Prepared by the general procedure described above and 17.7 mg (59%) was isolated as a 
light yellow oil. Spectroscopic data are consistent with those from compound 4.19. 
 
N
O
Ph CO2tBu  
(E)-5-(2-(tert-Butoxycarbonyl)vinyl)-1-phenyl-2,3-dihydropyridin-4(1H)-one (6.18). 
Prepared by the general procedure described above and 9.0 mg (32%) was isolated as a 
light yellow solid (mp 150–152 °C). Spectroscopic data are consistent with those from 
compound 4.17. 
 
N
O
CO2MeMe
PMP
 
(E)-5-(2-(Methoxycarbonyl)vinyl)-2-(4-methoxyphenyl)-1-methyl-2,3-
dihydropyridin-4(1H)-one (6.33). Prepared by the general procedure described above in 
8.2.1 and 8.4.1 as a starting material for the Diels-Alder tandem reaction and isolated as a 
light yellow solid (mp 123–125 °C). 1H NMR (400 MHz, CDCl3) δ 7.48 (s, 1H), 7.32 (d, 
J = 16.1 Hz, 1H), 7.25 (d, J = 8.7 Hz, 2H), 6.96 (d, J = 7.4 Hz, 2H), 6.74 (d, J = 13.9 Hz, 
1H), 4.60 (t, J = 6.8 Hz, 1H), 3.88 (s, 3H), 3.80 (s, 3H), 3.13–3.00 (m, 4H), 2.81 (dd, J = 
16.5, 7.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 187.9, 169.7, 160.0, 157.8, 140.3, 
129.6, 128.2, 114.8, 110.9, 106.0, 62.7, 55.5, 51.3, 44.1, 42.4; FTIR (NaCl, cm-1) 3055, 
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2987, 1654, 1607, 1514, 1422, 1317, 1171, 1099, 1034, 989, 896; HRMS (ESI+) m/z 
calculated for [M+Na]+ C17H19NO4Na: 324.1206, found 324.1210. 
 
O
OMe
S(O)2Me
O
PMP
 
(E)-Methyl 3-(3-(4-Methoxyphenyl)acryloyl)-5-(methylsulfonyl)benzoate (6.36). (In a 
compound name all new words are caps.) Prepared by the general procedure described 
above and 15.0 mg (82%) was isolated as a yellow solid (mp 185–187 °C). 1H NMR (400 
MHz, CDCl3) δ 8.89 (s, 1H), 8.77 (s, 1H), 8.72 (s, 1H), 7.89 (d, J = 15.4 Hz, 1H), 7.65 
(d, J = 7.8 Hz, 2H), 7.42 (d, J = 15.5 Hz, 1H), 6.96 (d, J = 7.8 Hz, 2H), 4.02 (s, 3H), 3.88 
(s, 3H), 3.15 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 187.6, 164.9, 162.5, 147.3, 142.2, 
140.4, 134.0, 132.5, 131.8, 131.1, 131.0, 127.1, 118.1, 114.7, 55.6, 53.1, 44.5; FTIR 
(NaCl, cm-1) 3055, 2987, 1732, 1665, 1592, 1571, 1513, 1422, 1325, 1308, 1212, 1174, 
1149, 1060, 1030, 984, 961, 896, 828; HRMS (ESI+) m/z calculated for [M+Na]+ 
C19H18O6SNa: 397.0716, found 397.0716. 
 
O
OMe
COMe
O
PMP
 
(E)-Methyl 3-Acetyl-5-(3-(4-methoxyphenyl)acryloyl)benzoate (6.39). Prepared by the 
general procedure described above and 17.5 mg (66%) was isolated as a yellow solid (mp 
72–74 °C). 1H NMR (400 MHz, CDCl3) δ 8.83 (s, 1H), 8.78 (s, 1H), 8.75 (s, 1H), 7.86 (d, 
J = 15.5 Hz, 1H), 7.65 (d, J = 7.7 Hz, 1H), 7.46 (d, J = 15.4 Hz, 1H), 6.96 (d, J = 7.8 Hz, 
2H), 4.00 (s, 3H), 3.87 (s, 3H), 2.72 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 196.8, 188.7, 
165.9, 162.3, 146.4, 139.5, 137.9, 133.4, 132.9, 132.0, 131.5, 130.8, 127.3, 118.7, 114.7, 
55.6, 52.8, 27.1; FTIR (NaCl, cm-1) 3055, 2987, 1728, 1693, 1664, 1599, 1572, 1513, 
1422, 1361, 1195, 1173, 1031, 985, 829; HRMS (ESI+) m/z calculated for [M+Na]+ 
C20H18O5Na: 361.1046, found 361.1044. 
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(E)-Dimethyl 5-(3-(4-Methoxyphenyl)acryloyl)isophthalate (6.40). Prepared by the 
general procedure described above and 20.3 mg (73%) was isolated as a yellow solid (mp 
111–113 °C). 1H NMR (400 MHz, CDCl3) δ 8.88 (s, 1H), 8.84 (s, 2H), 7.88 (d, J = 15.4 
Hz, 1H), 7.66 (d, J = 7.6 Hz, 2H), 7.46 (d, J = 15.3 Hz, 1H), 6.97 (d, J = 8.7 Hz, 2H), 
4.01 (s, 6H), 3.89 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 188.6, 165.8, 162.3, 146.3, 
139.4, 134.2, 133.4, 131.4, 130.8, 127.4, 118.8, 114.7, 55.6, 52.8; FTIR (NaCl, cm-1) 
3055, 2987, 2956, 1730, 1664, 1601, 1572, 1513, 1422, 1208, 1173, 1032, 1002, 896, 
830; HRMS (ESI+) m/z calculated for [M+Na]+ C20H18O6Na: 377.0996, found 377.1005. 
 
 
O
OMe
CO2nBu
O
PMP
 
(E)-1-Butyl 3-Methyl 5-(3-(4-Methoxyphenyl)acryloyl)isophthalate (6.41). Prepared 
by the general procedure described above and 23.2 mg (75%) was isolated as a yellow 
wax. 1H NMR (400 MHz, CDCl3) δ 8.85 (s, 1H), 8.82 (s, 2H), 7.86 (d, J = 15.3 Hz, 1H), 
7.64 (d, J = 8.1 Hz, 2H), 7.45 (d, J = 15.3 Hz, 1H), 6.96 (d, J = 8.2 Hz, 2H), 4.40 (t, J = 
7.2 Hz, 2H), 4.00 (s, 3H), 3.87 (s, 3H), 1.81 (m, 2H), 1.50 (h, J = 7.4, 6.9 Hz, 2H), 1.00 
(t, J = 8.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 188.7, 165.8, 165.4, 162.2, 146.3, 
139.3, 134.1, 133.4, 133.3, 131.8, 131.3, 130.7, 127.4, 118.8, 114.7, 65.8, 55.6, 52.8, 
30.9, 19.4, 13.9; FTIR (NaCl, cm-1) 3053, 2962, 2936, 1725, 1664, 1601, 1572, 1513, 
1464, 1443, 1424, 1386, 1288, 1204, 1173, 1109, 1065, 1032, 986, 828; HRMS (ESI+) 
m/z calculated for [2M+Na]+ C46H48O12Na: 815.3038, found 815.3044. 
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(E)-1-Benzyl 3-Methyl 5-(3-(4-Methoxyphenyl)acryloyl)isophthalate  (6.42). Prepared 
by the general procedure described above and 24.0 mg (86%) was isolated as a yellow 
wax. 1H NMR (400 MHz, CDCl3) δ 8.88 (s, 1H), 8.85 (s, 1H), 8.82 (s, 1H), 7.85 (d, J = 
15.5 Hz, 1H), 7.64 (d, J = 7.8 Hz, 2H), 7.50–7.37 (m, 6H), 6.96 (d, J = 7.8 Hz, 2H), 5.44 
(s, 2H), 3.99 (s, 3H), 3.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 188.6, 165.8, 165.2, 
162.2, 146.3, 139.4, 135.7, 134.2, 133.6, 133.5, 131.5, 131.4, 130.8, 128.8, 128.7, 128.6, 
127.4, 118.8, 114.7, 67.6, 55.6, 52.8; FTIR (NaCl, cm-1) 3055, 2987, 1728, 1664, 1601, 
1588, 1572, 1513, 1422, 1201, 1173, 1030, 986, 896, 829; HRMS (ESI+) m/z calculated 
for [M+Na]+ C26H22O6Na: 453.1309, found 453.1314. 
 
 
O
OMe
CN
O
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(E)-Methyl 3-Cyano-5-(3-(4-methoxyphenyl)acryloyl)benzoate (6.43). Prepared by the 
general procedure described above and 16.6 mg (80%) was isolated as a light yellow 
solid (mp 257–259 °C). 1H NMR (400 MHz, CDCl3) δ 8.82 (s, 1H), 8.49 (s, 1H), 8.45 (s, 
1H), 7.87 (d, J = 15.4 Hz, 1H), 7.65 (d, J = 7.2 Hz, 2H), 7.38 (d, J = 15.4 Hz, 1H), 6.97 
(d, J = 6.8 Hz, 2H), 4.01 (s, 3H), 3.88 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 187.3, 
164.7, 162.5, 147.3, 140.0, 136.3, 135.8, 133.0, 132.1, 130.9, 127.1, 117.9, 117.4, 114.8, 
113.8, 55.6, 53.2; FTIR (NaCl, cm-1) 3156, 2957, 2932, 2254, 1794, 1731, 1662, 1600, 
1571, 1513, 1465, 1444, 1382, 1307, 1287, 1225, 1173, 1096, 1034, 987, 827; HRMS 
(ESI+) m/z calculated for [M+Na]+ C19H15NO4Na: 344.0893, found 344.0891. 
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(E)-Methyl 3-(Dimethoxyphosphoryl)-5-(3-(4-methoxyphenyl)acryloyl)benzoate 
(6.44). Prepared by the general procedure described above and 6.0 mg (23%) was isolated 
as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 8.83 (s, 1H), 8.64 (d, J = 12.1 Hz, 1H), 
8.60 (d, J = 12.1 Hz, 1H), 7.87 (d, J = 15.6 Hz, 1H), 7.65 (d, J = 8.6 Hz, 2H), 7.44 (d, J = 
15.5 Hz, 1H), 6.96 (d, J = 8.6 Hz, 2H), 3.99 (s, 3H), 3.88 (s, 3H), 3.83 (d, J = 11.1 Hz, 
6H); 13C NMR (100 MHz, CDCl3) δ 188.5, 165.7, 162.3, 146.6, 139.4 (d, J = 13.9 Hz), 
136.4 (d, J = 10.9 Hz), 135.7 (d, J = 11.0 Hz), 133.2 (d, J = 3.0 Hz), 131.4 (d, J = 15.2 
Hz), 130.9, 129.1 (d, J = 191.5 Hz), 127.3, 118.6, 114.7, 55.6, 53.2 (d, J = 5.8 Hz), 52.9; 
FTIR (NaCl, cm-1) 3055, 2987, 1738, 1638, 1512, 1422, 1174, 1033, 896; HRMS (ESI+) 
m/z calculated for [M+Na]+ C20H21O7PNa: 427.0917, found 427.0929. 
 
 
O
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O
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NH
O
O
 
(E)-4-Methoxycarbonyl-6-(3-(4-methoxyphenyl)acryloyl)isoindoline-1,3-dione (6.45). 
Prepared by the general procedure described above and 4.4 mg (16%) was isolated as a 
bright yellow solid (mp 165–167 °C). 1H NMR (400 MHz, CDCl3) δ 8.61 (s, 1H), 8.56 (s, 
1H), 7.89 (d, J = 15.5 Hz, 2H), 7.65 (d, J = 8.7 Hz, 2H), 7.40 (d, J = 15.5 Hz, 1H), 6.97 
(d, J = 8.7 Hz, 2H), 4.05 (s, 3H), 3.88 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 187.5, 
165.9, 165.0, 164.5, 162.7, 147.7, 144.0, 134.7, 134.4, 132.7, 131.0, 130.8, 127.0, 125.4, 
118.1, 114.8, 55.7, 53.4; FTIR (NaCl, cm-1) 3413, 3055, 2987, 1783, 1744, 1638, 1513, 
1421, 1173, 896; HRMS (ESI+) m/z calculated for [M+Na]+ C20H15NO6Na: 388.0792, 
found 388.0791. 
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(E)-Methyl 3-(3-(4-Methoxyphenyl)acryloyl)benzoate (6.46). Prepared by the general 
procedure described above and 7.6 mg (33%) was isolated as an off-white solid (mp 93–
95 °C). 1H NMR (400 MHz, CDCl3) δ 8.65 (s, 1H), 8.29–8.14 (m, 2H), 7.83 (d, J = 15.5 
Hz, 1H), 7.61 (dd, J = 20.1, 8.0 Hz, 3H), 7.44 (d, J = 15.5 Hz, 1H), 6.95 (d, J = 8.0 Hz, 
2H), 3.97 (s, 3H), 3.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 189.5, 166.4, 161.9, 
145.5, 138.8, 133.4, 132.7, 130.6, 130.4, 129.4, 128.9, 127.4, 119.2, 114.5, 55.4, 52.4; 
FTIR (NaCl, cm-1) 3155, 2984, 2955, 2929, 1793, 1722, 1660, 1595, 1572, 1512, 1466, 
1382, 1305, 1291, 1208, 1173, 1096, 1034, 830; HRMS (ESI+) m/z calculated for 
[M+Na]+ C18H16O4Na: 319.0941, found 319.0946. 
 
Ph
CN
O
PMP
 
(E)-3-Cyano-5-(3-(4-methoxyphenyl)acryloyl)-1,1'-biphenyl (6.47). Prepared by the 
general procedure described above and 10.5 mg (46%) was isolated as a yellow solid (mp 
61–63°C). 1H NMR (400 MHz, CDCl3) δ 8.42 (s, 1H), 8.24 (s, 1H), 8.06 (s, 1H), 7.88 (d, 
J = 15.5 Hz, 1H), 7.70–7.62 (m, 4H), 7.51 (m, 3H), 7.40 (d, J = 15.7 Hz, 1H), 6.98 (d, J = 
7.8 Hz, 2H), 3.89 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 188.4, 162.4, 146.7, 143.3, 
140.1, 138.3, 134.0, 131.2, 130.8, 130.5, 129.4, 129.0, 127.3, 127.2, 118.6, 118.3, 114.7, 
113.6, 55.6; FTIR (NaCl, cm-1) 3155, 2929, 2254, 1794, 1710, 1663, 1597, 1571, 1513, 
1465, 1382, 1342, 1308, 1288, 1206, 1173, 1095, 1049, 1032, 985, 827; HRMS (ESI+) 
m/z calculated for [M+Na]+ C23H17NO2Na: 362.1151, found 362.1153. 
 
Ph
CO2Me
O
PMP
 
(E)-3-Methoxycarbonyl-5-(3-(4-methoxyphenyl)acryloyl)-1,1'-biphenyl (6.48). 
Prepared by the general procedure described above and 13.0 mg (52%) was isolated as a 
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yellow solid (mp 124–126 °C). 1H NMR (400 MHz, CDCl3) δ 8.61 (s, 1H), 8.48 (s, 1H), 
8.42 (s, 1H), 7.86 (d, J = 15.5 Hz, 1H), 7.73–7.62 (m, 4H), 7.52–7.40 (m, 4H), 6.96 (d, J 
= 8.0 Hz, 2H), 4.00 (s, 3H), 3.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 189.7, 166.6, 
162.1, 145.8, 142.3, 139.5, 139.4, 132.1, 131.3, 131.3, 130.6, 129.2, 128.4, 128.2, 127.6, 
127.4, 119.4, 114.6, 55.6, 52.6; FTIR (NaCl, cm-1) 3055, 2987, 1723, 1662, 1599, 1572, 
1513, 1438, 1422, 1349, 1197, 1173, 1048, 1031, 983, 896, 828; HRMS (ESI+) m/z 
calculated for [M+Na]+ C24H20O4Na: 395.1254, found 395.1254. 
 
CN
O
Me OtBu
O
 
tert-Butyl 3-Acetyl-5-cyanobenzoate (6.49). Prepared by the general procedure 
described above and 8.1 mg (48%) was isolated as a colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 8.71 (s, 1H), 8.42 (s, 1H), 8.37 (s, 1H), 2.67 (s, 3H), 1.63 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 195.3, 163.0, 138.2, 136.8, 135.1, 134.1, 133.0, 117.4, 113.7, 83.4, 
28.2, 26.8; FTIR (NaCl, cm-1) 3055, 2986, 2931, 2238, 1721, 1698, 1639, 1552, 1422, 
1371, 1330, 1158, 1129, 978, 896, 844; HRMS (ESI+) m/z calculated for [M+Na]+ 
C14H15NO3Na: 268.0944, found 268.0943. 
 
8.7 Chapter 7 
8.7.1 Procedure for direct C–H trifluoromethylation of cyclic enaminones  
Pd(OAc)2 (10 mol%)/L4
PhI(OAc)2, CsF
TEMPO (0.5 equiv)
EtOAc, rt, 24 h
N
O
Bn
+ N
O
Bn CF3
TMSCF3
H
PMP PMP
 
N N
O O H
HH
H
L4  
In a 2-dram vial, cyclic enaminone (29.3 mg, 0.1 mmol), Pd(OAc)2 (2.3 mg, 0.01 mmol), 
PhI(OAc)2 (64.4 mg, 0.2 mmol), ligand L4 (5.0 mg, 0.015 mmol), and TEMPO (7.8 mg, 
0.05 mmol) were added. The vial was transferred to a glove box to add CsF (60.8 mg, 0.4 
mmol). Sequentially, TMSCF3 (59 µL, 0.4 mmol) and anhydrous EtOAc (1 mL) were 
added. After stirring at room temperature for 24 h, the reaction was diluted with EtOAc 
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(2 mL) and filtered through Celite. The filter cake was then washed with EtOAc (20 mL). 
The filtrate was concentrated under reduced pressure and purified by flash 
chromatography on silica gel.  
 
8.7.2 Compound characterization 
N
O
Bn CF3
PMP
 
(E)-1-Benzyl-2-(4-methoxyphenyl)-5-trifluoromethyl-2,3-dihydropyridin-4(1H)-one 
(7.4). Prepared by the general procedure described above and 24.3 mg (70%) was isolated 
as a yellow wax. 1H NMR (400 MHz, CDCl3) δ 7.73 (s, 1H), 7.38 (d, J = 4.5 Hz, 3H), 
7.17–7.07 (m, 4H), 6.89 (d, J = 8.1 Hz, 2H), 4.51 (t, J = 6.2 Hz, 1H), 4.44 (d, J = 15.0 
Hz, 1H), 4.26 (d, J = 14.9 Hz, 1H), 3.81 (s, 3H), 2.89 (dd, J = 16.6, 7.0 Hz, 1H), 2.69 (dd, 
J = 16.5, 5.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 185.4, 160.1, 152.6, 134.7, 129.4, 
129.3, 128.9, 128.3, 127.9, 114.8, 59.8, 58.2, 55.5, 43.4; 19F NMR (376 MHz, ) δ -60.87; 
FTIR (NaCl, cm-1) 3055, 2987, 1660, 1622, 1514, 1441, 1422, 1396, 1357, 1181, 1125, 
1034, 1017, 972, 935, 896; HRMS (ESI+) m/z calculated for [M+Na]+ C20H18F3NO2Na: 
384.1182, found 384.1178. 
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